
<html lang="en"     class="pb-page"  data-request-id="977c9a3f-d7da-4357-9afc-4cbceb4e0a51"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2021.64.issue-10;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.1c00542;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="X-ray Crystal Structure-Guided Design and Optimization of 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile Scaffold as a Potent and Orally Active Monopolar Spindle 1 Inhibitor" /></meta><meta name="dc.Creator" content="Younho  Lee" /></meta><meta name="dc.Creator" content="Hyunkyung  Kim" /></meta><meta name="dc.Creator" content="Haelee  Kim" /></meta><meta name="dc.Creator" content="Ha Yeon  Cho" /></meta><meta name="dc.Creator" content="Jun-Goo  Jee" /></meta><meta name="dc.Creator" content="Kyung-Ah  Seo" /></meta><meta name="dc.Creator" content="Jung Beom  Son" /></meta><meta name="dc.Creator" content="Eunhwa  Ko" /></meta><meta name="dc.Creator" content="Hwan Geun  Choi" /></meta><meta name="dc.Creator" content="Nam Doo  Kim" /></meta><meta name="dc.Creator" content="Ikyon  Kim" /></meta><meta name="dc.Description" content="Triple-negative breast cancer (TNBC) is an aggressive breast-cancer subtype associated with poor prognosis and high relapse rates. Monopolar spindle 1 kinase (MPS1) is an apical dual-specificity pr..." /></meta><meta name="Description" content="Triple-negative breast cancer (TNBC) is an aggressive breast-cancer subtype associated with poor prognosis and high relapse rates. Monopolar spindle 1 kinase (MPS1) is an apical dual-specificity pr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 4, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00542" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00542" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00542" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00542" /></link>
        
    
    

<title>X-ray Crystal Structure-Guided Design and Optimization of 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile Scaffold as a Potent and Orally Active Monopolar Spindle 1 Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00542" /></meta><meta property="og:title" content="X-ray Crystal Structure-Guided Design and Optimization of 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile Scaffold as a Potent and Orally Active Monopolar Spindle 1 Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0018.jpeg" /></meta><meta property="og:description" content="Triple-negative breast cancer (TNBC) is an aggressive breast-cancer subtype associated with poor prognosis and high relapse rates. Monopolar spindle 1 kinase (MPS1) is an apical dual-specificity protein kinase that is over-expressed in TNBC. We herein report a highly selective MPS1 inhibitor based on a 7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile scaffold. Our lead optimization was guided by key X-ray crystal structure analysis. In vivo evaluation of candidate (9) is shown to effectively mitigate human TNBC cell proliferation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00542"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00542">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00542&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00542&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00542&amp;href=/doi/10.1021/acs.jmedchem.1c00542" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 6985-6995</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00533" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00560" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">X-ray Crystal Structure-Guided Design and Optimization of 7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile Scaffold as a Potent and Orally Active Monopolar Spindle 1 Inhibitor</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Younho Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Younho Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, South Korea</div><div class="loa-info-affiliations-info">Voronoibio, S11 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Younho++Lee">Younho Lee</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4235-1269" title="Orcid link">http://orcid.org/0000-0002-4235-1269</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hyunkyung Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hyunkyung Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Voronoibio, S11 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</div><div class="loa-info-affiliations-info">Research Institute of Pharmaceutical Researches, College of Pharmacy, Kyungpook National University, Daegu 41566, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hyunkyung++Kim">Hyunkyung Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Haelee Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haelee Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">B2Sbio, S23 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haelee++Kim">Haelee Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ha Yeon Cho</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ha Yeon Cho</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">B2Sbio, S23 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ha+Yeon++Cho">Ha Yeon Cho</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jun-Goo Jee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jun-Goo Jee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research Institute of Pharmaceutical Researches, College of Pharmacy, Kyungpook National University, Daegu 41566, Republic of Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jun-Goo++Jee">Jun-Goo Jee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kyung-Ah Seo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kyung-Ah Seo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Voronoibio, S11 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kyung-Ah++Seo">Kyung-Ah Seo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jung Beom Son</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jung Beom Son</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Voronoibio, S11 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jung+Beom++Son">Jung Beom Son</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eunhwa Ko</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eunhwa Ko</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">B2Sbio, S23 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eunhwa++Ko">Eunhwa Ko</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hwan Geun Choi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hwan Geun Choi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">B2Sbio, S23 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hwan+Geun++Choi">Hwan Geun Choi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nam Doo Kim</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nam Doo Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Voronoibio, S11 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#3a545b575e55557a4c55485554555358535514595557"><span class="__cf_email__" data-cfemail="3b555a565f54547b4d54495455545259525415585456">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nam+Doo++Kim">Nam Doo Kim</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ikyon Kim</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ikyon Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, South Korea</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#cca5a7b5a3a2a7a5a18cb5a3a2bfa9a5e2adafe2a7be"><span class="__cf_email__" data-cfemail="11787a687e7f7a787c51687e7f6274783f70723f7a63">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ikyon++Kim">Ikyon Kim</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0849-5517" title="Orcid link">http://orcid.org/0000-0002-0849-5517</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00542&amp;href=/doi/10.1021%2Facs.jmedchem.1c00542" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 6985–6995</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 4, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 March 2021</li><li><span class="item_label"><b>Published</b> online</span>4 May 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00542" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00542</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6985%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYounho%2BLee%252C%2BHyunkyung%2BKim%252C%2BHaelee%2BKim%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D10%26contentID%3Dacs.jmedchem.1c00542%26title%3DX-ray%2BCrystal%2BStructure-Guided%2BDesign%2Band%2BOptimization%2Bof%2B7H-Pyrrolo%255B2%252C3-d%255Dpyrimidine-5-carbonitrile%2BScaffold%2Bas%2Ba%2BPotent%2Band%2BOrally%2BActive%2BMonopolar%2BSpindle%2B1%2BInhibitor%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6995%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00542"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1238</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00542" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;X-ray Crystal Structure-Guided Design and Optimization of 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile Scaffold as a Potent and Orally Active Monopolar Spindle 1 Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Younho&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Hyunkyung&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Haelee&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Ha&quot;,&quot;last_name&quot;:&quot;Yeon Cho&quot;},{&quot;first_name&quot;:&quot;Jun-Goo&quot;,&quot;last_name&quot;:&quot;Jee&quot;},{&quot;first_name&quot;:&quot;Kyung-Ah&quot;,&quot;last_name&quot;:&quot;Seo&quot;},{&quot;first_name&quot;:&quot;Jung&quot;,&quot;last_name&quot;:&quot;Beom Son&quot;},{&quot;first_name&quot;:&quot;Eunhwa&quot;,&quot;last_name&quot;:&quot;Ko&quot;},{&quot;first_name&quot;:&quot;Hwan&quot;,&quot;last_name&quot;:&quot;Geun Choi&quot;},{&quot;first_name&quot;:&quot;Nam&quot;,&quot;last_name&quot;:&quot;Doo Kim&quot;},{&quot;first_name&quot;:&quot;Ikyon&quot;,&quot;last_name&quot;:&quot;Kim&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;6985-6995&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00542&quot;},&quot;abstract&quot;:&quot;Triple-negative breast cancer (TNBC) is an aggressive breast-cancer subtype associated with poor prognosis and high relapse rates. Monopolar spindle 1 kinase (MPS1) is an apical dual-specificity protein kinase that is over-expressed in TNBC. We herein report a highly selective MPS1 inhibitor based on a 7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile scaffold. Our lead optimization was guided by key X-ray crystal structure analysis. In vivo evaluation of candidate (9) is shown to effectively mitigate human TNBC cell proliferation.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00542&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00542" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00542&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00542" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00542&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00542" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00542&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00542&amp;href=/doi/10.1021/acs.jmedchem.1c00542" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00542" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00542" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00542%26sid%3Dliteratum%253Aachs%26pmid%3D33942608%26genre%3Darticle%26aulast%3DLee%26date%3D2021%26atitle%3DX-ray%2BCrystal%2BStructure-Guided%2BDesign%2Band%2BOptimization%2Bof%2B7H-Pyrrolo%255B2%252C3-d%255Dpyrimidine-5-carbonitrile%2BScaffold%2Bas%2Ba%2BPotent%2Band%2BOrally%2BActive%2BMonopolar%2BSpindle%2B1%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D10%26spage%3D6985%26epage%3D6995%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292288" title="X-rays">X-rays</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291774" title="Nuclear magnetic resonance spectroscopy">Nuclear magnetic resonance spectroscopy</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/jmcmar.2021.64.issue-10/20210527/jmcmar.2021.64.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Triple-negative breast cancer (TNBC) is an aggressive breast-cancer subtype associated with poor prognosis and high relapse rates. Monopolar spindle 1 kinase (MPS1) is an apical dual-specificity protein kinase that is over-expressed in TNBC. We herein report a highly selective MPS1 inhibitor based on a 7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile scaffold. Our lead optimization was guided by key X-ray crystal structure analysis. <i>In vivo</i> evaluation of candidate (<b>9</b>) is shown to effectively mitigate human TNBC cell proliferation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Advanced breast cancers are associated with poor prognosis and high rates of cancer-related deaths. Recently, a CDK4/6 inhibitor, Palbociclib, gained FDA approval for advanced estrogen receptor-positive (ER+) breast cancer, validating cell-cycle kinases as a druggable target.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> One of the subtypes of advanced breast cancer is triple-negative breast cancer (TNBC), which is characterized by the absence of two receptors (estrogen and progesterone) and lack of the HER2 protein. TNBC accounts for 14% of breast cancers and is known to be one of the most aggressive subtypes of breast cancer.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Among the different cell cycle-regulating kinases, monopolar spindle kinase 1 (MPS1; TTK) was known to be a promising TNBC drug target.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The biological role of MPS1 is to enable proper attachment of chromosomes to the mitotic spindle during cell mitosis. The inhibition of MPS1 activity causes cell death by the premature mitotic exit. In TNBC, it is reported that high levels of MPS1 correlate with high tumor grade and poor patient outcomes.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Known MPS1 inhibitors which are currently undergoing clinical trials for treating TNBC include NMS-P153, BOS-172722, CFI-402257, BAY1161909, and BAY 1217389.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a></div><div class="NLM_p">Herein, we disclose a novel, orally active, selective, and potent MPS1 inhibitor for TNBC treatment. The reported compounds selectively inhibit MPS1 based on kinase profiling studies and effectively decrease phosphorylation of MPS1 and phospho-histone H3 signaling. Some of the compounds disclosed here are currently undergoing further preclinical studies.</div><div class="NLM_p last">Our starting chemical scaffold was the pyrrolopyrimidine heterocycle. Its analogues have displayed significant inhibitory activity for MPS1 kinase.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> Recently, 5-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine scaffold was used to prepare potent MPS1 inhibitors.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The optimized preclinical candidate has shown good activity in <i>in vitro</i> experiments and in the TNBC xenograft model. With these promising preliminary studies in mind, we decided to design a novel MPS1 inhibitor with an emphasis on exploiting binding information gathered from X-ray structural analysis. Our results are described in detail below.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Except for the aforementioned compounds in clinical trials, various chemical scaffolds were studied as MPS1 inhibitors.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Among them, 9<i>H</i>-purine compounds, MPI-0479605 (<b>1</b>), and reversine (<b>2</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) effectively inhibit the MPS1 enzyme. In the cellular environment, it was shown that these compounds induce chromosome missegregation.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Known purine-based MPS1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As MPS1 is an attractive target for cancer research, various protein–ligand binding structures are publicly available in the Protein Data Bank (PDB). Importantly, the X-ray crystal structures of <b>1</b> and <b>2</b> complexed with MPS1 have been disclosed (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N7V">5N7V</a>.pdb and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LJJ">5LJJ</a>.pdb). We started to develop MPS1 inhibitors based on MPS1–compound <b>1</b> complexed structure. In an X-ray crystal structure of <b>1</b> with the MPS1 enzyme, a water molecule was observed in between N-7 of the purine ring and the K553 residue of the ATP-binding pocket.</div><div class="NLM_p">While maintaining the similar purine scaffold of <b>1</b>, we hoped that the introduction of an additional functional group on the N-7 position could replace the water molecule and establish additional hydrogen-bonding interactions to amino acids, K553 and D664. In this line, compound <b>7</b> was first designed and we executed a docking simulation of <b>7</b> on the MPS1 enzyme (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf" class="ext-link">Supporting Information</a>). We were able to observe that the C-5 nitrile moiety positions itself in exactly the same place as the water molecule. We, therefore, rationalized that the nitrogen atom of the nitrile moiety could act as a surrogate of the water molecular bridge, undergoing a hydrogen bonding interaction with K553.</div><div class="NLM_p">With this rationale in mind, we synthesized a series of 7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitriles, as detailed in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. In addition, analogues having Cl, CF<sub>3</sub>, or H at the C-5 site were also prepared. The C-4 position of 2-(trimethylsilyl)ethoxymethyl (SEM)-protected dichloride compounds (<b>3</b>, <b>4</b>, <b>5</b>, and <b>6</b>) was functionalized with an appropriate amine in a base-mediated S<sub>N</sub>Ar reaction to give R<sup>2</sup>-amine compounds (<b>3a–3n</b>, <b>4a</b>, <b>5a</b>, and <b>6a</b>) (see the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf" class="ext-link">Supporting Information</a>). Buchwald–Hartwig amination was used to introduce a substituent at the C-2 position to furnish <b>7–30</b> SEM. Final deprotection of SEM was carried out by a two-step process, involving trifluoroacetic acid (TFA) treatment followed by base-mediated cleavage of the hemiacetal to afford the desired <b>7–30</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Scheme<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sup>2</sup>-amine, ethanol, DIPEA, 80 °C; (b) R<sup>1</sup>-amine, Pd<sub>2</sub>(dba)<sub>3</sub>, XPhos, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 100 °C; (c) TFA, DCM, NH<sub>4</sub>OH, and MeOH.</p></p></figure><div class="NLM_p">To study the binding possibility to the MPS1 enzyme, a fluorescence-based thermal shift assay was conducted for the synthesized compound and reference compound.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The thermal shift (Δ<i>T</i><sub>m</sub>) values were 16 °C for <b>1</b> and 15 °C for <b>7</b>. It has been confirmed that the synthesized compound can be combined with MPS1 kinase as much as the purine compound (<b>1</b>).</div><div class="NLM_p">To confirm the binding mode of <b>7</b>, we determined the X-ray cocrystal complex structure of <b>7</b> with MPS1, where the nitrile moiety interacts with the side chain of K553 and D664 residues through water-mediated hydrogen bonds. This is an unexpected result since we anticipated that the nitrile replaces the water molecule, thereby leading to direct interaction with the protein. Replacement of the crystal water by other functional groups (such as pyrazole, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AP2">5AP2</a>.pdb and carbonyl, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZEG">4ZEG</a>.pdb) has been known in the literature. In our study, we confirmed that the water-mediated hydrogen bond interaction could be important for activity through the nitrile group change (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p">In addition, <b>7</b> interacts with the backbone of the hinge region through three hydrogen bonding interactions, as shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. A cyclohexyl moiety of <b>7</b> has hydrophobic interaction with the side chain of M671 and P673 residues from the activation loop. This interaction stabilizes the activation loop, rendering an ordered conformation. It forms an antiparallel β-sheet with the P-loop and blocks substrate binding. This ordered activation loop was also observed in MPI-0479605-bound and the reversine-bound structures. We found that this hydrophobic interaction of substituents on the pyrimidine ring with the activation loop significantly affects the binding affinity through the synthesis of various derivatives and evaluation (late in this paper). The methyl pyrazole ring sits in between the side chain of I531 and the backbone of I607 residues, with hydrophobic interactions.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structure of MPS1 kinase with <b>7</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CIL">7CIL</a>). The compound has water-mediated hydrogen bonding interaction with K553 and D664. Compound <b>7</b> is shown with magenta carbon atoms. Selected amino acids that contact the ligands are shown with yellow carbon atoms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Through X-ray crystal complex structural analysis, additional binding interactions could be introduced, especially by varying the pyrazole ring of <b>7</b> to accept a hydrogen bond from adjacent hydrophilic residues such as K529, D608, or S611. Especially, the carbonyl functional group was introduced to have hydrogen bond interaction. We synthesized derivatives with various R<sup>1</sup> groups, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. To evaluate the binding affinity, the synthesized compounds were screened against the purified MPS1 kinase domain using a fluorescence-based thermal shift assay.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Additionally, the potency was evaluated by the MDA-MB-231 cell proliferation assay.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. C-2 Position SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0012.gif" alt="" id="GRAPHIC-d7e582-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0013.gif" alt="" id="gr11" /></img><div></div></div><div class="NLM_p">The rationale for the design of <b>8</b> is that carbonyl oxygen in the compound may have hydrogen binding interaction with S611 through proper bonding rotations (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf" class="ext-link">Supporting Information</a>). However, it is not consistent with the analysis of the X-ray cocrystal structure of <b>8</b> with MPS1 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Unfortunately, the desired interaction of the carbonyl group was not observed. However, the binding affinity of <b>8</b> was increased because of the hydrophobic interaction of the morpholine ring with the side chain of I531 (distance 3.7 Å). The carbonyl region of the compound <b>8</b> is rotatable, and morpholine of compound <b>8</b> (light-blue line in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) generated by the docking experiment does not overlap with the one from the X-ray cocrystal structure. This is because movement of the active loop with P673 was not predicted in the normal docking experiment. In the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N7V">5N7V</a>.pdb protein structure, the X-ray crystal structure used in the docking experiment, P673, may collide with the morpholine functional group, so the actual structure and the docking model seem to be different (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). However, in a protein structure such as <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WZJ">3WZJ</a>.pdb, where P673 was pushed and space was secured, it was confirmed that compound <b>8</b> was docked in the same form as the actual X-ray structure (data not shown). In the docking experiment using MPS1, the movement of the activation loop should be considered.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray cocrystal structure of compound <b>8</b> (white) with MPS1 kinase (yellow carbon color shows the interaction residues of the X-ray structure; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHM">7CHM</a>). The docking pose of <b>8</b> was different from the real X-ray structure (docking model of <b>8</b> and P673; light-blue line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We proposed that elongation of the amide by one C–C bond length at the solvent exposure region would be more advantageous in forming additional interaction with MPS1. Lactam analogue <b>9</b> increased thermal shift to 18 °C, indicating tighter binding affinity compared to <b>7</b> or <b>8</b>. The X-ray cocrystal structure of <b>9</b> to MPS1 confirmed additional water-mediated hydrogen bond interaction between the carbonyl moiety of the lactam with the backbone carbonyl oxygen of the N606 residue (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Moreover, the distance between the lactam ring and P673 residue are ideal to have hydrophobic interactions (distance 4.5 Å).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray cocrystal structure of <b>9</b> with MPS1 kinase (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHN">7CHN</a>). The cyclohexyl functional group interacts with activation loop including P673. Compound <b>9</b> is shown with carbon atoms in blue color, and yellow carbon color shows the interaction residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analysis results of the X-ray complex structure of <b>9</b> indicated that the pyrrolopyrimidine core along with the amide linker forms three hydrogen-bonding interactions with the amide backbone at the hinge region (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). A similar binding interaction of the water molecule which forms a bridge from 5-CN to K553 and D664 was initially expected to take place, as can be seen in the X-ray structure of <b>7</b> with MPS1. In the X-ray cocrystal structure of <b>9</b>, however, we could not observe this type of interaction (because of low resolution). Additionally, for <b>9</b>, the carbonyl oxygen of the lactam functional group interacts through a water molecule to the carbonyl oxygen of the backbone N606.</div><div class="NLM_p">Through the analysis of the X-ray complex structure, we observed an important interaction between our synthesized compound and ordered activation loop (Ala668-Thr675). This ordered activation loop was often seen in other X-ray complex structures (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AP1">5AP1</a>.pdb, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JS8">4JS8</a>.pdb, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J">4C4J</a>.pdb) and was especially similar to the one observed in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AP1">5AP1</a>.pdb, where the activation loop of T675, T676, and S677 was phosphorylated. This common phenomenon was explained with the conformation of the activation loop induced by compounds.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">In an X-ray cocrystal structure of <b>9</b>, the activation loop of the side chain of P673 was observed to form van der Waals interaction with cyclohexyl and the lactam at the distance 3.9–4.2 Å. The positioning of the cyclohexyl is approximately at the location of ATP’s ribose ring (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HMN">3HMN</a>.pdb).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> This region is originally inhabited by the side chain P673 of the activation loop. The cyclohexyl functional group had pushed the activation loop and its P673 side chain away and bound at this site. It has been reported that the MPS1 activation loop can fit into the ATP-binding pocket and interferes with ATP. Besides, the activation loop allowed potential conformational change when competitive inhibitors displace ATP.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Similarly, we believe that the activation loop was dynamically moved by the binding of our MPS1 inhibitors.</div><div class="NLM_p">For further optimization, several aniline derivatives with a different substituent at the C-2 position were synthesized while keeping the favorable lactam ring (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The methoxy group at the C-2 position of the aniline was found to be essential as replacement of the methoxy group of <b>9</b> by an ethoxy (<b>10</b>) or removal of the methoxy group (<b>11</b> and <b>12</b>), which led to the entire loss of binding affinity, as indicated by a decrease in the thermal shift values. When lactam was exchanged with bioisosteric morpholin-3-one to effect change in size and polarity at the solvent-exposure region, further loss in binding affinity was observed (<b>13</b>). In the cellular activity assay against the TNBC cell line, indicated compounds <b>8</b>, <b>9</b>, and <b>13</b> showed strong proliferation inhibitory activity.</div><div class="NLM_p">The structure–activity relationship (SAR) in varying the C-5 position of pyrrolopyrimidine was also explored by assaying compounds with −H, −Cl, and −CF<sub>3</sub> substituents, and the data are shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. The 5-H (<b>14</b>) and 5-CF<sub>3</sub> (<b>15</b>) derivatives revealed a significant loss of binding affinity, and cellular proliferation inhibitory activity was also decreased for 5-CN (<b>9</b>). Based on the aforementioned MPI-0479605 (<b>1</b>), we also prepared a series of analogues with a 3-methylphenyl-4-morpholine substituent at the C-2 position (<b>16</b>, <b>17</b>, and <b>18</b>) and measured their binding affinity. In these cases, pyrrolopyrimidine with a 5-CN substituent shows stronger binding interaction than those with 5-Cl or 5-CF<sub>3</sub> groups. This is due to the interaction between the −CN substituent and K553 and D664 of MPS1 through the water-molecule bridge, as mentioned in the cocrystal structure of <b>7</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. C-2 and C-5 Position SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0014.gif" alt="" id="GRAPHIC-d7e804-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0015.gif" alt="" id="gr12" /></img><div></div></div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, in order to establish a SAR with respect to the C-3 functional group, we prepared a series of compounds having another alkyl group instead of the cyclohexyl ring. When a small functional group such as methyl was introduced as in <b>19</b>, the thermal shift value was 7 °C. For compounds with moieties such as isopropyl (<b>20</b>) or isobutyl (<b>21</b>), thermal shift values increased to 14 °C and a further increase in bulk such as <i>sec</i>-butyl (<b>23</b>) resulted in an additional increase in binding affinity. However, the use of <i>n</i>-butyl (<b>22</b>) led to a decrease of the thermal shift value to 11 °C. Cyclobutyl and cyclopentyl analogues (<b>24</b> and <b>25</b>) had less binding affinity compared to the cyclohexyl analogue (<b>9</b>). A general trend of larger steric bulk leading to increased binding affinity was observed.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. C-3 Position SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0016.gif" alt="" id="GRAPHIC-d7e849-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0017.gif" alt="" id="gr13" /></img><div></div></div><div class="NLM_p">In addition, analogues of <b>26</b>, <b>27</b>, <b>28</b>, and <b>29</b> were found to have decreased binding affinity as that of <b>9</b>. The difference in binding affinity was induced by how much the chemical functional group binds to the binding pocket composed of the activation loop. <b>9</b> was structurally confirmed to bind tightly with the pocket consisting of the M671, Q672, and P673 residues (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). Although the methyl-cyclopentyl functional group of <b>28</b> has steric bulk similar to cyclohexyl, it cannot perfectly bind with the pocket (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). For any larger substituents, it is thought that the activation loop cannot effectively bind to the inhibitor or induces an energetically unstable change to the protein, resulting in a disordered activation loop.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray cocrystal structures of <b>9</b> (blue sphere; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHN">7CHN</a>) and <b>28</b> (green sphere; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CJA">7CJA</a>) with MPS1 kinase. (A) <b>9</b> can tightly bind with the MPS1 protein. (B) <b>28</b> could not occupy the whole pocket space made by the activation loop (white circle).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The thermal shift value of <b>30</b> possessing a pyran which is sterically comparable to a cyclohexyl indicated a decrease in binding affinity. It is shown that for effective hydrophobic interaction with P673, nonpolar substituents are favorable (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray cocrystal structure of <b>30</b> (whitish blue; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHT">7CHT</a>). The carbonyl functional group of the lactam interacts with K529 by hydrogen bonding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Sterically smaller-size compounds such as <b>19</b> have less influence on the activation loop, compared with complex <b>9</b>, as evident in the comparison of cocrystal structures of the two compounds (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). As can be seen from the X-ray complex structure of various inhibitors, the MPS1 activation loop is located in the ATP-binding pocket and changes shape, depending on which inhibitor binds. Substituents with less steric bulk than the cyclohexyl moiety cannot effectively push the activation loop away, which may hamper efficient binding with MPS1.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Superimposed crystal structure of the MPS1 proteins of <b>9</b> (green; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHN">7CHN</a>) and <b>19</b> (pink; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CLH">7CLH</a>). The position of activation loops differs depending on the compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In this study, we evaluated the compounds by thermal shift and cellular assay. The correlation of the thermal shift and real enzymatic inhibition assay was confirmed. However, it did not show a correlation between thermal shift and cellular activity (see <a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf" class="ext-link">Figure S1B</a>). The reason is thought to be that the nonoptimized compounds do not have proper properties such as cell permeability or solubility. Compound <b>16</b> with high binding affinity as indicated by the thermal shift value and compounds <b>8</b> and <b>9</b> with high cellular inhibitory activity in the MDA-MB-231 proliferation assay were selected and compared with the reference compound, CFI-402257, which is in clinical trials. For the enzyme inhibitory assay, three in-house compounds having nanomolar potency were used. Metabolic stability (MS) in the human microsome for these compounds revealed that higher than 50% of the compounds remained after 30 min. Pharmacokinetic (PK) studies in normal mice were carried out for the compounds. <b>8</b> and <b>9</b> had better exposure than <b>16</b> from the studies (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. <i>In Vitro</i> and PK Profiles of Compounds <b>8</b>, <b>9</b>, <b>16</b>, and CFI-402257<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="±">MPS1 enzyme IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="±">MDA-MB-231 GI<sub>90</sub> (nM)</th><th class="colsep0 rowsep0" align="center">MS (human) %</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center">AUC (h ng/mL)</th><th class="colsep0 rowsep0" align="center">BA (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="char" char="±">3.2 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">43 ± 3</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">995</td><td class="colsep0 rowsep0" align="left">3766</td><td class="colsep0 rowsep0" align="left">98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="char" char="±">6.4 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">37 ± 3</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">2225</td><td class="colsep0 rowsep0" align="left">6152</td><td class="colsep0 rowsep0" align="left">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="char" char="±">6.3 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">313 ± 10</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">749</td><td class="colsep0 rowsep0" align="left">1270</td><td class="colsep0 rowsep0" align="left">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CFI-402257</td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">20 ± 2</td><td class="colsep0 rowsep0" align="left">N.D.</td><td class="colsep0 rowsep0" align="left">N.D.</td><td class="colsep0 rowsep0" align="left">N.D.</td><td class="colsep0 rowsep0" align="left">N.D.</td><td class="colsep0 rowsep0" align="left">N.D.</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">PK; female ICR mice (<i>n</i> = 3), 10 mg/kg, PO. N.D.: not determined.</p></div></div></div><div class="NLM_p">Kinase profiling with <b>8</b> and <b>9</b> was conducted against 468 kinases in Eurofins. The results indicated that <b>9</b> has more kinase selectivity than <b>8</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf" class="ext-link">Supporting Information</a>). It was shown that a design strategy with more hydrogen bond interactions with the solvent exposure area leads to more kinase selectivity. The kinase profiling results confirmed the actual enzymatic activity of some kinases that are active (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf" class="ext-link">Table S4</a>). In these results, <b>9</b> has more activity on MPS1 than other kinases. However, it was confirmed that <b>9</b> is still active against proteins such as JNK. This part was approached in view of the fact that JNK inhibitors can act as sensitizers for the treatment of TNBC.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">Further experiments (CYP450, hERG, and MiniAMES) for <b>9</b> were conducted. There are no critical toxicity issues in these experiments (data not shown). As a result of the western blot experiment of <b>9</b>, it was confirmed that inhibition of MPS1 autophosphorylation and histone H3 phosphorylation such as CFI402257 occurred (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. MPS1 substrate phosphorylation inhibition after treatment with <b>9</b> and CFI402257.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, we have conducted <i>in vivo</i> studies with <b>9</b> due to having favorable <i>in vitro</i> and pharmacokinetic parameters. Paclitaxel was given once a week at a dosage of 12.5 mg/kg, and <b>9</b> was given daily at the dose 2 mg/kg. <b>9</b> displayed 57% tumor growth inhibition with no bodyweight loss. The mean body weight gain was 15.5% for the vehicle group and 7.6% for the <b>9</b> group (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). To determine the on-target toxicity of the compound <b>9</b>, morphology of the small intestine and villi length change were examined in xenograft mice. Fortunately, no specific toxicity in the intestine by <b>9</b> was observed (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf" class="ext-link">Figure S3</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf" class="ext-link">Table S7</a>).</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. MDA-MB-231 tumor xenograft studies with QD dosing of <b>9</b>, which is compared with paclitaxel (weekly once dose).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In conclusion, new pyrrolopyrimidine-based compounds were synthesized and evaluated as MPS1 inhibitors. The C5-position of the nitrile functional group of pyrrolopyrimidine compounds have shown good binding affinity. Structural optimization was guided by the analysis of X-ray cocrystal structures. The selected compound (<b>9</b>) shows proper <i>in vitro</i> activity, kinase selectivity, and good PK profiles. It also shows tumor growth inhibition in a xenograft model. From these optimization steps, <b>9</b> has currently advanced as a preclinical candidate.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Chemistry</h3><div class="NLM_p">All materials were obtained from commercial sources unless otherwise noted and used without further purification. Chromatography solvents were of the high-performance liquid chromatography (HPLC) grade. <sup>1</sup>H NMR spectra were obtained on 400 MHz spectrometers. Chemical shifts are relative to tetramethylsilane as the internal standard or relative to a residual solvent peak. Chemical shifts (δ) are reported in ppm, and coupling constants (<i>J</i>) are given in Hz. Purity of all compounds was confirmed by analysis using LCMS methods reported below.</div><div class="NLM_p">Method 1: instrument: Agilent 1200\G6110A; software: Agilent ChemStation Rev. B. 04.03[52]; column: Agilent ZORBAX 5 μm, SB-Aq, 2.1 × 50 mm; mobile phase: (A): 0.0375% TFA in water(v/v), (B): 0.01875% TFA in acetonitrile (v/v); gradient: 0.0 min 1% B–0.4 min 1% B–3.4 min 90% B–3.9 min 100% B–3.91 min 1% B–4.0 min 1% B–4.5 min 1% B; flow: 0.8 mL/min; column temperature: 50 °C; detector: DAD (220 & 254 nm)</div><div class="NLM_p">Method 2: instrument: Agilent 1200\G6110A; software: Agilent ChemStation Rev. B. 04.03[52]; column: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="83c8eaede6f7e6fbc3">[email protected]</a> 5 μm EVO C18 30 × 2.1 mm; mobile phase: (A): 0.0375% TFA in water (v/v), (B): 0.01875% TFA in acetonitrile (v/v); gradient: 0.01 min 5% B–0.8 min 95% B–1.2 min 95% B–1.21 min 5% B–1.5 min 5% B; flow: 1.5 mL/min; column temperature: 50 °C; detector: DAD (220 & 254 nm).</div><div class="NLM_p last">Method 3: instrument: ACQUITY UPLC H-Class Waters; software: MassLynx 4.1; column: ACQUITY UPLCBEH C18 2.1 × 50 mm, 1.7 μm; mobile phase: (A): 0.1% formic acid in water (v/v), (B): 0.1% formic acid in acetonitrile (v/v); gradient: 0.01 min 10% B–1.6 min 100% B–2.0 min 100% B–2.2 min 10% B–3.0 min 10% B; flow: 1.5 mL/min; column temperature: 30 °C; detector: PDA (200–400 nm).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General Procedure for the Synthesis of Compounds</h3><div class="NLM_p">To a solution of compound <b>3</b> (11.54 mmol) in EtOH (40 mL) were added cyclohexanamine (13.99 mmol) and DIPEA (3.76 g, 29.11 mmol, 5.07 mL). The mixture was stirred at 80 °C for 12 h. After cooling to 25 °C, the mixture was concentrated under reduced pressure. The residue was dissolved in EtOAc (50 mL) and washed with HCl aqueous solution (50 mL ×2, 1 N) and brine (50 mL). The organic layer was dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the compound <b>3h</b>. <b>3a–3n</b>, <b>4a</b>, <b>5a</b>, and <b>6a</b> were synthesized in a similar manner (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">To a solution of compound <b>3h</b> (0.4 mmol) in <i>sec</i>-butyl alcohol (4 mL) were added aniline (0.48 mmol), XPhos (23.84 mg, 0.025 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (22.89 mg, 0.025 mmol), and K<sub>2</sub>CO<sub>3</sub> (345 mg, 2.5 mmol). The reaction mixture was degassed and purged with N<sub>2</sub> three times, and then, the mixture was stirred at 100 °C for 2 h under a N<sub>2</sub> atmosphere. After cooling to 25 °C, the mixture was filtered and the filtrate was concentrated to give the crude compound <b>7-SEM</b> as a brown oil. The crude product was used for the next step without further purification.</div><div class="NLM_p">The compound <b>7-SEM</b> of the previous step was dissolved in TFA (1 mL) and stirred at 25 °C for 1 h. The mixture was concentrated to give the crude product. To the solution of this crude residue in EtOH (2 mL) was added NH<sub>3</sub>–H<sub>2</sub>O (1 mL), and then, the mixture was stirred at 60 °C for 1 h. After cooling to 25 °C, the solvent was removed under vacuum. The crude product was purified by prep-HPLC to give compound <b>7</b>. Compounds <b>8–30</b> were synthesized in a similar manner.</div><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> 4-(Cyclohexylamino)-2-((1-methyl-1<i>H</i>-pyrazol-4-yl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>7</b>)</h4><div class="NLM_p last">Yield 23.2 mg, 25.0% over final two steps. The purity is >95% by LCMS (method 3) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.04 (s, 1H), 8.86 (s, 1H), 7.81 (s, 1H), 7.78 (d, <i>J</i> = 2.4 Hz, 1H), 7.50 (s, 1H), 5.66 (s, 1H), 3.79 (s, 3H), 2.02 (s, 2H), 1.78–1.70 (m, 2H), 1.64–1.60 (m, 1H), 1.46–1.34 (m, 4H), 1.27–1.23 (m, 1H). MS (ESI) <i>m</i>/<i>z</i>: 337.3 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> 4-(Cyclohexylamino)-2-((2-methoxy-4-(morpholine-4-carbonyl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>8</b>)</h4><div class="NLM_p last">Yield 28.47 mg, 15.0% over final two steps. The purity is >95% by LCMS (method 2) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.52–11.80 (m, 1H), 8.69–8.40 (m, 1H), 7.93–7.83 (m, 1H), 7.62–7.53 (m, 1H), 7.08–7.04 (m, 1H), 7.03–6.95 (m, 1H), 5.98–5.72 (m, 1H), 4.14–4.01 (m, 1H), 3.98–3.85 (m, 3H), 3.66–3.58 (m, 4H), 3.57–3.43 (m, 4H), 2.08–1.93 (m, 2H), 1.83–1.69 (m, 2H), 1.68–1.56 (m, 1H), 1.49–1.35 (m, 4H), 1.33–1.08 (m, 1H). MS (ESI) <i>m</i>/<i>z</i>: 476.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 4-(Cyclohexylamino)-2-((2-methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>9</b>)</h4><div class="NLM_p last">Yield 25.88 mg, 14.5% over final two steps. The purity is >95% by LCMS (method 3) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.18 (br s, 1H), 8.32 (d, <i>J</i> = 8.8 Hz, 1H), 7.84 (s, 1H), 7.49 (d, <i>J</i> = 2.3 Hz, 1H), 7.43 (s, 1H), 7.05 (dd, <i>J</i> = 2.3, 8.9 Hz, 1H), 5.71 (d, <i>J</i> = 7.7 Hz, 1H), 4.11–4.01 (m, 1H), 3.87 (s, 3H), 3.86–3.82 (m, 2H), 2.47 (s, 2H), 2.11–2.04 (m, 2H), 2.01 (br dd, <i>J</i> = 5.2, 7.8 Hz, 2H), 1.80–1.69 (m, 2H), 1.62 (br d, <i>J</i> = 11.7 Hz, 1H), 1.48–1.36 (m, 4H), 1.32–1.22 (m, 1H). MS (ESI) <i>m</i>/<i>z</i>: 446.3 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 4-(Cyclohexylamino)-2-((2-ethoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>10</b>)</h4><div class="NLM_p last">Yield 27.12 mg, 18.2% over final two steps. The purity is >95% by LCMS (method 3) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.17 (s, 1H), 8.36 (d, <i>J</i> = 8.8 Hz, 1H), 7.84 (s, 1H), 7.49 (d, <i>J</i> = 2.3 Hz, 1H), 7.39 (s, 1H), 7.03 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 5.78–5.73 (m, 1H), 4.12 (q, <i>J</i> = 6.9 Hz, 2H), 3.83 (t, <i>J</i> = 7.0 Hz, 2H), 2.47 (d, <i>J</i> = 8.0 Hz, 2H), 2.06 (d, <i>J</i> = 7.5 Hz, 2H), 2.03 (d, <i>J</i> = 7.9 Hz, 2H), 1.74 (s, 2H), 1.62 (d, <i>J</i> = 12.7 Hz, 1H), 1.41 (s, 2H), 1.40 (s, 3H), 1.38 (s, 2H), 1.23 (s, 1H). MS (ESI) <i>m</i>/<i>z</i>: 460.3 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 4-(Cyclohexylamino)-2-((4-(2-oxopyrrolidin-1-yl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>11</b>)</h4><div class="NLM_p last">Yield 19.57 mg, 19.0% over final two steps. The purity is >95% by LCMS (method 3) analysis. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.76 (d, <i>J</i> = 9.0 Hz, 2H), 7.53 (s, 1H), 7.45 (d, <i>J</i> = 9.0 Hz, 2H), 4.22–4.11 (m, 1H), 3.91 (t, <i>J</i> = 7.1 Hz, 2H), 2.59 (t, <i>J</i> = 8.1 Hz, 2H), 2.25–2.08 (m, 5H), 1.87–1.77 (m, 2H), 1.69 (d, <i>J</i> = 12.6 Hz, 1H), 1.54–1.32 (m, 4H). MS (ESI) <i>m</i>/<i>z</i>: 416.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 4-(Cyclohexylamino)-2-((5-(2-oxopyrrolidin-1-yl)pyridin-2-yl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>12</b>)</h4><div class="NLM_p last">Yield 21.72 mg, 16.1% over final two steps. The purity is >95% by LCMS (method 3) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.15 (s, 1H), 9.05 (s, 1H), 8.47 (d, <i>J</i> = 2.7 Hz, 1H), 8.35 (d, <i>J</i> = 9.1 Hz, 1H), 8.03–7.98 (m, 1H), 7.88 (s, 1H), 5.79 (d, <i>J</i> = 7.6 Hz, 1H), 3.85 (t, <i>J</i> = 7.0 Hz, 2H), 2.46 (s, 2H), 2.13–2.06 (m, 2H), 2.03 (s, 2H), 1.74 (s, 2H), 1.63 (d, <i>J</i> = 12.7 Hz, 1H), 1.40 (d, <i>J</i> = 10.1 Hz, 4H), 1.24 (s, 1H). MS (ESI) <i>m</i>/<i>z</i>: 417.3 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 4-(Cyclohexylamino)-2-((2-methoxy-4-(3-oxomorpholino)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>13</b>)</h4><div class="NLM_p last">Yield 25.17 mg, 16.2% over final two steps. The purity is >95% by LCMS (method 3) analysis. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.66 (d, <i>J</i> = 8.6 Hz, 1H), 7.57 (s, 1H), 7.00 (d, <i>J</i> = 2.3 Hz, 1H), 6.89 (dd, <i>J</i> = 2.3, 8.7 Hz, 1H), 4.28 (s, 2H), 4.21–4.09 (m, 1H), 4.05 (dd, <i>J</i> = 4.2, 5.9 Hz, 2H), 3.96 (s, 3H), 3.78 (dd, <i>J</i> = 4.2, 6.0 Hz, 2H), 2.19–2.08 (m, 2H), 1.90–1.78 (m, 3H), 1.76–1.64 (m, 1H), 1.59–1.35 (m, 4H). MS (ESI) <i>m</i>/<i>z</i>: 462.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 1-(4-((4-(Cyclohexylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-3-methoxyphenyl)pyrrolidin-2-one (<b>14</b>)</h4><div class="NLM_p last">Yield 50.56 mg, 23.7% over final two steps. The purity is >95% by LCMS (method 2) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.97–11.71 (m, 1H), 8.91–8.75 (m, 1H), 8.68–8.43 (m, 1H), 8.24–8.08 (m, 1H), 7.57 (d, <i>J</i> = 2.1 Hz, 1H), 7.14 (dd, <i>J</i> = 2.1, 8.9 Hz, 1H), 6.98 (br s, 1H), 6.69 (br s, 1H), 3.92 (br s, 1H), 3.89 (s, 3H), 3.87–3.83 (m, 2H), 2.53 (s, 2H), 2.12–2.04 (m, 2H), 1.99 (br s, 2H), 1.81 (br d, <i>J</i> = 4.8 Hz, 2H), 1.67 (br d, <i>J</i> = 12.0 Hz, 1H), 1.48–1.28 (m, 4H), 1.26–1.10 (m, 1H). MS (ESI) <i>m</i>/<i>z</i>: 421.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 1-(4-((4-(Cyclohexylamino)-5-(trifluoromethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)-3-methoxyphenyl)pyrrolidin-2-one (<b>15</b>)</h4><div class="NLM_p last">Yield 15.57 mg, 7.7% over final two steps. The purity is >95% by LCMS (method 2) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.92 (br d, <i>J</i> = 1.2 Hz, 1H), 8.35 (d, <i>J</i> = 8.8 Hz, 1H), 7.55 (s, 1H), 7.49 (d, <i>J</i> = 2.2 Hz, 1H), 7.39 (s, 1H), 7.04 (dd, <i>J</i> = 2.3, 8.8 Hz, 1H), 5.13 (br d, <i>J</i> = 6.5 Hz, 1H), 4.21–4.01 (m, 1H), 3.94–3.74 (m, 5H), 2.46 (br s, 2H), 2.12–1.94 (m, 4H), 1.69 (br dd, <i>J</i> = 3.8, 8.7 Hz, 2H), 1.59 (br dd, <i>J</i> = 3.7, 8.6 Hz, 1H), 1.48–1.25 (m, 5H). MS (ESI) <i>m</i>/<i>z</i>: 489.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 4-(Cyclohexylamino)-2-((2-methyl-4-morpholinophenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>16</b>)</h4><div class="NLM_p last">Yield 21.3 mg, 13.2% over final two steps. The purity is >95% by LCMS (method 3) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.87 (s, 1H), 7.70 (s, 1H), 7.26 (d, <i>J</i> = 8.6 Hz, 1H), 6.78 (d, <i>J</i> = 2.6 Hz, 1H), 6.72 (dd, <i>J</i> = 8.6, 2.7 Hz, 1H), 5.45 (d, <i>J</i> = 7.8 Hz, 1H), 4.00 (s, 1H), 3.77–3.70 (m, 4H), 3.07–3.02 (m, 4H), 2.16 (s, 3H), 1.94 (s, 2H), 1.70 (s, 2H), 1.58 (d, <i>J</i> = 11.2 Hz, 1H), 1.38–1.20 (m, 5H). MS (ESI) <i>m</i>/<i>z</i>: 432.3 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 5-Chloro-N4-cyclohexyl-N2-(2-methyl-4-morpholinophenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-2,4-diamine (<b>17</b>)</h4><div class="NLM_p last">Yield 22.45 mg, 16.1% over final two steps. The purity is >95% by LCMS (method 3) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.14 (s, 1H), 7.66 (s, 1H), 7.31 (d, <i>J</i> = 8.7 Hz, 1H), 6.82 (s, 1H), 6.77 (d, <i>J</i> = 2.5 Hz, 1H), 6.71 (dd, <i>J</i> = 8.7, 2.7 Hz, 1H), 5.64 (d, <i>J</i> = 8.0 Hz, 1H), 4.02 (s, 1H), 3.77–3.70 (m, 4H), 3.08–3.01 (m, 4H), 2.16 (s, 3H), 1.93 (s, 2H), 1.71 (s, 2H), 1.59 (d, <i>J</i> = 11.7 Hz, 1H), 1.39–1.17 (m, 5H). MS (ESI) <i>m</i>/<i>z</i>: 441.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> N4-Cyclohexyl-N2-(2-methyl-4-morpholinophenyl)-5-(trifluoromethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-2,4-diamine (<b>18</b>)</h4><div class="NLM_p last">Yield 25.30 mg, 13.2% over final two steps. The purity is >95% by LCMS (method 3) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.72 (s, 1H), 7.83 (s, 1H), 7.40 (s, 1H), 7.28 (d, <i>J</i> = 8.7 Hz, 1H), 6.78 (d, <i>J</i> = 2.6 Hz, 1H), 6.72 (dd, <i>J</i> = 8.7, 2.7 Hz, 1H), 4.97 (d, <i>J</i> = 5.9 Hz, 1H), 4.03 (d, <i>J</i> = 7.0 Hz, 1H), 3.78–3.71 (m, 4H), 3.09–3.01 (m, 4H), 2.17 (s, 3H), 1.93 (d, <i>J</i> = 11.1 Hz, 2H), 1.66 (d, <i>J</i> = 4.9 Hz, 2H), 1.56 (d, <i>J</i> = 7.5 Hz, 1H), 1.39–1.24 (m, 5H). MS (ESI) <i>m</i>/<i>z</i>: 475.4 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-((2-Methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-4-(methylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>19</b>)</h4><div class="NLM_p last">Yield 10.43 mg, 6.9% over final two steps. The purity is >95% by LCMS (method 2) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.31 (br s, 1H), 8.34 (d, <i>J</i> = 8.8 Hz, 1H), 7.87 (s, 1H), 7.72 (br s, 1H), 7.53 (d, <i>J</i> = 2.2 Hz, 1H), 7.07 (dd, <i>J</i> = 2.3, 8.9 Hz, 1H), 6.71 (br s, 1H), 3.93–3.81 (m, 5H), 3.02 (d, <i>J</i> = 3.5 Hz, 3H), 2.11–2.03 (m, 2H). MS (ESI) <i>m</i>/<i>z</i>: 378.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4-(Isopropylamino)-2-((2-methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>20</b>)</h4><div class="NLM_p last">Yield 26.72 mg, 16.2% over final two steps. The purity is >95% by LCMS (method 2) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.29 (br s, 1H), 8.29 (d, <i>J</i> = 8.7 Hz, 1H), 7.87 (s, 1H), 7.68 (br s, 1H), 7.53 (d, <i>J</i> = 2.3 Hz, 1H), 7.07 (dd, <i>J</i> = 2.3, 8.8 Hz, 1H), 5.98 (br s, 1H), 4.37–4.30 (m, 1H), 3.93–3.80 (m, 5H), 2.48 (s, 2H), 2.11–2.03 (m, 2H). MS (ESI) <i>m</i>/<i>z</i>: 406.1 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-(Isobutylamino)-2-((2-methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>21</b>)</h4><div class="NLM_p last">Yield 46.29 mg, 27.6% over final two steps. The purity is >95% by LCMS (method 2) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.33 (br s, 1H), 8.27 (d, <i>J</i> = 8.8 Hz, 1H), 7.88 (s, 1H), 7.78 (br s, 1H), 7.52 (d, <i>J</i> = 2.3 Hz, 1H), 7.07 (dd, <i>J</i> = 2.3, 8.8 Hz, 1H), 6.56 (br s, 1H), 3.88–3.83 (m, 4H), 3.37 (t, <i>J</i> = 6.3 Hz, 2H), 2.48 (s, 2H), 2.11–1.95 (m, 3H), 0.96 (d, <i>J</i> = 6.7 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i>: 420.1 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-(Butylamino)-2-((2-methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>22</b>)</h4><div class="NLM_p last">Yield 28.27 mg, 16.9% over final two steps. The purity is >95% by LCMS (method 2) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.18 (br s, 1H), 8.34 (d, <i>J</i> = 8.8 Hz, 1H), 7.84 (s, 1H), 7.50 (d, <i>J</i> = 2.3 Hz, 1H), 7.41 (s, 1H), 7.04 (dd, <i>J</i> = 2.3, 8.8 Hz, 1H), 6.27 (t, <i>J</i> = 5.6 Hz, 1H), 3.92–3.77 (m, 5H), 3.51 (m, 2H), 2.49–2.45 (m, 2H), 2.07 (m, 2H), 1.63 (m, 2H), 1.47–1.29 (m, 2H), 0.94 (t, <i>J</i> = 7.4 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i>: 420.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>S</i>)-4-(<i>sec</i>-Butylamino)-2-((2-methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>23</b>)</h4><div class="NLM_p last">Yield 23.67 mg, 14.1% over final two steps. The purity is >95% by LCMS (method 1) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.20 (br s, 1H), 8.32 (d, <i>J</i> = 8.8 Hz, 1H), 7.84 (s, 1H), 7.51 (d, <i>J</i> = 2.3 Hz, 1H), 7.43 (s, 1H), 7.05 (dd, <i>J</i> = 2.3, 8.8 Hz, 1H), 5.64 (br d, <i>J</i> = 8.0 Hz, 1H), 4.25–4.15 (m, 1H), 3.88–3.82 (m, 5H), 2.49–2.39 (m, 2H), 2.10–2.00 (m, 2H), 1.71–1.54 (m, 2H), 1.25 (d, <i>J</i> = 6.5 Hz, 3H), 0.94 (t, <i>J</i> = 7.4 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i>: 420.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-(Cyclobutylamino)-2-((2-methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>24</b>)</h4><div class="NLM_p last">Yield 14.46 mg, 11.8% over final two steps. The purity is >95% by LCMS (method 1) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.46 (d, <i>J</i> = 8.8 Hz, 1H), 7.75 (s, 1H), 7.50 (d, <i>J</i> = 2.3 Hz, 1H), 7.29 (s, 1H), 7.04 (dd, <i>J</i> = 2.3, 8.9 Hz, 1H), 6.02 (br d, <i>J</i> = 6.7 Hz, 1H), 4.67–4.57 (m, 1H), 3.89–3.83 (m, 5H), 2.50–2.46 (m, 3H), 2.39–2.32 (m, 2H), 2.10–2.01 (m, 4H), 1.78–1.70 (m, 2H). MS (ESI) <i>m</i>/<i>z</i>: 418.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-(Cyclopentylamino)-2-((2-methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>25</b>)</h4><div class="NLM_p last">Yield 29.51 mg, 17.1% over final two steps. The purity is >95% by LCMS (method 1) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.19 (br s, 1H), 8.35 (d, <i>J</i> = 8.8 Hz, 1H), 7.84 (s, 1H), 7.51 (d, <i>J</i> = 2.2 Hz, 1H), 7.44 (s, 1H), 7.05 (dd, <i>J</i> = 2.3, 8.8 Hz, 1H), 5.86 (d, <i>J</i> = 7.1 Hz, 1H), 4.51–4.38 (m, 1H), 3.87 (s, 3H), 3.86–3.82 (m, 2H), 2.49–2.44 (m, 2H), 2.10–2.01 (m, 4H), 1.80–1.69 (m, 2H), 1.67–1.49 (m, 4H). MS (ESI) <i>m</i>/<i>z</i>: 432.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4-((Cyclobutylmethyl)amino)-2-((2-methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>26</b>)</h4><div class="NLM_p last">Yield 12.77 mg, 7.4% over final two steps. The purity is >95% by LCMS (method 1) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.33–12.01 (m, 1H), 8.33 (d, <i>J</i> = 8.8 Hz, 1H), 7.84 (s, 1H), 7.50 (d, <i>J</i> = 2.3 Hz, 1H), 7.42 (s, 1H), 7.04 (dd, <i>J</i> = 2.3, 8.9 Hz, 1H), 6.19 (t, <i>J</i> = 5.6 Hz, 1H), 3.92–3.80 (m, 5H), 3.63–3.53 (m, 2H), 2.74–2.65 (m, 1H), 2.49–2.44 (m, 2H), 2.11–2.01 (m, 4H), 1.92–1.71 (m, 4H). MS (ESI) <i>m</i>/<i>z</i>: 432.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-((2-Methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-4-(neopentylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>27</b>)</h4><div class="NLM_p last">Yield 23.11 mg, 16.3% over final two steps. The purity is >95% by LCMS (method 3) analysis. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.56 (d, <i>J</i> = 8.8 Hz, 1H), 7.57 (s, 1H), 7.41 (d, <i>J</i> = 2.3 Hz, 1H), 6.99 (dd, <i>J</i> = 2.4, 8.9 Hz, 1H), 3.94 (d, <i>J</i> = 5.1 Hz, 5H), 3.49 (s, 2H), 2.60 (t, <i>J</i> = 8.1 Hz, 2H), 2.20 (td, <i>J</i> = 6.8, 8.0 Hz, 2H), 1.04 (s, 9H). MS (ESI) <i>m</i>/<i>z</i>: 434.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-((Cyclopentylmethyl)amino)-2-((2-methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>28</b>)</h4><div class="NLM_p last">Yield 15.69 mg, 8.8% over final two steps. The purity is >95% by LCMS (method 2) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.20 (s, 1H), 8.33 (d, <i>J</i> = 8.8 Hz, 1H), 7.84 (s, 1H), 7.50 (d, <i>J</i> = 2.3 Hz, 1H), 7.42 (s, 1H), 7.04 (dd, <i>J</i> = 2.3, 8.8 Hz, 1H), 6.20 (t, <i>J</i> = 5.6 Hz, 1H), 3.91–3.79 (m, 5H), 3.47–3.44 (m, 2H), 2.49–2.47 (m, 2H), 2.37–2.20 (m, 1H), 2.06 (m, 2H), 1.81–1.69 (m, 2H), 1.69–1.61 (m, 2H), 1.58–1.46 (m, 2H), 1.41–1.21 (m, 2H). MS (ESI) <i>m</i>/<i>z</i>: 446.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 4-((1-Methoxy-2-methylpropan-2-yl)amino)-2-((2-methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>29</b>)</h4><div class="NLM_p last">Yield 21.35 mg, 11.9% over final two steps. The purity is >95% by LCMS (method 1) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.20 (br s, 1H), 8.13 (d, <i>J</i> = 8.8 Hz, 1H), 7.82 (s, 1H), 7.58–7.44 (m, 2H), 7.06 (dd, <i>J</i> = 2.3, 8.8 Hz, 1H), 5.73 (s, 1H), 3.89–3.81 (m, 5H), 3.48 (s, 2H), 3.34 (s, 3H), 2.11–2.00 (m, 2H), 1.47 (s, 6H). MS (ESI) <i>m</i>/<i>z</i>: 450.2 (M + H)<sup>+</sup>.</div></div><div id="sec3_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-((2-Methoxy-4-(2-oxopyrrolidin-1-yl)phenyl)amino)-4-((tetrahydro-2<i>H</i>-pyran-4-yl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>30</b>)</h4><div class="NLM_p last">Yield 12.16 mg, 6.8% over final two steps. The purity is >95% by LCMS (method 2) analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.13 (br s, 1H), 8.21 (d, <i>J</i> = 8.8 Hz, 1H), 7.78 (s, 1H), 7.43 (d, <i>J</i> = 2.4 Hz, 1H), 7.39 (s, 1H), 6.97 (dd, <i>J</i> = 2.3, 8.8 Hz, 1H), 5.88 (d, <i>J</i> = 7.4 Hz, 1H), 4.29–4.08 (m, 1H), 3.87–3.80 (m, 2H), 3.80–3.75 (m, 5H), 3.40 (dt, <i>J</i> = 1.9, 11.4 Hz, 2H), 2.46 (br d, <i>J</i> = 1.9 Hz, 2H), 2.06–1.94 (m, 2H), 1.90 (br dd, <i>J</i> = 2.2, 12.3 Hz, 2H), 1.61–1.47 (m, 2H). MS (ESI) <i>m</i>/<i>z</i>: 448.2 (M + H)<sup>+</sup>.</div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>In Vitro</i> Kinase Selectivity Profiling</h3><div class="NLM_p last">The kinase selectivity profiles of <b>8</b> and <b>9</b> were assessed at 1 μM against 468 kinases at Eurofins.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Kinase Enzyme Assay</h3><div class="NLM_p last">Assay kits from Promega Corporation were used according to instructions and adapted as outlined in the results. Test compounds were generally prepared with 1:3 serial dilutions for 12 concentrations (from 50 μM to 0.01 nM) in ATP competition experiments. The kinase reaction was performed with kinase reaction buffer (40 mM Tris base pH 7.4, 20 mM MgCl<sub>2</sub>, 0.5 mM dithiothreitol), 0.1 mg/mL bovine serum albumin, distilled H<sub>2</sub>O). The reaction mixtures contained pure ATP solution (50 μM), the specific substrate (0.2 μg), and human TTK kinase (7.5 ng) in a total assay volume of 5 μL as per the manufacturer’s protocol. In brief, the kinase reactions were started by addition of ATP, incubated for 4 h at 25 °C, and then stopped by adding 5 μL of ADP Glo Reagent. After incubation at room temperature in the dark for 40 min, 10 μL of the kinase detection reagent was added per well and incubated for 10 min reaction. Luminescence was measured using an SynergyNEO2 plate reader (BioTek) with an integration time of 1 s per well. Positive and negative controls were performed in 0.5% dimethyl sulfoxide (DMSO) in the presence and absence of TTK kinases. Curve fitting and data presentations were performed GraphPad Prism 8.3.0. (GraphPad Software, Inc.). All experiments were performed in triplicate.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Western Blot Analysis</h3><div class="NLM_p last">Cells were rinsed with phosphate-buffered saline and lysed directly with RIPA lysis buffer (Biosesang). Total protein lysates were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to nitrocellulose membranes, and subjected to western blot analysis. The protein was then transferred and blotted with primary antibodies. Primary antibodies used were as follows: phospho-TTK1 T33/S36 (Invitrogen, # 44–1325) and TTK1 (CST: #3255), phosphohistone H3 S10 (CST, #9701) antirabbit IgG, and HRP-linked antibody (CST: #7074).</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Cellular Proliferation Dose–response Assays</h3><div class="NLM_p last">MDA-MB-231 human breast cancer cell lines were obtained from the ATCC. Cells were propagated under the suggested growth conditions in a humidified 37 °C incubator. Cells were plated at a density of 1500 cells per well into 96-well plates in triplicate and treated with serial drug dilutions. After 5 d of treatment, CellTiter-Glo reagent was added to each well, and the luminescence was measured on the SynergyNeo (BioTek) plate reader. The percent inhibition at each compound concentration was determined by normalizing data to the DMSO control values for each set wells. All experiments were performed in triplicate.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Cloning and Expression</h3><div class="NLM_p last">The kinase domain of human MPS1 was expressed in <i>Escherichia coli</i>. In brief, a segment of MPS1 spanning residues 515–795 of the human MPS1 was cloned into a pET28a expression vector, in which the thrombin recognition sequence following the hexa histidine tag was present. To increase yield of soluble MPS1, we coexpressed MPS1 with λ phosphatase, which was cloned into the <i>E. coli</i> expression vector pCDFDuet-1. <i>E. coli</i> strain BL21-DE3 codon plus cells were cotransformed with 0.5 μL of the 515–795 MPS1 plasmid and 0.5 μL of λ phosphatase-pCDF duet plasmid via heat shock. Cells were grown to OD600 of 0.5 in LB medium containing 50 μg/mL kanamycin and 50 μg/mL streptomycin at 37 °C, at which point the temperature was reduced to 18 °C. Protein expression was induced with 0.2 mM isopropyl β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside and continued at 18 °C for 21 h. Cells were harvested by spinning at 5000<i>g</i> for 15 min. Bacterial pellets were frozen at −80 °C.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Protein Purification</h3><div class="NLM_p last">Protein purification was carried out at 4 °C. The expressed protein was purified by affinity chromatography using an Ni-NTA column (Qiagen). The recombinant protein was digested using thrombin at 4 °C. After complete digestion, the hexa-His tag was removed using an Ni-NTA column. Gel filtration was performed with a HiLoad 16/600 Superdex 200 pg column equilibrated with 50 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM dithiothreitol (DTT), and the fractions containing MPS1 protein were collected and concentrated to 11.8 mg/mL and frozen in small aliquots at −80 °C for crystallization screening.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Thermal Shift Assays</h3><div class="NLM_p last">Thermal shift assays were carried out using a reverse transcriptase polymerase chain reaction in a 96-well plate format. The samples were heated from 25 to 90 °C while measuring the fluorescence intensity of the dye. Melting curves were obtained for MPS1 at a protein concentration of 4 μM with 5× SYPRO orange using buffer containing 50 mM HEPES pH 7.5, 150 mM NaCl, and 5 mM DTT. To protect samples from evaporation, they were covered with MicroAmp optical adhesive film. MPS1 was measured in the presence or absence of 12.5 μM ligand.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Crystallization and Structure Determination</h3><div class="NLM_p">For inhibitor complex formation with MPS1 (515–795), frozen aliquots of MPS1 were thawed and the inhibitor was added from 10 mM DMSO stock solution to a final concentration of 1 mM. The mix was incubated for 2 h at 4 °C. Crystals were grown at 21 °C using the sitting-drop vapor diffusion method. For the structures of MPS1 with compounds, drops were made form 1 μL of mixed protein and 1 μL of reservoir solution (7–9% PEG 10,000, 0.08–0.14 M magnesium acetate, 0.1 M MES pH 6.0). Crystals grew within 2–3 days. The cryobuffer consisted of 20% glycerol.</div><div class="NLM_p last">X-ray diffraction data were collected using beamline 5C at the Pohang Accelerator Laboratory (PAL) in Korea. The crystals of MPS1-compounds belonged to space groups <i>I</i>222. The data sets were processed using the HKL2000 program. The structures were determined by the molecular replacement method, based on MPS1 in complex with the inhibitor (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B4W">6B4W</a>) using the program phenix.phaser. Model building and structure refinement were carried out using COOT and phenix.refine, respectively. Data collection and model statistics are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf" class="ext-link">Table S6</a>. The final models were deposited in the worldwide PDB under their respective ID codes (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Computational Methods and Modeling</h3><div class="NLM_p last">Molecular docking was studied using Maestro (Schrödinger Release 2019–1). The MPS1 structure was prepared from the PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N7V">5N7V</a>. The MPS1 X-ray crystal structure was prepared by removing all water and hydrogen assignments at pH 7.0 with the Protein Preparation Wizard module. The compounds were minimized by using the conjugate gradient algorithm and the OPLS2005 force field with the Minimization module in Maestro. The receptor grid was generated, and ligand docking was accomplished with the Glide module.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Animal Efficacy Studies</h3><div class="NLM_p">All animal studies were performed under protocols approved by Qu-Best Bio Co., Ltd. which is a clinical research organization in the Republic of Korea. They were reviewed and approved by the IACUC (Institutional Animal Care and Use Committee) of Qu-Best Bio Co., Ltd. Non-Clinical Evaluation Center (approval no: QBIACUC-A19027). Animals were acclimatized to the animal housing facility for a period of 14 days prior to the beginning of the experiment. Female 5-weeks old Athymic nude (severe combined immunodeficiency) (ENVIGO RMS, France) mice were housed in a barrier facility in microisolator cages. Mice were fed with Purina Rodent Chow 38057 diet and autoclaved water ad libitum and maintained on a 12 h light/dark cycle.</div><div class="NLM_p last">Athymic nude mice were inoculated subcutaneously with 5 × 10<sup>6</sup> MDA-MB-231 breast cells. Tumor volumes were determined prior to the initiation of treatment and considered as the starting volumes. Tumors were measured twice a week for the duration of the study. The long and short axes of each tumor were measured using an electric caliper (Mitutoyo Corp., Model no: CD-15CPX, Japan) in millimeters. The tumor volumes were calculated using the formula width<sup>2</sup> × length/2. The tumor volumes were expressed in cubic millimeters (mm<sup>3</sup>). Data are expressed as tumor volume means ± standard error of the mean (SEM). Statistical analysis included one-way ANOVA, and differences were compared versus the control group by a pairwise comparison procedure using GraphPad Prism 8.3.0.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00542" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00542?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00542</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures; the comparison of enzymatic and thermal shift assay of compounds; correlation of activity evaluation methods; kinase profiling results of <b>8</b> and <b>9</b>; cell proliferation and other enzymatic activity of <b>9</b>; plasma and tumor concentration of MDA-MB-231 xenograft model; crystallographic data for <b>7</b>, <b>8</b>, <b>9</b>, <b>19</b>, <b>28</b>, and <b>30</b>; expression of MPS1 in cancer cell lines; histological features of the representative small intestine of each group; and villous length of the individuals in each group (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Molecular docking model of <b>7</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular docking model of <b>8</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">HPLC–MS result of compound <b>9</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_005.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf">jm1c00542_si_001.pdf (842.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_002.csv">jm1c00542_si_002.csv (2.18 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_003.pdb">jm1c00542_si_003.pdb (349.69 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_004.pdb">jm1c00542_si_004.pdb (351.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_005.pdf">jm1c00542_si_005.pdf (78.7 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00542" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57757" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57757" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nam Doo Kim</span> - <span class="hlFld-Affiliation affiliation">Voronoibio, S11 Floor, 32 Songdogwahak-ro,
Yeonsu-gu, Incheon 21984, South Korea</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7e101f131a11113e08110c111011171c1711501d1113"><span class="__cf_email__" data-cfemail="b3ddd2ded7dcdcf3c5dcc1dcdddcdad1dadc9dd0dcde">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ikyon Kim</span> - <span class="hlFld-Affiliation affiliation">College
of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, South Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0849-5517" title="Orcid link">http://orcid.org/0000-0002-0849-5517</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8fe6e4f6e0e1e4e6e2cff6e0e1fceae6a1eeeca1e4fd"><span class="__cf_email__" data-cfemail="1a73716375747173775a637574697f73347b79347168">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Younho Lee</span> - <span class="hlFld-Affiliation affiliation">College
of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, South Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Voronoibio, S11 Floor, 32 Songdogwahak-ro,
Yeonsu-gu, Incheon 21984, South Korea</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4235-1269" title="Orcid link">http://orcid.org/0000-0002-4235-1269</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyunkyung Kim</span> - <span class="hlFld-Affiliation affiliation">Voronoibio, S11 Floor, 32 Songdogwahak-ro,
Yeonsu-gu, Incheon 21984, South Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Research
Institute of Pharmaceutical Researches, College of Pharmacy, Kyungpook National University, Daegu 41566, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haelee Kim</span> - <span class="hlFld-Affiliation affiliation">B2Sbio, S23 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ha Yeon Cho</span> - <span class="hlFld-Affiliation affiliation">B2Sbio, S23 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun-Goo Jee</span> - <span class="hlFld-Affiliation affiliation">Research
Institute of Pharmaceutical Researches, College of Pharmacy, Kyungpook National University, Daegu 41566, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyung-Ah Seo</span> - <span class="hlFld-Affiliation affiliation">Voronoibio, S11 Floor, 32 Songdogwahak-ro,
Yeonsu-gu, Incheon 21984, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jung Beom Son</span> - <span class="hlFld-Affiliation affiliation">Voronoibio, S11 Floor, 32 Songdogwahak-ro,
Yeonsu-gu, Incheon 21984, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eunhwa Ko</span> - <span class="hlFld-Affiliation affiliation">B2Sbio, S23 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hwan Geun Choi</span> - <span class="hlFld-Affiliation affiliation">B2Sbio, S23 Floor, 32 Songdogwahak-ro, Yeonsu-gu, Incheon 21984, South Korea</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.L. (Chemistry), H.K. (Biology), and H.K. (Structure biology) contributed equally. H.C., J.G.J., and N.D.K. contributed for X-ray crystal structure and molecular modeling works. K.A.S. contributed for DMPK works. J.B.S, E.K., H.G.C., and I.K. contributed for compounds’ design and medicinal chemistry.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Y.L.; H.K.; K.S.; J.B.S.; and N.K. are current employees of Voronoibio. H.K.; H.C.; E.K.; and H.G.C. are current employees of B2Sbio.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61830" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61830" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the National Research Foundation of Korea (NRF-2018R1A6A1A03023718 and NRF-2020R1A2C2005961 to I.K.) for generous financial support.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviationspara</td></tr><tr><td class="NLM_term">MPS1</td><td class="NLM_def"><p class="first last">monopolar spindle 1</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">LRRK2</td><td class="NLM_def"><p class="first last">leucine-rich repeat kinase 2</p></td></tr><tr><td class="NLM_term">RIP5</td><td class="NLM_def"><p class="first last">receptor-interacting protein 5</p></td></tr><tr><td class="NLM_term">GAK</td><td class="NLM_def"><p class="first last">cyclin G-associated kinase</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">microsome stability</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 21 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spring, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wander, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zangardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardia, A.</span></span> <span> </span><span class="NLM_article-title">Cdk 4/6 inhibitors in breast cancer: current controversies and future directions</span>. <i>Curr. Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1007/s11912-019-0769-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1007%2Fs11912-019-0769-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=30806829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A280%3ADC%252BB3cfnslaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=25-33&author=L.+M.+Springauthor=S.+A.+Wanderauthor=M.+Zangardiauthor=A.+Bardia&title=Cdk+4%2F6+inhibitors+in+breast+cancer%3A+current+controversies+and+future+directions&doi=10.1007%2Fs11912-019-0769-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions</span></div><div class="casAuthors">Spring Laura M; Wander Seth A; Zangardi Mark; Bardia Aditya</div><div class="citationInfo"><span class="NLM_cas:title">Current oncology reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  To describe the clinical role of CDK 4/6 inhibitors in hormone receptor-positive (HR+) metastatic breast cancer (HR+ MBC) as well as current controversies and evolving areas of research.  RECENT FINDINGS:  Palbociclib, ribociclib, and abemaciclib are each approved in combination with an aromatase inhibitor or fulvestrant for HR+ MBC.  Abemaciclib is also approved as monotherapy for pre-treated patients.  Key questions in the field include whether all patients with HR+ MBC should receive a CDK 4/6 inhibitor up front versus later line, impact on overall survival, role of continued CDK 4/6 blockade, mechanism of clinical resistance, and treatment sequencing.  The development of CDK 4/6 inhibitors has changed the therapeutic management of HR+ MBC.  Additional research is needed to determine optimal treatment sequencing, understand mechanisms governing resistance, and develop novel therapeutic strategies to circumvent or overcome clinical resistance and further improve the outcomes of patients with MBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrxfgSXVsVydenUz0lpNqnfW6udTcc2eZQEsCWLdR2P7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfnslaktQ%253D%253D&md5=10c94359ea71ad1fc523c3ea452591a3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11912-019-0769-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11912-019-0769-3%26sid%3Dliteratum%253Aachs%26aulast%3DSpring%26aufirst%3DL.%2BM.%26aulast%3DWander%26aufirst%3DS.%2BA.%26aulast%3DZangardi%26aufirst%3DM.%26aulast%3DBardia%26aufirst%3DA.%26atitle%3DCdk%25204%252F6%2520inhibitors%2520in%2520breast%2520cancer%253A%2520current%2520controversies%2520and%2520future%2520directions%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2019%26volume%3D21%26spage%3D25%26epage%3D33%26doi%3D10.1007%2Fs11912-019-0769-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isakoff, S. J.</span></span> <span> </span><span class="NLM_article-title">Triple-negative breast cancer role of specific chemotherapy agents</span>. <i>Cancer J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1097/ppo.0b013e3181d24ff7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1097%2FPPO.0b013e3181d24ff7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=20164691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVKktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=53-61&author=S.+J.+Isakoff&title=Triple-negative+breast+cancer+role+of+specific+chemotherapy+agents&doi=10.1097%2Fppo.0b013e3181d24ff7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Triple-negative breast cancer: role of specific chemotherapy agents</span></div><div class="casAuthors">Isakoff, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Journal (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-61</span>CODEN:
                <span class="NLM_cas:coden">CAJOCB</span>;
        ISSN:<span class="NLM_cas:issn">1528-9117</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Cytotoxic chemotherapy remains the mainstay of treatment for triple-neg. breast cancer (TNBC) despite the promise of new targeted and biol. agents.  Many studies have shown significant benefit of chemotherapy in the neoadjuvant, adjuvant, and metastatic treatment of TNBC.  Neoadjuvant chemotherapy studies have consistently reported higher response rates in TNBC than non-TNBC, and pathol. complete response has been shown to predict improved long-term outcomes for TNBC.  Although the specific adjuvant regimens that may be most effective for TNBC are still being detd., third-generation chemotherapy regimens using dose dense or metronomic polychemotherapy are among the most effective tools presently available.  The role of specific chemotherapy agents in the treatment of TNBC remains incompletely defined and warrants careful review to ensure that the most effective therapy is delivered while minimizing unnecessary toxicity.  Platinum agents have seen renewed interest in TNBC based on a growing body of preclin. and clin. data suggesting encouraging activity.  Taxanes and anthracyclines are active in TNBC and remain important agents but have not shown specific benefit over non-TNBC.  Capecitabine has limited reported data in TNBC, but some reports suggest differential activity in TNBC compared with hormone receptor-pos. breast cancer.  TNBC is itself a heterogeneous group in which subgroups such as BRCA1 mutation carriers may have particular sensitivity to platinum agents and relatively less sensitivity to taxanes.  Therefore, the identification of addnl. mol. biomarkers to predict response to specific chemotherapy is required to further improve treatment strategies with the current menu of chemotherapy options and future combinations with targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_j84tQBAAnLVg90H21EOLACvtfcHk0lgq0rSXHT17RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVKktLw%253D&md5=0f903f4449b6c657392cb0a129ac185c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1097%2FPPO.0b013e3181d24ff7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FPPO.0b013e3181d24ff7%26sid%3Dliteratum%253Aachs%26aulast%3DIsakoff%26aufirst%3DS.%2BJ.%26atitle%3DTriple-negative%2520breast%2520cancer%2520role%2520of%2520specific%2520chemotherapy%2520agents%26jtitle%3DCancer%2520J.%26date%3D2010%26volume%3D16%26spage%3D53%26epage%3D61%26doi%3D10.1097%2Fppo.0b013e3181d24ff7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thu, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ba-Alawi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elia, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mer, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smirnov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safikhani, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haibe-Kains, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescon, D. W.</span></span> <span> </span><span class="NLM_article-title">Disruption of the anaphase-promoting complex confers resistance to ttk inhibitors in triple-negative breast cancer</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E1570</span>– <span class="NLM_lpage">E1577</span>, <span class="refDoi"> DOI: 10.1073/pnas.1719577115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1073%2Fpnas.1719577115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=29378962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWjtbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E1570-E1577&author=K.+L.+Thuauthor=J.+Silvesterauthor=M.+J.+Elliottauthor=W.+Ba-Alawiauthor=M.+H.+Duncanauthor=A.+C.+Eliaauthor=A.+S.+Merauthor=P.+Smirnovauthor=Z.+Safikhaniauthor=B.+Haibe-Kainsauthor=T.+W.+Makauthor=D.+W.+Cescon&title=Disruption+of+the+anaphase-promoting+complex+confers+resistance+to+ttk+inhibitors+in+triple-negative+breast+cancer&doi=10.1073%2Fpnas.1719577115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer</span></div><div class="casAuthors">Thu, K. L.; Silvester, J.; Elliott, M. J.; Ba-alawi, W.; Duncan, M. H.; Elia, A. C.; Mer, A. S.; Smirnov, P.; Safikhani, Z.; Haibe-Kains, B.; Mak, T. W.; Cescon, D. W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">E1570-E1577</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">TTK protein kinase (TTK), also known as Monopolar spindle 1 (MPS1), is a key regulator of the spindle assembly checkpoint (SAC), which functions to maintain genomic integrity.  TTK has emerged as a promising therapeutic target in human cancers, including triple-neg. breast cancer (TNBC).  Several TTK inhibitors (TTKis) are being evaluated in clin. trials, and an understanding of the mechanisms mediating TTKi sensitivity and resistance could inform the successful development of this class of agents.  We evaluated the cellular effects of the potent clin. TTKi CFI-402257 in TNBC models.  CFI-402257 induced apoptosis and potentiated aneuploidy in TNBC lines by accelerating progression through mitosis and inducing mitotic segregation errors.  We used genome-wide CRISPR/Cas9 screens in multiple TNBC cell lines to identify mechanisms of resistance to CFI-402257.  Our functional genomic screens identified members of the anaphase-promoting complex/cyclosome (APC/C) complex, which promotes mitotic progression following inactivation of the SAC.  Several screen candidates were validated to confer resistance to CFI-402257 and other TTKis using CRISPR/Cas9 and siRNA methods.  These findings extend the observation that impairment of the APC/C enables cells to tolerate genomic instability caused by SAC inactivation, and support the notion that a measure of APC/C function could predict the response to TTK inhibition.  Indeed, an APC/C gene expression signature is significantly assocd. with CFI-402257 response in breast and lung adenocarcinoma cell line panels.  This expression signature, along with somatic alterations in genes involved in mitotic progression, represent potential biomarkers that could be evaluated in ongoing clin. trials of CFI-402257 or other TTKis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokADygOqo097Vg90H21EOLACvtfcHk0ljSIE-qf6EWBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWjtbbO&md5=658a55fa8061a50192417f7b51357c62</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1719577115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1719577115%26sid%3Dliteratum%253Aachs%26aulast%3DThu%26aufirst%3DK.%2BL.%26aulast%3DSilvester%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%2BJ.%26aulast%3DBa-Alawi%26aufirst%3DW.%26aulast%3DDuncan%26aufirst%3DM.%2BH.%26aulast%3DElia%26aufirst%3DA.%2BC.%26aulast%3DMer%26aufirst%3DA.%2BS.%26aulast%3DSmirnov%26aufirst%3DP.%26aulast%3DSafikhani%26aufirst%3DZ.%26aulast%3DHaibe-Kains%26aufirst%3DB.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DCescon%26aufirst%3DD.%2BW.%26atitle%3DDisruption%2520of%2520the%2520anaphase-promoting%2520complex%2520confers%2520resistance%2520to%2520ttk%2520inhibitors%2520in%2520triple-negative%2520breast%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2018%26volume%3D115%26spage%3DE1570%26epage%3DE1577%26doi%3D10.1073%2Fpnas.1719577115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saavedra, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J. T.</span></span> <span> </span><span class="NLM_article-title">Ttk promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer</span>. <i>Oncogenesis</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1038/s41389-018-0077-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1038%2Fs41389-018-0077-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=30206215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A280%3ADC%252BB3c3nvFWrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=69-81&author=J.+L.+Kingauthor=B.+Zhangauthor=Y.+Liauthor=K.+P.+Liauthor=J.+J.+Niauthor=H.+I.+Saavedraauthor=J.+T.+Dong&title=Ttk+promotes+mesenchymal+signaling+via+multiple+mechanisms+in+triple+negative+breast+cancer&doi=10.1038%2Fs41389-018-0077-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer</span></div><div class="casAuthors">King Jamie L; Zhang Baotong; Li Yixiang; Li Kathy P; Ni Jianping J; Dong Jin-Tang; King Jamie L; Li Yixiang; Dong Jin-Tang; Saavedra Harold I</div><div class="citationInfo"><span class="NLM_cas:title">Oncogenesis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">69</span>
        ISSN:<span class="NLM_cas:issn">2157-9024</span>.
    </div><div class="casAbstract">Abnormal expression of TTK kinase has been associated with the initiation, progression, and therapeutic resistance of breast and other cancers, but its roles remain to be clarified.  In this study, we examined the role of TTK in triple negative breast cancer (TNBC), and found that higher TTK expression correlated with mesenchymal and proliferative phenotypes in TNBC cells.  Pharmacologic inhibition and genomic silencing of TTK not only reversed the epithelial-to-mesenchymal transition (EMT) in TNBC cells, but also increased the expression of KLF5, an effector of TGF-β signaling and inhibitor of EMT.  In addition, TTK inhibition decreased the expression of EMT-associated micro-RNA miR-21 but increased the expression of miR-200 family members and suppressed TGF-β signaling.  To test if upregulation of KLF5 plays a role in TTK-induced EMT, TTK and KLF5 were silenced simultaneously, which reversed the decreased EMT caused by loss of TTK.  Consistently, the decrease in miR-21 expression and increase in miR-200 expression caused by TTK silencing were rescued by loss of KLF5.  Altogether, this study highlights a novel role and signaling pathway for TTK in regulating EMT of TN breast cancer cells through TGF-β and KLF5 signaling, highlighting targetable signaling pathways for TTK inhibitors in aggressive breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQF382y4lQtoS6Ufuk_1xoTfW6udTcc2eax0QIkc4ve9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3nvFWrtg%253D%253D&md5=f8cd4a9025d749d00b468596e29d5bdf</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fs41389-018-0077-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41389-018-0077-z%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%2BP.%26aulast%3DNi%26aufirst%3DJ.%2BJ.%26aulast%3DSaavedra%26aufirst%3DH.%2BI.%26aulast%3DDong%26aufirst%3DJ.%2BT.%26atitle%3DTtk%2520promotes%2520mesenchymal%2520signaling%2520via%2520multiple%2520mechanisms%2520in%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DOncogenesis%26date%3D2018%26volume%3D7%26spage%3D69%26epage%3D81%26doi%3D10.1038%2Fs41389-018-0077-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><a href="https://clinicaltrials.gov/ct2/show/NCT03411161" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03411161</a> (accessed 16
April 2021).web</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03411161+%28accessed+16%0AApril+2021%29.web"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K.-M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G. W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven
Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broccatelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Introduction of a methyl group curbs metabolism of pyrido[3,4-<i>d</i>]pyrimidine monopolar spindle 1 (mps1) inhibitors and enables the discovery of the phase 1 clinical candidate N(2)-(2-ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N(8)-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine (bos172722)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8226</span>– <span class="NLM_lpage">8240</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00690</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00690" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Kku7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8226-8240&author=H.+L.+Woodwardauthor=P.+Innocentiauthor=K.-M.+J.+Cheungauthor=A.+Hayesauthor=J.+Robertsauthor=A.+T.+Henleyauthor=A.+Faisalauthor=G.+W.-Y.+Makauthor=G.+Boxauthor=I.+M.+Westwoodauthor=N.+Croninauthor=M.+Carterauthor=M.+Valentiauthor=A.+De+Haven%0ABrandonauthor=L.+O%E2%80%99Feeauthor=H.+Savilleauthor=J.+Schmittauthor=R.+Burkeauthor=F.+Broccatelliauthor=R.+L.+M.+van+Montfortauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Linardopoulosauthor=J.+Blaggauthor=S.+Hoelder&title=Introduction+of+a+methyl+group+curbs+metabolism+of+pyrido%5B3%2C4-d%5Dpyrimidine+monopolar+spindle+1+%28mps1%29+inhibitors+and+enables+the+discovery+of+the+phase+1+clinical+candidate+N%282%29-%282-ethoxy-4-%284-methyl-4H-1%2C2%2C4-triazol-3-yl%29phenyl%29-6-methyl-N%288%29-neopentylpyrido%5B3%2C4-d%5Dpyrimidine-2%2C8-diamine+%28bos172722%29&doi=10.1021%2Facs.jmedchem.8b00690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4-d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N2-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine (BOS172722)</span></div><div class="casAuthors">Woodward, Hannah L.; Innocenti, Paolo; Cheung, Kwai-Ming J.; Hayes, Angela; Roberts, Jennie; Henley, Alan T.; Faisal, Amir; Mak, Grace Wing-Yan; Box, Gary; Westwood, Isaac M.; Cronin, Nora; Carter, Michael; Valenti, Melanie; De Haven Brandon, Alexis; O'Fee, Lisa; Saville, Harry; Schmitt, Jessica; Burke, Rosemary; Broccatelli, Fabio; van Montfort, Rob L. M.; Raynaud, Florence I.; Eccles, Suzanne A.; Linardopoulos, Spiros; Blagg, Julian; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8226-8240</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monopolar spindle (MPS1) occupies a central role in mitosis as one of the main components of the spindle assembly checkpoint.  The MPS1 kinase is an attractive cancer target and herein we report the discovery of the clin. candidate BOS172722.  The starting point for our work was a series of pyrido[3,4-d]pyrimidine inhibitors that demonstrated excellent potency and kinase selectivity but suffered from rapid turnover in human liver microsomes (HLM).  Optimizing HLM stability proved challenging since it was not possible to identify a consistent site of metab. and lowering lipophilicity proved unsuccessful.  Key to overcoming this problem was the finding that introduction of a Me group at the 6-position of the pyrido[3,4-d]pyrimidine core significantly improved HLM stability.  Met ID studies suggested that the Me group suppressed metab. at the distant aniline portion of the mol., likely by blocking the preferred pharmacophore through which P 450 recognized the compd.  This work ultimately led to the discovery of BOS172722 as a Phase 1 clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGtOFZ_iiUQrVg90H21EOLACvtfcHk0lhocRZUk2hO4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Kku7jF&md5=7d899afeb61ab58f970b63b1313177ec</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00690%26sid%3Dliteratum%253Aachs%26aulast%3DWoodward%26aufirst%3DH.%2BL.%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%2BW.-Y.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DCronin%26aufirst%3DN.%26aulast%3DCarter%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DSaville%26aufirst%3DH.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DBroccatelli%26aufirst%3DF.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DIntroduction%2520of%2520a%2520methyl%2520group%2520curbs%2520metabolism%2520of%2520pyrido%255B3%252C4-d%255Dpyrimidine%2520monopolar%2520spindle%25201%2520%2528mps1%2529%2520inhibitors%2520and%2520enables%2520the%2520discovery%2520of%2520the%2520phase%25201%2520clinical%2520candidate%2520N%25282%2529-%25282-ethoxy-4-%25284-methyl-4H-1%252C2%252C4-triazol-3-yl%2529phenyl%2529-6-methyl-N%25288%2529-neopentylpyrido%255B3%252C4-d%255Dpyrimidine-2%252C8-diamine%2520%2528bos172722%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8226%26epage%3D8240%26doi%3D10.1021%2Facs.jmedchem.8b00690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Functional characterization of cfi-402257, a potent and selective mps1/ttk kinase inhibitor, for the treatment of cancer</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">3127</span>– <span class="NLM_lpage">3132</span>, <span class="refDoi"> DOI: 10.1073/pnas.1700234114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1073%2Fpnas.1700234114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=28270606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVyjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=3127-3132&author=J.+M.+Masonauthor=X.+Weiauthor=G.+C.+Fletcherauthor=R.+Kiarashauthor=R.+Brokxauthor=R.+Hodgsonauthor=I.+Beletskayaauthor=M.+R.+Brayauthor=T.+W.+Mak&title=Functional+characterization+of+cfi-402257%2C+a+potent+and+selective+mps1%2Fttk+kinase+inhibitor%2C+for+the+treatment+of+cancer&doi=10.1073%2Fpnas.1700234114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer</span></div><div class="casAuthors">Mason, Jacqueline M.; Wei, Xin; Fletcher, Graham C.; Kiarash, Reza; Brokx, Richard; Hodgson, Richard; Beletskaya, Irina; Bray, Mark R.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3127-3132</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Loss of cell-cycle control is a hallmark of human cancer.  Cell-cycle checkpoints are essential for maintaining genome integrity and balanced growth and division.  They are specifically deregulated in cancer cells and contain regulators that represent potential therapeutic targets.  Monopolar spindle 1 (Mps1; also known as TTK protein kinase) is a core component of the spindle assembly checkpoint (SAC), a genome-surveillance mechanism that is important for cell survival, and has emerged as a candidate target for anticancer therapy.  Here, the authors report the cellular and antitumor effects of CFI-402257, a potent (Mps1 Ki = 0.09±0.02 nM; cellular Mps1 EC50 = 6.5±0.5 nM), highly selective, and orally active small-mol. inhibitor of Mps1 that was identified through a drug-discovery program.  Human cancer cells treated with CFI-402257 exhibit effects consistent with Mps1 kinase inhibition, specifically SAC inactivation, leading to chromosome missegregation, aneuploidy, and ultimately cell death.  Oral administration of CFI-402257 in monotherapy or in combination with an anti-programmed cell death 1 (PD-1) antibody in mouse models of human cancer results in inhibition of tumor growth at doses that are well-tolerated.  The authors' findings provide a rationale for the clin. evaluation of CFI-402257 in patients with solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFQJ3eg_c-qLVg90H21EOLACvtfcHk0lhocRZUk2hO4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVyjsL8%253D&md5=bb9742c8d07314e7d3c322bef71ef0ff</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1700234114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1700234114%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DBrokx%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DFunctional%2520characterization%2520of%2520cfi-402257%252C%2520a%2520potent%2520and%2520selective%2520mps1%252Fttk%2520kinase%2520inhibitor%252C%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D3127%26epage%3D3132%26doi%3D10.1073%2Fpnas.1700234114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosemund, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stöckigt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prechtl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briem, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquardt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirok, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jautelat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohlmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Montalván, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bömer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberspaecher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüning, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döhr, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raschke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreft, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegelbauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brands, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppitz, M.</span></span> <span> </span><span class="NLM_article-title">Treating cancer by spindle assembly checkpoint abrogation: discovery of two clinical candidates, bay 1161909 and bay 1217389, targeting mps1 kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8025</span>– <span class="NLM_lpage">8042</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b02035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b02035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnslKgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=8025-8042&author=V.+K.+Schulzeauthor=U.+Klarauthor=D.+Kosemundauthor=A.+M.+Wengnerauthor=G.+Siemeisterauthor=D.+St%C3%B6ckigtauthor=R.+Neuhausauthor=P.+Lienauauthor=B.+Baderauthor=S.+Prechtlauthor=S.+J.+Holtonauthor=H.+Briemauthor=T.+Marquardtauthor=H.+Schirokauthor=R.+Jautelatauthor=R.+Bohlmannauthor=D.+Nguyenauthor=A.+E.+Fern%C3%A1ndez-Montalv%C3%A1nauthor=U.+B%C3%B6merauthor=U.+Eberspaecherauthor=M.+Br%C3%BCningauthor=O.+D%C3%B6hrauthor=M.+Raschkeauthor=B.+Kreftauthor=D.+Mumbergauthor=K.+Ziegelbauerauthor=M.+Brandsauthor=F.+von+Nussbaumauthor=M.+Koppitz&title=Treating+cancer+by+spindle+assembly+checkpoint+abrogation%3A+discovery+of+two+clinical+candidates%2C+bay+1161909+and+bay+1217389%2C+targeting+mps1+kinase&doi=10.1021%2Facs.jmedchem.9b02035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase</span></div><div class="casAuthors">Schulze, Volker K.; Klar, Ulrich; Kosemund, Dirk; Wengner, Antje M.; Siemeister, Gerhard; Stoeckigt, Detlef; Neuhaus, Roland; Lienau, Philip; Bader, Benjamin; Prechtl, Stefan; Holton, Simon J.; Briem, Hans; Marquardt, Tobias; Schirok, Hartmut; Jautelat, Rolf; Bohlmann, Rolf; Nguyen, Duy; Fernandez-Montalvan, Amaury E.; Boemer, Ulf; Eberspaecher, Uwe; Bruening, Michael; Doehr, Olaf; Raschke, Marian; Kreft, Bertolt; Mumberg, Dominik; Ziegelbauer, Karl; Brands, Michael; von Nussbaum, Franz; Koppitz, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8025-8042</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of monopolar spindle 1 (MPS1) kinase represents a novel approach to cancer treatment: instead of arresting the cell cycle in tumor cells, cells are driven into mitosis irresp. of DNA damage and unattached/misattached chromosomes, resulting in aneuploidy and cell death.  Starting points for our optimization efforts with the goal to identify MPS1 inhibitors were two HTS hits from the distinct chem. series "triazolopyridines" and "imidazopyrazines".  The major initial issue of the triazolopyridine series was the moderate potency of the HTS hits.  The imidazopyrazine series displayed more than 10-fold higher potencies; however, in the early project phase, this series suffered from poor metabolic stability.  Here, we outline the evolution of the two hit series to clin. candidates BAY 1161909 (I) and BAY 1217389 (II), and reveal how both clin. candidates bind to the ATP site of MPS1 kinase, while addressing different pockets utilizing different binding interactions, along with their synthesis and preclin. characterization in selected in vivo efficacy models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq_7hRpVUQrbVg90H21EOLACvtfcHk0liEIsZkS7UNRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnslKgsLY%253D&md5=68edb5e4d5ffc731fcb890fa062c268e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b02035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b02035%26sid%3Dliteratum%253Aachs%26aulast%3DSchulze%26aufirst%3DV.%2BK.%26aulast%3DKlar%26aufirst%3DU.%26aulast%3DKosemund%26aufirst%3DD.%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DSt%25C3%25B6ckigt%26aufirst%3DD.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DBader%26aufirst%3DB.%26aulast%3DPrechtl%26aufirst%3DS.%26aulast%3DHolton%26aufirst%3DS.%2BJ.%26aulast%3DBriem%26aufirst%3DH.%26aulast%3DMarquardt%26aufirst%3DT.%26aulast%3DSchirok%26aufirst%3DH.%26aulast%3DJautelat%26aufirst%3DR.%26aulast%3DBohlmann%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DD.%26aulast%3DFern%25C3%25A1ndez-Montalv%25C3%25A1n%26aufirst%3DA.%2BE.%26aulast%3DB%25C3%25B6mer%26aufirst%3DU.%26aulast%3DEberspaecher%26aufirst%3DU.%26aulast%3DBr%25C3%25BCning%26aufirst%3DM.%26aulast%3DD%25C3%25B6hr%26aufirst%3DO.%26aulast%3DRaschke%26aufirst%3DM.%26aulast%3DKreft%26aufirst%3DB.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DZiegelbauer%26aufirst%3DK.%26aulast%3DBrands%26aufirst%3DM.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DKoppitz%26aufirst%3DM.%26atitle%3DTreating%2520cancer%2520by%2520spindle%2520assembly%2520checkpoint%2520abrogation%253A%2520discovery%2520of%2520two%2520clinical%2520candidates%252C%2520bay%25201161909%2520and%2520bay%25201217389%252C%2520targeting%2520mps1%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D8025%26epage%3D8042%26doi%3D10.1021%2Facs.jmedchem.9b02035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelluma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manak, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deveraux, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kops, G. J. P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Small-molecule kinase inhibitors provide insight into mps1 cell cycle function</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.1038/nchembio.345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1038%2Fnchembio.345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=20383151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=359-368&author=N.+Kwiatkowskiauthor=N.+Jellumaauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=M.+S.+Manakauthor=M.+Kwonauthor=H.+G.+Choiauthor=T.+Simauthor=Q.+L.+Deverauxauthor=S.+Rottmannauthor=D.+Pellmanauthor=J.+V.+Shahauthor=G.+J.+P.+L.+Kopsauthor=S.+Knappauthor=N.+S.+Gray&title=Small-molecule+kinase+inhibitors+provide+insight+into+mps1+cell+cycle+function&doi=10.1038%2Fnchembio.345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span></div><div class="casAuthors">Kwiatkowski, Nicholas; Jelluma, Nannette; Filippakopoulos, Panagis; Soundararajan, Meera; Manak, Michael S.; Kwon, Mijung; Choi, Hwan Geun; Sim, Taebo; Deveraux, Quinn L.; Rottmann, Sabine; Pellman, David; Shah, Jagesh V.; Kops, Geert J. P. L.; Knapp, Stefan; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-368</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mps1, a dual-specificity kinase, is required for the proper functioning of the spindle assembly checkpoint and for the maintenance of chromosomal stability.  As Mps1 function has been implicated in numerous phases of the cell cycle, the development of a potent, selective small-mol. inhibitor of Mps1 should facilitate dissection of Mps1-related biol.  We describe the cellular effects and Mps1 cocrystal structures of new, selective small-mol. inhibitors of Mps1.  Consistent with RNAi studies, chem. inhibition of Mps1 leads to defects in Mad1 and Mad2 establishment at unattached kinetochores, decreased Aurora B kinase activity, premature mitotic exit and gross aneuploidy, without any evidence of centrosome duplication defects.  However, in U2OS cells having extra centrosomes (an abnormality found in some cancers), Mps1 inhibition increases the frequency of multipolar mitoses.  Lastly, Mps1 inhibitor treatment resulted in a decrease in cancer cell viability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUsnJhF04gwrVg90H21EOLACvtfcHk0liEIsZkS7UNRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D&md5=965e5e5e4f85e21c5ec27b0ea9417914</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.345%26sid%3Dliteratum%253Aachs%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DJelluma%26aufirst%3DN.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DManak%26aufirst%3DM.%2BS.%26aulast%3DKwon%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DDeveraux%26aufirst%3DQ.%2BL.%26aulast%3DRottmann%26aufirst%3DS.%26aulast%3DPellman%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DJ.%2BV.%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSmall-molecule%2520kinase%2520inhibitors%2520provide%2520insight%2520into%2520mps1%2520cell%2520cycle%2520function%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D359%26epage%3D368%26doi%3D10.1038%2Fnchembio.345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tannous, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der
Stoop, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewandrowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiddingh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sol, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagerweij, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedekind, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niers, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barazas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, R. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geerts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Witt Hamer, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagemann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandertop, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tellingen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noske, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Würdinger, T.</span></span> <span> </span><span class="NLM_article-title">Effects of the selective mps1 inhibitor mps1-in-3 on glioblastoma sensitivity to antimitotic drugs</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1331</span>, <span class="refDoi"> DOI: 10.1093/jnci/djt168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1093%2Fjnci%2Fdjt168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=23940287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKgu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2013&pages=1322-1331&author=B.+A.+Tannousauthor=M.+Keramiauthor=P.+M.+Van+der%0AStoopauthor=N.+Kwiatkowskiauthor=J.+Wangauthor=W.+Zhouauthor=A.+F.+Kesslerauthor=G.+Lewandrowskiauthor=L.+Hiddinghauthor=N.+Solauthor=T.+Lagerweijauthor=L.+Wedekindauthor=J.+M.+Niersauthor=M.+Barazasauthor=R.+J.+A.+Nilssonauthor=D.+Geertsauthor=P.+C.+De+Witt+Hamerauthor=C.+Hagemannauthor=W.+P.+Vandertopauthor=O.+Van+Tellingenauthor=D.+P.+Noskeauthor=N.+S.+Grayauthor=T.+W%C3%BCrdinger&title=Effects+of+the+selective+mps1+inhibitor+mps1-in-3+on+glioblastoma+sensitivity+to+antimitotic+drugs&doi=10.1093%2Fjnci%2Fdjt168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs</span></div><div class="casAuthors">Tannous, Bakhos A.; Kerami, Mariam; Van der Stoop, Petra M.; Kwiatkowski, Nicholas; Wang, Jinhua; Zhou, Wenjun; Kessler, Almuth F.; Lewandrowski, Grant; Hiddingh, Lotte; Sol, Nik; Lagerweij, Tonny; Wedekind, Laurine; Niers, Johanna M.; Barazas, Marco; Nilsson, R. Jonas A.; Geerts, Dirk; De Witt Hamer, Philip C.; Hagemann, Carsten; Vandertop, W. Peter; Van Tellingen, Olaf; Noske, David P.; Gray, Nathanael S.; Wuerdinger, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1322-1331</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Glioblastomas exhibit a high level of chemotherapeutic resistance, including to the antimitotic agents vincristine and taxol.  During the mitotic agent-induced arrest, glioblastoma cells are able to perform damage-control and self-repair to continue proliferation.  Monopolar spindle 1 (MPS1/TTK) is a checkpoint kinase and a gatekeeper of the mitotic arrest.  Methods We used glioblastoma cells to det. the expression of MPS1 and to det. the effects of MPS1 inhibition on mitotic errors and cell viability in combination with vincristine and taxol.  The effect of MPS1 inhibition was assessed in different orthotopic glioblastoma mouse models (n = 3-7 mice/group).  MPS1 expression levels were examd. in relation to patient survival.  Results Using publicly available gene expression data, we detd. that MPS1 overexpression corresponds pos. with tumor grade and neg. with patient survival (two-sided t test, P < .001).  Patients with high MPS1 expression (n = 203) had a median and mean survival of 487 and 913 days (95% confidence intervals [CI] = 751 to 1075), resp., and a 2-yr survival rate of 35%, whereas patients with intermediate MPS1 expression (n = 140) had a median and mean survival of 858 and 1183 days (95% CI = 1177 to 1189), resp., and a 2-yr survival rate of 56%.  We demonstrate that MPS1 inhibition by RNAi results in sensitization to antimitotic agents.  We developed a selective small-mol. inhibitor of MPS1, MPS1-IN-3, which caused mitotic aberrancies in glioblastoma cells and, in combination with vincristine, induced mitotic checkpoint override, increased aneuploidy, and augmented cell death.  MPS1-IN-3 sensitizes glioblastoma cells to vincristine in orthotopic mouse models (two-sided log-rank test, P < .01), resulting in prolonged survival without toxicity.  Conclusions Our results collectively demonstrate that MPS1, a putative therapeutic target in glioblastoma, can be selectively inhibited by MPS1-IN-3 sensitizing glioblastoma cells to antimitotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUG67Lkc5qcbVg90H21EOLACvtfcHk0lgHzDwLuMYJbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKgu7fK&md5=b7e51ef38e02d9fbf0ce0191af530b3a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjt168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjt168%26sid%3Dliteratum%253Aachs%26aulast%3DTannous%26aufirst%3DB.%2BA.%26aulast%3DKerami%26aufirst%3DM.%26aulast%3DVan%2Bder%2BStoop%26aufirst%3DP.%2BM.%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DKessler%26aufirst%3DA.%2BF.%26aulast%3DLewandrowski%26aufirst%3DG.%26aulast%3DHiddingh%26aufirst%3DL.%26aulast%3DSol%26aufirst%3DN.%26aulast%3DLagerweij%26aufirst%3DT.%26aulast%3DWedekind%26aufirst%3DL.%26aulast%3DNiers%26aufirst%3DJ.%2BM.%26aulast%3DBarazas%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DR.%2BJ.%2BA.%26aulast%3DGeerts%26aufirst%3DD.%26aulast%3DDe%2BWitt%2BHamer%26aufirst%3DP.%2BC.%26aulast%3DHagemann%26aufirst%3DC.%26aulast%3DVandertop%26aufirst%3DW.%2BP.%26aulast%3DVan%2BTellingen%26aufirst%3DO.%26aulast%3DNoske%26aufirst%3DD.%2BP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DW%25C3%25BCrdinger%26aufirst%3DT.%26atitle%3DEffects%2520of%2520the%2520selective%2520mps1%2520inhibitor%2520mps1-in-3%2520on%2520glioblastoma%2520sensitivity%2520to%2520antimitotic%2520drugs%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2013%26volume%3D105%26spage%3D1322%26epage%3D1331%26doi%3D10.1093%2Fjnci%2Fdjt168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawant, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisk, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chettiar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darby, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueggemeier, R. W.</span></span> <span> </span><span class="NLM_article-title">Novel pyrrolopyrimidines as mps1/ttk kinase inhibitors for breast cancer</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2156</span>– <span class="NLM_lpage">2166</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1016%2Fj.bmc.2017.02.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=28259529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1OrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=2156-2166&author=Y.+Sugimotoauthor=D.+B.+Sawantauthor=H.+A.+Fiskauthor=L.+Maoauthor=C.+Liauthor=S.+Chettiarauthor=P.-K.+Liauthor=M.+V.+Darbyauthor=R.+W.+Brueggemeier&title=Novel+pyrrolopyrimidines+as+mps1%2Fttk+kinase+inhibitors+for+breast+cancer&doi=10.1016%2Fj.bmc.2017.02.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancer</span></div><div class="casAuthors">Sugimoto, Yasuro; Sawant, Dwitiya B.; Fisk, Harold A.; Mao, Liguang; Li, Chenglong; Chettiar, Somsundaram; Li, Pui-Kai; Darby, Michael V.; Brueggemeier, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2156-2166</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">New targeted therapy approaches for certain subtypes of breast cancer, such as triple-neg. breast cancers and other aggressive phenotypes, are desired.  High levels of the mitotic checkpoint kinase Mps1/TTK have correlated with high histol. grade in breast cancer, suggesting a potential new therapeutic target for aggressive breast cancers (BC).  Novel small mols. targeting Mps1 were designed by computer assisted docking analyses, and several candidate compds. were synthesized.  These compds. were evaluated in anti-proliferative assays of a panel of 15 breast cancer cell lines and further examd. for their ability to inhibit a variety of Mps1-dependent biol. functions.  The results indicate that the lead compds. have strong anti-proliferative potential through Mps1/TTK inhibition in both basal and luminal BC cell lines, exhibiting IC50 values ranging from 0.05 to 1.0 μM.  In addn., the lead compds. 1 and 13 inhibit Mps1 kinase enzymic activity with IC50 values from 0.356 μM to 0.809 μM, and inhibited Mps1-assocd. cellular functions such as centrosome duplication and the spindle checkpoint in triple neg. breast cancer cells.  The most promising analog, compd. 13, significantly decreased tumor growth in nude mice contg. Cal-51 triple neg. breast cancer cell xenografts.  Using drug discovery technologies, computational modeling, medicinal chem., cell culture and in vivo assays, novel small mol. Mps1/TTK inhibitors have been identified as potential targeted therapies for breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgeWzEbJTDiLVg90H21EOLACvtfcHk0lgHzDwLuMYJbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1OrsLs%253D&md5=627c45230117d6f261f2b098e8a9ebff</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DSawant%26aufirst%3DD.%2BB.%26aulast%3DFisk%26aufirst%3DH.%2BA.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DChettiar%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DP.-K.%26aulast%3DDarby%26aufirst%3DM.%2BV.%26aulast%3DBrueggemeier%26aufirst%3DR.%2BW.%26atitle%3DNovel%2520pyrrolopyrimidines%2520as%2520mps1%252Fttk%2520kinase%2520inhibitors%2520for%2520breast%2520cancer%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D2156%26epage%3D2166%26doi%3D10.1016%2Fj.bmc.2017.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riggs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cashion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehrani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deyanat-Yazdi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moghaddam, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahmanyar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagarigan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBrun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlain, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leftheris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boylan, J. F.</span></span> <span> </span><span class="NLM_article-title">The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8989</span>– <span class="NLM_lpage">9002</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01223</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01223" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1amu77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8989-9002&author=J.+R.+Riggsauthor=M.+Nagyauthor=J.+Elsnerauthor=P.+Erdmanauthor=D.+Cashionauthor=D.+Robinsonauthor=R.+Harrisauthor=D.+Huangauthor=L.+Tehraniauthor=G.+Deyanat-Yazdiauthor=R.+K.+Narlaauthor=X.+Pengauthor=T.+Tranauthor=L.+Barnesauthor=T.+Millerauthor=J.+Katzauthor=Y.+Tangauthor=M.+Chenauthor=M.+F.+Moghaddamauthor=S.+Bahmanyarauthor=B.+Pagariganauthor=S.+Delkerauthor=L.+LeBrunauthor=P.+P.+Chamberlainauthor=A.+Calabreseauthor=S.+S.+Cananauthor=K.+Leftherisauthor=D.+Zhuauthor=J.+F.+Boylan&title=The+Discovery+of+a+Dual+TTK+Protein+Kinase%2FCDC2-Like+Kinase+%28CLK2%29+Inhibitor+for+the+Treatment+of+Triple+Negative+Breast+Cancer+Initiated+from+a+Phenotypic+Screen&doi=10.1021%2Facs.jmedchem.7b01223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen</span></div><div class="casAuthors">Riggs, Jennifer R.; Nagy, Mark; Elsner, Jan; Erdman, Paul; Cashion, Dan; Robinson, Dale; Harris, Roy; Huang, Dehua; Tehrani, Lida; Deyanat-Yazdi, Gordafaried; Narla, Rama Krishna; Peng, Xiaohui; Tran, Tam; Barnes, Leo; Miller, Terra; Katz, Jason; Tang, Yang; Chen, Ming; Moghaddam, Mehran F.; Bahmanyar, Sogole; Pagarigan, Barbra; Delker, Silvia; LeBrun, Laurie; Chamberlain, Philip P.; Calabrese, Andrew; Canan, Stacie S.; Leftheris, Katerina; Zhu, Dan; Boylan, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8989-9002</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Triple neg. breast cancer (TNBC) remains a serious unmet medical need with discouragingly high relapse rates.  The authors report here the synthesis and structure-activity relationship (SAR) of a novel series of 2,4,5-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines with potent activity against TNBC tumor cell lines.  These compds. were discovered from a TNBC phenotypic screen and possess a unique dual inhibition profile targeting TTK (mitotic exit) and CLK2 (mRNA splicing).  Design and optimization, driven with a TNBC tumor cell assay, identified potent and selective compds. with favorable in vitro and in vivo activity profiles and good iv PK properties.  This cell-based driven SAR produced compds. with strong single agent in vivo efficacy in multiple TNBC xenograft models without significant body wt. loss.  These data supported the nomination of CC-671 (compd. I) into IND-enabling studies as a single agent TNBC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZC5zKGXAFFLVg90H21EOLACvtfcHk0lg1OhPBVuWIIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1amu77E&md5=0e55c6e9ad0e57dd189cccfd19b574bc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01223%26sid%3Dliteratum%253Aachs%26aulast%3DRiggs%26aufirst%3DJ.%2BR.%26aulast%3DNagy%26aufirst%3DM.%26aulast%3DElsner%26aufirst%3DJ.%26aulast%3DErdman%26aufirst%3DP.%26aulast%3DCashion%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DD.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DDeyanat-Yazdi%26aufirst%3DG.%26aulast%3DNarla%26aufirst%3DR.%2BK.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DBarnes%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DMoghaddam%26aufirst%3DM.%2BF.%26aulast%3DBahmanyar%26aufirst%3DS.%26aulast%3DPagarigan%26aufirst%3DB.%26aulast%3DDelker%26aufirst%3DS.%26aulast%3DLeBrun%26aufirst%3DL.%26aulast%3DChamberlain%26aufirst%3DP.%2BP.%26aulast%3DCalabrese%26aufirst%3DA.%26aulast%3DCanan%26aufirst%3DS.%2BS.%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DBoylan%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520Discovery%2520of%2520a%2520Dual%2520TTK%2520Protein%2520Kinase%252FCDC2-Like%2520Kinase%2520%2528CLK2%2529%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Triple%2520Negative%2520Breast%2520Cancer%2520Initiated%2520from%2520a%2520Phenotypic%2520Screen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8989%26epage%3D9002%26doi%3D10.1021%2Facs.jmedchem.7b01223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riggs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cashion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehrani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fultz, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna Narla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahmanyar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condroski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagarigan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenalti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBrun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leftheris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boylan, J. F.</span></span> <span> </span><span class="NLM_article-title">Design and optimization leading to an orally active ttk protein kinase inhibitor with robust single agent efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4401</span>– <span class="NLM_lpage">4410</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01869</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01869" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvVGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4401-4410&author=J.+R.+Riggsauthor=J.+Elsnerauthor=D.+Cashionauthor=D.+Robinsonauthor=L.+Tehraniauthor=M.+Nagyauthor=K.+E.+Fultzauthor=R.+Krishna+Narlaauthor=X.+Pengauthor=T.+Tranauthor=A.+Kulkarniauthor=S.+Bahmanyarauthor=K.+Condroskiauthor=B.+Pagariganauthor=G.+Fenaltiauthor=L.+LeBrunauthor=K.+Leftherisauthor=D.+Zhuauthor=J.+F.+Boylan&title=Design+and+optimization+leading+to+an+orally+active+ttk+protein+kinase+inhibitor+with+robust+single+agent+efficacy&doi=10.1021%2Facs.jmedchem.8b01869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design and optimization leading to an orally active TTK protein kinase inhibitor with robust single agent efficacy</span></div><div class="casAuthors">Riggs, Jennifer R.; Elsner, Jan; Cashion, Dan; Robinson, Dale; Tehrani, Lida; Nagy, Mark; Fultz, Kimberly E.; Krishna Narla, Rama; Peng, Xiaohui; Tran, Tam; Kulkarni, Ashutosh; Bahmanyar, Sogole; Condroski, Kevin; Pagarigan, Barbra; Fenalti, Gustavo; LeBrun, Laurie; Leftheris, Katerina; Zhu, Dan; Boylan, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4401-4410</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Triple neg. breast cancer (TNBC) is an aggressive disease with high relapse rates and few treatment options.  Outlined in previous publications, we identified a series of potent, dual TTK/CLK2 inhibitors with strong efficacy in TNBC xenograft models.  Pharmacokinetic properties and kinome selectivity were optimized, resulting in the identification of a new series of potent, selective, and orally bioavailable TTK inhibitors.  We describe here the structure-activity relationship of the 2,4-disubstituted-7H-pyrrolo[2,3-d]pyrimidine series, leading to significant single agent efficacy in a TNBC xenograft model without body wt. loss.  The design effort evolving an iv-dosed TTK/CLK2 inhibitor to an orally bioavailable TTK inhibitor is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2GvWr4APbYLVg90H21EOLACvtfcHk0lg1OhPBVuWIIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvVGkur0%253D&md5=d72fcc3bc1da378b804738d83bf5133b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01869%26sid%3Dliteratum%253Aachs%26aulast%3DRiggs%26aufirst%3DJ.%2BR.%26aulast%3DElsner%26aufirst%3DJ.%26aulast%3DCashion%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DD.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DNagy%26aufirst%3DM.%26aulast%3DFultz%26aufirst%3DK.%2BE.%26aulast%3DKrishna%2BNarla%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DBahmanyar%26aufirst%3DS.%26aulast%3DCondroski%26aufirst%3DK.%26aulast%3DPagarigan%26aufirst%3DB.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLeBrun%26aufirst%3DL.%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DBoylan%26aufirst%3DJ.%2BF.%26atitle%3DDesign%2520and%2520optimization%2520leading%2520to%2520an%2520orally%2520active%2520ttk%2520protein%2520kinase%2520inhibitor%2520with%2520robust%2520single%2520agent%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4401%26epage%3D4410%26doi%3D10.1021%2Facs.jmedchem.8b01869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uitdehaag, J. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Man, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemsen-Seegers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinsen, M. B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libouban, M. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterrenburg, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, J. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Vetter, J. R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Roos, J. A. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buijsman, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, G. J. R.</span></span> <span> </span><span class="NLM_article-title">Target residence time-guided optimization on ttk kinase results in inhibitors with potent anti-proliferative activity</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>429</i></span>,  <span class="NLM_fpage">2211</span>– <span class="NLM_lpage">2230</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2017.05.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1016%2Fj.jmb.2017.05.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=28539250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1Wiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=429&publication_year=2017&pages=2211-2230&author=J.+C.+M.+Uitdehaagauthor=J.+de+Manauthor=N.+Willemsen-Seegersauthor=M.+B.+W.+Prinsenauthor=M.+A.+A.+Liboubanauthor=J.+G.+Sterrenburgauthor=J.+J.+P.+de+Witauthor=J.+R.+F.+de%0AVetterauthor=J.+A.+D.+M.+de+Roosauthor=R.+C.+Buijsmanauthor=G.+J.+R.+Zaman&title=Target+residence+time-guided+optimization+on+ttk+kinase+results+in+inhibitors+with+potent+anti-proliferative+activity&doi=10.1016%2Fj.jmb.2017.05.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative Activity</span></div><div class="casAuthors">Uitdehaag, Joost C. M.; de Man, Jos; Willemsen-Seegers, Nicole; Prinsen, Martine B. W.; Libouban, Marion A. A.; Sterrenburg, Jan Gerard; de Wit, Joeri J. P.; de Vetter, Judith R. F.; de Roos, Jeroen A. D. M.; Buijsman, Rogier C.; Zaman, Guido J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">429</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2211-2230</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The protein kinase threonine tyrosine kinase (TTK; also known as Mps1) is a crit. component of the spindle assembly checkpoint and a promising drug target for the treatment of aggressive cancers, such as triple neg. breast cancer.  While the first TTK inhibitors have entered clin. trials, little is known about how the inhibition of TTK with small-mol. compds. affects cellular activity.  The authors studied the selective TTK inhibitor NTRC 0066-0, which was developed in the authors' own lab., together with 11 TTK inhibitors developed by other companies, including Mps-BAY2b, BAY 1161909, BAY 1217389 (Bayer), TC-Mps1-12 (Shionogi), and MPI-0479605 (Myrexis).  Parallel testing shows that the cellular activity of these TTK inhibitors correlates with their binding affinity to TTK and, more strongly, with target residence time.  TTK inhibitors are therefore an example where target residence time dets. activity in in vitro cellular assays.  X-ray structures and thermal stability expts. reveal that the most potent compds. induce a shift of the glycine-rich loop as a result of binding to the catalytic lysine at position 553.  This "lysine trap" disrupts the catalytic machinery.  Based on these insights, the authors developed TTK inhibitors, based on a (5,6-dihydro)pyrimido[4,5-e]indolizine scaffold, with longer target residence times, which further exploit an allosteric pocket surrounding Lys 553.  Their binding mode is new for kinase inhibitors and can be classified as hybrid Type I/Type III.  These inhibitors have very potent anti-proliferative activity that rivals classic cytotoxic therapy.  The authors' findings will open up new avenues for more applications for TTK inhibitors in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT_6mZVMoVTrVg90H21EOLACvtfcHk0lg1OhPBVuWIIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1Wiuro%253D&md5=c02b149e673dec7b0212b37a4c7b0831</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2017.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2017.05.014%26sid%3Dliteratum%253Aachs%26aulast%3DUitdehaag%26aufirst%3DJ.%2BC.%2BM.%26aulast%3Dde%2BMan%26aufirst%3DJ.%26aulast%3DWillemsen-Seegers%26aufirst%3DN.%26aulast%3DPrinsen%26aufirst%3DM.%2BB.%2BW.%26aulast%3DLibouban%26aufirst%3DM.%2BA.%2BA.%26aulast%3DSterrenburg%26aufirst%3DJ.%2BG.%26aulast%3Dde%2BWit%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3Dde%2BVetter%26aufirst%3DJ.%2BR.%2BF.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%2BA.%2BD.%2BM.%26aulast%3DBuijsman%26aufirst%3DR.%2BC.%26aulast%3DZaman%26aufirst%3DG.%2BJ.%2BR.%26atitle%3DTarget%2520residence%2520time-guided%2520optimization%2520on%2520ttk%2520kinase%2520results%2520in%2520inhibitors%2520with%2520potent%2520anti-proliferative%2520activity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2017%26volume%3D429%26spage%3D2211%26epage%3D2230%26doi%3D10.1016%2Fj.jmb.2017.05.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tardif, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassiano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimbora, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douce, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorweiler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostanin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papac, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baichwal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlexander, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B. L.</span></span> <span> </span><span class="NLM_article-title">Characterization of the cellular and antitumor effects of mpi-0479605, a small-molecule inhibitor of the mitotic kinase mps1</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2267</span>– <span class="NLM_lpage">2275</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-11-0453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1158%2F1535-7163.MCT-11-0453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=21980130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2267-2275&author=K.+D.+Tardifauthor=A.+Rogersauthor=J.+Cassianoauthor=B.+L.+Rothauthor=D.+M.+Cimboraauthor=R.+McKinnonauthor=A.+Petersonauthor=T.+B.+Douceauthor=R.+Robinsonauthor=I.+Dorweilerauthor=T.+Davisauthor=M.+A.+Hessauthor=K.+Ostaninauthor=D.+I.+Papacauthor=V.+Baichwalauthor=I.+McAlexanderauthor=J.+A.+Willardsenauthor=M.+Saundersauthor=H.+Christopheauthor=D.+V.+Kumarauthor=D.+A.+Wettsteinauthor=R.+O.+Carlsonauthor=B.+L.+Williams&title=Characterization+of+the+cellular+and+antitumor+effects+of+mpi-0479605%2C+a+small-molecule+inhibitor+of+the+mitotic+kinase+mps1&doi=10.1158%2F1535-7163.mct-11-0453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1</span></div><div class="casAuthors">Tardif, Keith D.; Rogers, Aaron; Cassiano, Jared; Roth, Bruce L.; Cimbora, Daniel M.; McKinnon, Rena; Peterson, Ashley; Douce, Thomas B.; Robinson, Rosann; Dorweiler, Irene; Davis, Thaylon; Hess, Mark A.; Ostanin, Kirill; Papac, Damon I.; Baichwal, Vijay; McAlexander, Ian; Willardsen, J. Adam; Saunders, Michael; Christophe, Hoarau; Kumar, D. Vijay; Wettstein, Daniel A.; Carlson, Robert O.; Williams, Brandi L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2267-2275</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mps1 is a dual specificity protein kinase that is essential for the bipolar attachment of chromosomes to the mitotic spindle and for maintaining the spindle assembly checkpoint until all chromosomes are properly attached.  Mps1 is expressed at high levels during mitosis and is abundantly expressed in cancer cells.  Disruption of Mps1 function induces aneuploidy and cell death.  We report the identification of MPI-0479605, a potent and selective ATP competitive inhibitor of Mps1.  Cells treated with MPI-0479605 undergo aberrant mitosis, resulting in aneuploidy and formation of micronuclei.  In cells with wild-type p53, this promotes the induction of a postmitotic checkpoint characterized by the ATM- and RAD3-related-dependent activation of the p53-p21 pathway.  In both wild-type and p53 mutant cells lines, there is a growth arrest and inhibition of DNA synthesis.  Subsequently, cells undergo mitotic catastrophe and/or an apoptotic response.  In xenograft models, MPI-0479605 inhibits tumor growth, suggesting that drugs targeting Mps1 may have utility as novel cancer therapeutics.  Mol Cancer Ther; 10(12); 2267-75.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMIODujnZWCLVg90H21EOLACvtfcHk0ljo8rqMgu9iCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO&md5=e243764443e9dfda40fc84a329d776c2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0453%26sid%3Dliteratum%253Aachs%26aulast%3DTardif%26aufirst%3DK.%2BD.%26aulast%3DRogers%26aufirst%3DA.%26aulast%3DCassiano%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCimbora%26aufirst%3DD.%2BM.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DPeterson%26aufirst%3DA.%26aulast%3DDouce%26aufirst%3DT.%2BB.%26aulast%3DRobinson%26aufirst%3DR.%26aulast%3DDorweiler%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DHess%26aufirst%3DM.%2BA.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DPapac%26aufirst%3DD.%2BI.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DMcAlexander%26aufirst%3DI.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DChristophe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DD.%2BV.%26aulast%3DWettstein%26aufirst%3DD.%2BA.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DWilliams%26aufirst%3DB.%2BL.%26atitle%3DCharacterization%2520of%2520the%2520cellular%2520and%2520antitumor%2520effects%2520of%2520mpi-0479605%252C%2520a%2520small-molecule%2520inhibitor%2520of%2520the%2520mitotic%2520kinase%2520mps1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2267%26epage%3D2275%26doi%3D10.1158%2F1535-7163.mct-11-0453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santaguida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tighe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Alise, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musacchio, A.</span></span> <span> </span><span class="NLM_article-title">Dissecting the role of mps1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1083/jcb.201001036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1083%2Fjcb.201001036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=20624901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVOhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2010&pages=73-87&author=S.+Santaguidaauthor=A.+Tigheauthor=A.+M.+D%E2%80%99Aliseauthor=S.+S.+Taylorauthor=A.+Musacchio&title=Dissecting+the+role+of+mps1+in+chromosome+biorientation+and+the+spindle+checkpoint+through+the+small+molecule+inhibitor+reversine&doi=10.1083%2Fjcb.201001036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine</span></div><div class="casAuthors">Santaguida, Stefano; Tighe, Anthony; D'Alise, Anna Morena; Taylor, Stephen S.; Musacchio, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-87</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The catalytic activity of the MPS1 kinase is crucial for the spindle assembly checkpoint and for chromosome biorientation on the mitotic spindle.  We report that the small mol. reversine is a potent mitotic inhibitor of MPS1.  Reversine inhibits the spindle assembly checkpoint in a dose-dependent manner.  Its addn. to mitotic HeLa cells causes the ejection of Mad1 and the ROD-ZWILCH-ZW10 complex, both of which are important for the spindle checkpoint, from unattached kinetochores.  By using reversine, we also demonstrate that MPS1 is required for the correction of improper chromosome-microtubule attachments.  We provide evidence that MPS1 acts downstream from the AURORA B kinase, another crucial component of the error correction pathway.  Our expts. describe a very useful tool to interfere with MPS1 activity in human cells.  They also shed light on the relationship between the error correction pathway and the spindle checkpoint and suggest that these processes are coregulated and are likely to share at least a subset of their catalytic machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPbUVMH1KC_7Vg90H21EOLACvtfcHk0ljo8rqMgu9iCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVOhtL0%253D&md5=fd022c4a8a7284eb5da7d67b04a6f8bb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201001036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201001036%26sid%3Dliteratum%253Aachs%26aulast%3DSantaguida%26aufirst%3DS.%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Alise%26aufirst%3DA.%2BM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DMusacchio%26aufirst%3DA.%26atitle%3DDissecting%2520the%2520role%2520of%2520mps1%2520in%2520chromosome%2520biorientation%2520and%2520the%2520spindle%2520checkpoint%2520through%2520the%2520small%2520molecule%2520inhibitor%2520reversine%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2010%26volume%3D190%26spage%3D73%26epage%3D87%26doi%3D10.1083%2Fjcb.201001036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niesen, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berglund, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span> <span> </span><span class="NLM_article-title">The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2212</span>– <span class="NLM_lpage">2221</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1038%2Fnprot.2007.321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=17853878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFagsb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=2212-2221&author=F.+H.+Niesenauthor=H.+Berglundauthor=M.+Vedadi&title=The+use+of+differential+scanning+fluorimetry+to+detect+ligand+interactions+that+promote+protein+stability&doi=10.1038%2Fnprot.2007.321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability</span></div><div class="casAuthors">Niesen, Frank H.; Berglund, Helena; Vedadi, Masoud</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2212-2221</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Differential scanning fluorometry (DSF) is a rapid and inexpensive screening method to identify low-mol.-wt. ligands that bind and stabilize purified proteins.  The temp. at which a protein unfolds is measured by an increase in the fluorescence of a dye with affinity for hydrophobic parts of the protein, which are exposed as the protein unfolds.  A simple fitting procedure allows quick calcn. of the transition midpoint; the difference in the temp. of this midpoint in the presence and absence of ligand is related to the binding affinity of the small mol., which can be a low-mol.-wt. compd., a peptide or a nucleic acid.  DSF is best performed using a conventional real-time PCR instrument.  Ligand solns. from a storage plate are added to a soln. of protein and dye, distributed into the wells of the PCR plate and fluorescence intensity measured as the temp. is raised gradually.  Results can be obtained in a single day.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomViqp6Tq7krVg90H21EOLACvtfcHk0ljo8rqMgu9iCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFagsb7N&md5=8a74dbb348ab81179614ab4ae5797d94</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.321%26sid%3Dliteratum%253Aachs%26aulast%3DNiesen%26aufirst%3DF.%2BH.%26aulast%3DBerglund%26aufirst%3DH.%26aulast%3DVedadi%26aufirst%3DM.%26atitle%3DThe%2520use%2520of%2520differential%2520scanning%2520fluorimetry%2520to%2520detect%2520ligand%2520interactions%2520that%2520promote%2520protein%2520stability%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D2212%26epage%3D2221%26doi%3D10.1038%2Fnprot.2007.321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrake, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavetsias, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atrash, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K.-M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haven Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAndrew, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matijssen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of orally bioavailable 1H-pyrrolo[3,2-c]pyridine inhibitors of mitotic kinase monopolar spindle 1 (mps1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">10045</span>– <span class="NLM_lpage">10065</span>, <span class="refDoi"> DOI: 10.1021/jm401395s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401395s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShsLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10045-10065&author=S.+Naudauthor=I.+M.+Westwoodauthor=A.+Faisalauthor=P.+Sheldrakeauthor=V.+Bavetsiasauthor=B.+Atrashauthor=K.-M.+J.+Cheungauthor=M.+Liuauthor=A.+Hayesauthor=J.+Schmittauthor=A.+Woodauthor=V.+Choiauthor=K.+Boxallauthor=G.+Makauthor=M.+Gurdenauthor=M.+Valentiauthor=A.+de+Haven+Brandonauthor=A.+Henleyauthor=R.+Bakerauthor=C.+McAndrewauthor=B.+Matijssenauthor=R.+Burkeauthor=S.+Hoelderauthor=S.+A.+Ecclesauthor=F.+I.+Raynaudauthor=S.+Linardopoulosauthor=R.+L.+M.+van+Montfortauthor=J.+Blagg&title=Structure-based+design+of+orally+bioavailable+1H-pyrrolo%5B3%2C2-c%5Dpyridine+inhibitors+of+mitotic+kinase+monopolar+spindle+1+%28mps1%29&doi=10.1021%2Fjm401395s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)</span></div><div class="casAuthors">Naud, Sebastien; Westwood, Isaac M.; Faisal, Amir; Sheldrake, Peter; Bavetsias, Vassilios; Atrash, Butrus; Cheung, Kwai-Ming J.; Liu, Manjuan; Hayes, Angela; Schmitt, Jessica; Wood, Amy; Choi, Vanessa; Boxall, Kathy; Mak, Grace; Gurden, Mark; Valenti, Melanie; de Haven Brandon, Alexis; Henley, Alan; Baker, Ross; McAndrew, Craig; Matijssen, Berry; Burke, Rosemary; Hoelder, Swen; Eccles, Suzanne A.; Raynaud, Florence I.; Linardopoulos, Spiros; van Montfort, Rob L. M.; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10045-10065</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase MPS1 is a crucial component of the spindle assembly checkpoint signal and is aberrantly overexpressed in many human cancers.  MPS1 is one of the top 25 genes overexpressed in tumors with chromosomal instability and aneuploidy.  PTEN-deficient breast tumor cells are particularly dependent upon MPS1 for their survival, making it a target of significant interest in oncol.  The authors report the discovery and optimization of potent and selective MPS1 inhibitors based on the 1H-pyrrolo-[3,2-c]-pyridine scaffold, guided by structure-based design and cellular characterization of MPS1 inhibition, leading to CCT251455.  This potent and selective chem. tool stabilizes an inactive conformation of MPS1 with the activation loop ordered in a manner incompatible with ATP and substrate-peptide binding; it displays a favorable oral pharmacokinetic profile, shows dose-dependent inhibition of MPS1 in an HCT116 human tumor xenograft model, and is an attractive tool compd. to elucidate further the therapeutic potential of MPS1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVRsRcyzCEBLVg90H21EOLACvtfcHk0ljqaSnNBKUswA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShsLzO&md5=6564efe14dec83774e94c355be756845</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm401395s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401395s%26sid%3Dliteratum%253Aachs%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DSheldrake%26aufirst%3DP.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DV.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DGurden%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DMcAndrew%26aufirst%3DC.%26aulast%3DMatijssen%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DStructure-based%2520design%2520of%2520orally%2520bioavailable%25201H-pyrrolo%255B3%252C2-c%255Dpyridine%2520inhibitors%2520of%2520mitotic%2520kinase%2520monopolar%2520spindle%25201%2520%2528mps1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10045%26epage%3D10065%26doi%3D10.1021%2Fjm401395s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, M. L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavas, L. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorova, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyers, P. A.</span></span> <span> </span><span class="NLM_article-title">Biophysical and x-ray crystallographic analysis of mps1 kinase inhibitor complexes</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1689</span>– <span class="NLM_lpage">1701</span>, <span class="refDoi"> DOI: 10.1021/bi901970c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi901970c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyhu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1689-1701&author=M.+L.+H.+Chuauthor=Z.+Langauthor=L.+M.+G.+Chavasauthor=J.+Neresauthor=O.+S.+Fedorovaauthor=L.+Taberneroauthor=M.+Cherryauthor=D.+H.+Williamsauthor=K.+T.+Douglasauthor=P.+A.+Eyers&title=Biophysical+and+x-ray+crystallographic+analysis+of+mps1+kinase+inhibitor+complexes&doi=10.1021%2Fbi901970c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Biophysical and X-ray Crystallographic Analysis of Mps1 Kinase Inhibitor Complexes</span></div><div class="casAuthors">Chu, Matthew L. H.; Lang, Zhaolei; Chavas, Leonard M. G.; Neres, Joao; Fedorova, Olga S.; Tabernero, Lydia; Cherry, Mike; Williams, David H.; Douglas, Kenneth T.; Eyers, Patrick A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1689-1701</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dual-specificity protein kinase monopolar spindle 1 (Mps1) is a central component of the mitotic spindle assembly checkpoint (SAC), a sensing mechanism that prevents anaphase until all chromosomes are bioriented on the metaphase plate.  Partial depletion of Mps1 protein levels sensitizes transformed, but not untransformed, human cells to therapeutic doses of the anticancer agent Taxol, making it an attractive novel therapeutic cancer target.  We have previously detd. the x-ray structure of the catalytic domain of human Mps1 in complex with the anthrapyrazolone kinase inhibitor SP600125.  In order to validate distinct inhibitors that target this enzyme and improve our understanding of nucleotide binding site architecture, we now report a biophys. and structural evaluation of the Mps1 catalytic domain in the presence of ATP and the aspecific model kinase inhibitor staurosporine.  Collective in silico, enzymic, and fluorescent screens also identified several new lead quinazoline Mps1 inhibitors, including a low-affinity compd. termed Compd. 4 (Cpd 4), whose interaction with the Mps1 kinase domain was further characterized by x-ray crystallog.  A novel biophys. anal. demonstrated that the intrinsic fluorescence of SP600125 changed markedly upon Mps1 binding, allowing spectrophotometric displacement anal. and detn. of dissocn. consts. for ATP-competitive Mps1 inhibitors.  By illuminating the structure of the Mps1 ATP-binding site our results provide novel biophys. insights into Mps1-ligand interactions that will be useful for the development of specific Mps1 inhibitors, including those employing a therapeutically validated quinazoline template.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOzu1FDS9vwrVg90H21EOLACvtfcHk0ljqaSnNBKUswA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyhu7Y%253D&md5=4cf60cff2d475fa0233d7519574d31d8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fbi901970c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi901970c%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DM.%2BL.%2BH.%26aulast%3DLang%26aufirst%3DZ.%26aulast%3DChavas%26aufirst%3DL.%2BM.%2BG.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DFedorova%26aufirst%3DO.%2BS.%26aulast%3DTabernero%26aufirst%3DL.%26aulast%3DCherry%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DDouglas%26aufirst%3DK.%2BT.%26aulast%3DEyers%26aufirst%3DP.%2BA.%26atitle%3DBiophysical%2520and%2520x-ray%2520crystallographic%2520analysis%2520of%2520mps1%2520kinase%2520inhibitor%2520complexes%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D1689%26epage%3D1701%26doi%3D10.1021%2Fbi901970c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roorda, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joosten, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiruma, Y.</span></span> <span> </span><span class="NLM_article-title">A crystal structure of the human protein kinase mps1 reveals an ordered conformation of the activation loop</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1002/prot.25651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1002%2Fprot.25651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=30582207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlvVOmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2019&pages=348-352&author=J.+C.+Roordaauthor=R.+P.+Joostenauthor=A.+Perrakisauthor=Y.+Hiruma&title=A+crystal+structure+of+the+human+protein+kinase+mps1+reveals+an+ordered+conformation+of+the+activation+loop&doi=10.1002%2Fprot.25651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A crystal structure of the human protein kinase Mps1 reveals an ordered conformation of the activation loop</span></div><div class="casAuthors">Roorda, Jacomina C.; Joosten, Robbie P.; Perrakis, Anastassis; Hiruma, Yoshitaka</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">348-352</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>;
        ISSN:<span class="NLM_cas:issn">1097-0134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (Mps1) is a dual-specificity protein kinase, orchestrating faithful chromosome segregation during mitosis.  All reported structures of the Mps1 kinase adopt the hallmarks of an inactive conformation, which includes a mostly disordered activation loop.  Here, we present a 2.4 Å resoln. crystal structure of an "extended" version of the Mps1 kinase domain, which shows an ordered activation loop.  However, the other structural characteristics of an active kinase are not present.  Our structure shows that the Mps1 activation loop can fit to the ATP binding pocket and interferes with ATP, but less so with inhibitors binding, partly explain the potency of various Mps1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4ShF4RiGVE7Vg90H21EOLACvtfcHk0lj_fTB5eNiTuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlvVOmsA%253D%253D&md5=813fe6deb987db9009039d56c95db247</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fprot.25651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.25651%26sid%3Dliteratum%253Aachs%26aulast%3DRoorda%26aufirst%3DJ.%2BC.%26aulast%3DJoosten%26aufirst%3DR.%2BP.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DHiruma%26aufirst%3DY.%26atitle%3DA%2520crystal%2520structure%2520of%2520the%2520human%2520protein%2520kinase%2520mps1%2520reveals%2520an%2520ordered%2520conformation%2520of%2520the%2520activation%2520loop%26jtitle%3DProteins%26date%3D2019%26volume%3D87%26spage%3D348%26epage%3D352%26doi%3D10.1002%2Fprot.25651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ebelt, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaoud, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edupuganti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ravenstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalby, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Berg, C. L.</span></span> <span> </span><span class="NLM_article-title">A c-jun n-terminal kinase inhibitor, jnk-in-8, sensitizes triple negative breast cancer cells to lapatinib</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">104894</span>– <span class="NLM_lpage">104912</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.20581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.18632%2Foncotarget.20581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=29285221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A280%3ADC%252BC1MzlvVynug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=104894-104912&author=N.+D.+Ebeltauthor=T.+S.+Kaoudauthor=R.+Edupugantiauthor=S.+Van+Ravensteinauthor=K.+N.+Dalbyauthor=C.+L.+Van+Den+Berg&title=A+c-jun+n-terminal+kinase+inhibitor%2C+jnk-in-8%2C+sensitizes+triple+negative+breast+cancer+cells+to+lapatinib&doi=10.18632%2Foncotarget.20581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib</span></div><div class="casAuthors">Ebelt Nancy D; Van Den Berg Carla L; Ebelt Nancy D; Kaoud Tamer S; Edupuganti Ramakrishna; Van Ravenstein Sabrina; Dalby Kevin N; Kaoud Tamer S; Van Den Berg Carla L</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">62</span>),
    <span class="NLM_cas:pages">104894-104912</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Triple negative breast cancers (TNBC) have poor prognosis compared to other breast cancer subtypes and represent 15-20% of breast cancers diagnosed.  Unique targets and new molecularly-targeted therapies are urgently needed for this subtype.  Despite high expression of Epidermal Growth Factor Receptor, inhibitors such as lapatinib have not shown therapeutic efficacy in TNBC patients.  Herein, we report that treatment with the covalent JNK inhibitor, JNK-IN-8, synergizes with lapatinib to cause cell death, while these compounds as single agents have little effect.  The combination significantly increases survival of mice bearing xenografts of MDA-MB-231 human TNBC cells.  Our studies demonstrate that lapatinib treatment increases c-Jun and JNK phosphorylation indicating a mechanism of resistance.  Combined, these compounds significantly reduce transcriptional activity of Nuclear Factor kappa B, Activating Protein 1, and Nuclear factor erythroid 2-Related Factor 2.  As master regulators of antioxidant response, their decreased activity induces a 10-fold increase in reactive oxygen species that is cytotoxic, and is rescued by addition of exogenous antioxidants.  Over expression of p65 or Nrf2 also significantly rescues viability during JNK-IN-8 and lapatinib treatment.  Further studies combining JNK-IN-8 and lapatinib may reveal a benefit for patients with TNBC, fulfilling a critical medical need.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6Zmm-z5wHBBpyrDyM_m9cfW6udTcc2eYEgzgWmZnaaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzlvVynug%253D%253D&md5=85d59d746549e5dec4ba985b3390145b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.20581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.20581%26sid%3Dliteratum%253Aachs%26aulast%3DEbelt%26aufirst%3DN.%2BD.%26aulast%3DKaoud%26aufirst%3DT.%2BS.%26aulast%3DEdupuganti%26aufirst%3DR.%26aulast%3DVan%2BRavenstein%26aufirst%3DS.%26aulast%3DDalby%26aufirst%3DK.%2BN.%26aulast%3DVan%2BDen%2BBerg%26aufirst%3DC.%2BL.%26atitle%3DA%2520c-jun%2520n-terminal%2520kinase%2520inhibitor%252C%2520jnk-in-8%252C%2520sensitizes%2520triple%2520negative%2520breast%2520cancer%2520cells%2520to%2520lapatinib%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D104894%26epage%3D104912%26doi%3D10.18632%2Foncotarget.20581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Known purine-based MPS1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Scheme<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sup>2</sup>-amine, ethanol, DIPEA, 80 °C; (b) R<sup>1</sup>-amine, Pd<sub>2</sub>(dba)<sub>3</sub>, XPhos, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 100 °C; (c) TFA, DCM, NH<sub>4</sub>OH, and MeOH.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structure of MPS1 kinase with <b>7</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CIL">7CIL</a>). The compound has water-mediated hydrogen bonding interaction with K553 and D664. Compound <b>7</b> is shown with magenta carbon atoms. Selected amino acids that contact the ligands are shown with yellow carbon atoms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray cocrystal structure of compound <b>8</b> (white) with MPS1 kinase (yellow carbon color shows the interaction residues of the X-ray structure; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHM">7CHM</a>). The docking pose of <b>8</b> was different from the real X-ray structure (docking model of <b>8</b> and P673; light-blue line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray cocrystal structure of <b>9</b> with MPS1 kinase (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHN">7CHN</a>). The cyclohexyl functional group interacts with activation loop including P673. Compound <b>9</b> is shown with carbon atoms in blue color, and yellow carbon color shows the interaction residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray cocrystal structures of <b>9</b> (blue sphere; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHN">7CHN</a>) and <b>28</b> (green sphere; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CJA">7CJA</a>) with MPS1 kinase. (A) <b>9</b> can tightly bind with the MPS1 protein. (B) <b>28</b> could not occupy the whole pocket space made by the activation loop (white circle).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray cocrystal structure of <b>30</b> (whitish blue; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHT">7CHT</a>). The carbonyl functional group of the lactam interacts with K529 by hydrogen bonding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Superimposed crystal structure of the MPS1 proteins of <b>9</b> (green; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHN">7CHN</a>) and <b>19</b> (pink; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CLH">7CLH</a>). The position of activation loops differs depending on the compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. MPS1 substrate phosphorylation inhibition after treatment with <b>9</b> and CFI402257.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/medium/jm1c00542_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. MDA-MB-231 tumor xenograft studies with QD dosing of <b>9</b>, which is compared with paclitaxel (weekly once dose).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00542/20210520/images/large/jm1c00542_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00542&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 21 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spring, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wander, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zangardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardia, A.</span></span> <span> </span><span class="NLM_article-title">Cdk 4/6 inhibitors in breast cancer: current controversies and future directions</span>. <i>Curr. Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1007/s11912-019-0769-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1007%2Fs11912-019-0769-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=30806829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A280%3ADC%252BB3cfnslaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=25-33&author=L.+M.+Springauthor=S.+A.+Wanderauthor=M.+Zangardiauthor=A.+Bardia&title=Cdk+4%2F6+inhibitors+in+breast+cancer%3A+current+controversies+and+future+directions&doi=10.1007%2Fs11912-019-0769-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions</span></div><div class="casAuthors">Spring Laura M; Wander Seth A; Zangardi Mark; Bardia Aditya</div><div class="citationInfo"><span class="NLM_cas:title">Current oncology reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  To describe the clinical role of CDK 4/6 inhibitors in hormone receptor-positive (HR+) metastatic breast cancer (HR+ MBC) as well as current controversies and evolving areas of research.  RECENT FINDINGS:  Palbociclib, ribociclib, and abemaciclib are each approved in combination with an aromatase inhibitor or fulvestrant for HR+ MBC.  Abemaciclib is also approved as monotherapy for pre-treated patients.  Key questions in the field include whether all patients with HR+ MBC should receive a CDK 4/6 inhibitor up front versus later line, impact on overall survival, role of continued CDK 4/6 blockade, mechanism of clinical resistance, and treatment sequencing.  The development of CDK 4/6 inhibitors has changed the therapeutic management of HR+ MBC.  Additional research is needed to determine optimal treatment sequencing, understand mechanisms governing resistance, and develop novel therapeutic strategies to circumvent or overcome clinical resistance and further improve the outcomes of patients with MBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrxfgSXVsVydenUz0lpNqnfW6udTcc2ea15xF4SLGbhLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfnslaktQ%253D%253D&md5=10c94359ea71ad1fc523c3ea452591a3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11912-019-0769-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11912-019-0769-3%26sid%3Dliteratum%253Aachs%26aulast%3DSpring%26aufirst%3DL.%2BM.%26aulast%3DWander%26aufirst%3DS.%2BA.%26aulast%3DZangardi%26aufirst%3DM.%26aulast%3DBardia%26aufirst%3DA.%26atitle%3DCdk%25204%252F6%2520inhibitors%2520in%2520breast%2520cancer%253A%2520current%2520controversies%2520and%2520future%2520directions%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2019%26volume%3D21%26spage%3D25%26epage%3D33%26doi%3D10.1007%2Fs11912-019-0769-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isakoff, S. J.</span></span> <span> </span><span class="NLM_article-title">Triple-negative breast cancer role of specific chemotherapy agents</span>. <i>Cancer J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1097/ppo.0b013e3181d24ff7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1097%2FPPO.0b013e3181d24ff7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=20164691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVKktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=53-61&author=S.+J.+Isakoff&title=Triple-negative+breast+cancer+role+of+specific+chemotherapy+agents&doi=10.1097%2Fppo.0b013e3181d24ff7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Triple-negative breast cancer: role of specific chemotherapy agents</span></div><div class="casAuthors">Isakoff, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Journal (Hagerstown, MD, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-61</span>CODEN:
                <span class="NLM_cas:coden">CAJOCB</span>;
        ISSN:<span class="NLM_cas:issn">1528-9117</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Cytotoxic chemotherapy remains the mainstay of treatment for triple-neg. breast cancer (TNBC) despite the promise of new targeted and biol. agents.  Many studies have shown significant benefit of chemotherapy in the neoadjuvant, adjuvant, and metastatic treatment of TNBC.  Neoadjuvant chemotherapy studies have consistently reported higher response rates in TNBC than non-TNBC, and pathol. complete response has been shown to predict improved long-term outcomes for TNBC.  Although the specific adjuvant regimens that may be most effective for TNBC are still being detd., third-generation chemotherapy regimens using dose dense or metronomic polychemotherapy are among the most effective tools presently available.  The role of specific chemotherapy agents in the treatment of TNBC remains incompletely defined and warrants careful review to ensure that the most effective therapy is delivered while minimizing unnecessary toxicity.  Platinum agents have seen renewed interest in TNBC based on a growing body of preclin. and clin. data suggesting encouraging activity.  Taxanes and anthracyclines are active in TNBC and remain important agents but have not shown specific benefit over non-TNBC.  Capecitabine has limited reported data in TNBC, but some reports suggest differential activity in TNBC compared with hormone receptor-pos. breast cancer.  TNBC is itself a heterogeneous group in which subgroups such as BRCA1 mutation carriers may have particular sensitivity to platinum agents and relatively less sensitivity to taxanes.  Therefore, the identification of addnl. mol. biomarkers to predict response to specific chemotherapy is required to further improve treatment strategies with the current menu of chemotherapy options and future combinations with targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_j84tQBAAnLVg90H21EOLACvtfcHk0lhI-l04GIvVkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVKktLw%253D&md5=0f903f4449b6c657392cb0a129ac185c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1097%2FPPO.0b013e3181d24ff7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FPPO.0b013e3181d24ff7%26sid%3Dliteratum%253Aachs%26aulast%3DIsakoff%26aufirst%3DS.%2BJ.%26atitle%3DTriple-negative%2520breast%2520cancer%2520role%2520of%2520specific%2520chemotherapy%2520agents%26jtitle%3DCancer%2520J.%26date%3D2010%26volume%3D16%26spage%3D53%26epage%3D61%26doi%3D10.1097%2Fppo.0b013e3181d24ff7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thu, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ba-Alawi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elia, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mer, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smirnov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safikhani, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haibe-Kains, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescon, D. W.</span></span> <span> </span><span class="NLM_article-title">Disruption of the anaphase-promoting complex confers resistance to ttk inhibitors in triple-negative breast cancer</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">E1570</span>– <span class="NLM_lpage">E1577</span>, <span class="refDoi"> DOI: 10.1073/pnas.1719577115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1073%2Fpnas.1719577115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=29378962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWjtbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=E1570-E1577&author=K.+L.+Thuauthor=J.+Silvesterauthor=M.+J.+Elliottauthor=W.+Ba-Alawiauthor=M.+H.+Duncanauthor=A.+C.+Eliaauthor=A.+S.+Merauthor=P.+Smirnovauthor=Z.+Safikhaniauthor=B.+Haibe-Kainsauthor=T.+W.+Makauthor=D.+W.+Cescon&title=Disruption+of+the+anaphase-promoting+complex+confers+resistance+to+ttk+inhibitors+in+triple-negative+breast+cancer&doi=10.1073%2Fpnas.1719577115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer</span></div><div class="casAuthors">Thu, K. L.; Silvester, J.; Elliott, M. J.; Ba-alawi, W.; Duncan, M. H.; Elia, A. C.; Mer, A. S.; Smirnov, P.; Safikhani, Z.; Haibe-Kains, B.; Mak, T. W.; Cescon, D. W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">E1570-E1577</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">TTK protein kinase (TTK), also known as Monopolar spindle 1 (MPS1), is a key regulator of the spindle assembly checkpoint (SAC), which functions to maintain genomic integrity.  TTK has emerged as a promising therapeutic target in human cancers, including triple-neg. breast cancer (TNBC).  Several TTK inhibitors (TTKis) are being evaluated in clin. trials, and an understanding of the mechanisms mediating TTKi sensitivity and resistance could inform the successful development of this class of agents.  We evaluated the cellular effects of the potent clin. TTKi CFI-402257 in TNBC models.  CFI-402257 induced apoptosis and potentiated aneuploidy in TNBC lines by accelerating progression through mitosis and inducing mitotic segregation errors.  We used genome-wide CRISPR/Cas9 screens in multiple TNBC cell lines to identify mechanisms of resistance to CFI-402257.  Our functional genomic screens identified members of the anaphase-promoting complex/cyclosome (APC/C) complex, which promotes mitotic progression following inactivation of the SAC.  Several screen candidates were validated to confer resistance to CFI-402257 and other TTKis using CRISPR/Cas9 and siRNA methods.  These findings extend the observation that impairment of the APC/C enables cells to tolerate genomic instability caused by SAC inactivation, and support the notion that a measure of APC/C function could predict the response to TTK inhibition.  Indeed, an APC/C gene expression signature is significantly assocd. with CFI-402257 response in breast and lung adenocarcinoma cell line panels.  This expression signature, along with somatic alterations in genes involved in mitotic progression, represent potential biomarkers that could be evaluated in ongoing clin. trials of CFI-402257 or other TTKis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokADygOqo097Vg90H21EOLACvtfcHk0lj9M2nETBs2pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWjtbbO&md5=658a55fa8061a50192417f7b51357c62</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1719577115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1719577115%26sid%3Dliteratum%253Aachs%26aulast%3DThu%26aufirst%3DK.%2BL.%26aulast%3DSilvester%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DM.%2BJ.%26aulast%3DBa-Alawi%26aufirst%3DW.%26aulast%3DDuncan%26aufirst%3DM.%2BH.%26aulast%3DElia%26aufirst%3DA.%2BC.%26aulast%3DMer%26aufirst%3DA.%2BS.%26aulast%3DSmirnov%26aufirst%3DP.%26aulast%3DSafikhani%26aufirst%3DZ.%26aulast%3DHaibe-Kains%26aufirst%3DB.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DCescon%26aufirst%3DD.%2BW.%26atitle%3DDisruption%2520of%2520the%2520anaphase-promoting%2520complex%2520confers%2520resistance%2520to%2520ttk%2520inhibitors%2520in%2520triple-negative%2520breast%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2018%26volume%3D115%26spage%3DE1570%26epage%3DE1577%26doi%3D10.1073%2Fpnas.1719577115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saavedra, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, J. T.</span></span> <span> </span><span class="NLM_article-title">Ttk promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer</span>. <i>Oncogenesis</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1038/s41389-018-0077-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1038%2Fs41389-018-0077-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=30206215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A280%3ADC%252BB3c3nvFWrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=69-81&author=J.+L.+Kingauthor=B.+Zhangauthor=Y.+Liauthor=K.+P.+Liauthor=J.+J.+Niauthor=H.+I.+Saavedraauthor=J.+T.+Dong&title=Ttk+promotes+mesenchymal+signaling+via+multiple+mechanisms+in+triple+negative+breast+cancer&doi=10.1038%2Fs41389-018-0077-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer</span></div><div class="casAuthors">King Jamie L; Zhang Baotong; Li Yixiang; Li Kathy P; Ni Jianping J; Dong Jin-Tang; King Jamie L; Li Yixiang; Dong Jin-Tang; Saavedra Harold I</div><div class="citationInfo"><span class="NLM_cas:title">Oncogenesis</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">69</span>
        ISSN:<span class="NLM_cas:issn">2157-9024</span>.
    </div><div class="casAbstract">Abnormal expression of TTK kinase has been associated with the initiation, progression, and therapeutic resistance of breast and other cancers, but its roles remain to be clarified.  In this study, we examined the role of TTK in triple negative breast cancer (TNBC), and found that higher TTK expression correlated with mesenchymal and proliferative phenotypes in TNBC cells.  Pharmacologic inhibition and genomic silencing of TTK not only reversed the epithelial-to-mesenchymal transition (EMT) in TNBC cells, but also increased the expression of KLF5, an effector of TGF-β signaling and inhibitor of EMT.  In addition, TTK inhibition decreased the expression of EMT-associated micro-RNA miR-21 but increased the expression of miR-200 family members and suppressed TGF-β signaling.  To test if upregulation of KLF5 plays a role in TTK-induced EMT, TTK and KLF5 were silenced simultaneously, which reversed the decreased EMT caused by loss of TTK.  Consistently, the decrease in miR-21 expression and increase in miR-200 expression caused by TTK silencing were rescued by loss of KLF5.  Altogether, this study highlights a novel role and signaling pathway for TTK in regulating EMT of TN breast cancer cells through TGF-β and KLF5 signaling, highlighting targetable signaling pathways for TTK inhibitors in aggressive breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQF382y4lQtoS6Ufuk_1xoTfW6udTcc2eazp7F-DMdCRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3nvFWrtg%253D%253D&md5=f8cd4a9025d749d00b468596e29d5bdf</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fs41389-018-0077-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41389-018-0077-z%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%2BP.%26aulast%3DNi%26aufirst%3DJ.%2BJ.%26aulast%3DSaavedra%26aufirst%3DH.%2BI.%26aulast%3DDong%26aufirst%3DJ.%2BT.%26atitle%3DTtk%2520promotes%2520mesenchymal%2520signaling%2520via%2520multiple%2520mechanisms%2520in%2520triple%2520negative%2520breast%2520cancer%26jtitle%3DOncogenesis%26date%3D2018%26volume%3D7%26spage%3D69%26epage%3D81%26doi%3D10.1038%2Fs41389-018-0077-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><a href="https://clinicaltrials.gov/ct2/show/NCT03411161" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03411161</a> (accessed 16
April 2021).web</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03411161+%28accessed+16%0AApril+2021%29.web"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innocenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K.-M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G. W.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cronin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Haven
Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Fee, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broccatelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span> <span> </span><span class="NLM_article-title">Introduction of a methyl group curbs metabolism of pyrido[3,4-<i>d</i>]pyrimidine monopolar spindle 1 (mps1) inhibitors and enables the discovery of the phase 1 clinical candidate N(2)-(2-ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N(8)-neopentylpyrido[3,4-<i>d</i>]pyrimidine-2,8-diamine (bos172722)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8226</span>– <span class="NLM_lpage">8240</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00690</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00690" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Kku7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8226-8240&author=H.+L.+Woodwardauthor=P.+Innocentiauthor=K.-M.+J.+Cheungauthor=A.+Hayesauthor=J.+Robertsauthor=A.+T.+Henleyauthor=A.+Faisalauthor=G.+W.-Y.+Makauthor=G.+Boxauthor=I.+M.+Westwoodauthor=N.+Croninauthor=M.+Carterauthor=M.+Valentiauthor=A.+De+Haven%0ABrandonauthor=L.+O%E2%80%99Feeauthor=H.+Savilleauthor=J.+Schmittauthor=R.+Burkeauthor=F.+Broccatelliauthor=R.+L.+M.+van+Montfortauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=S.+Linardopoulosauthor=J.+Blaggauthor=S.+Hoelder&title=Introduction+of+a+methyl+group+curbs+metabolism+of+pyrido%5B3%2C4-d%5Dpyrimidine+monopolar+spindle+1+%28mps1%29+inhibitors+and+enables+the+discovery+of+the+phase+1+clinical+candidate+N%282%29-%282-ethoxy-4-%284-methyl-4H-1%2C2%2C4-triazol-3-yl%29phenyl%29-6-methyl-N%288%29-neopentylpyrido%5B3%2C4-d%5Dpyrimidine-2%2C8-diamine+%28bos172722%29&doi=10.1021%2Facs.jmedchem.8b00690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4-d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N2-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N8-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine (BOS172722)</span></div><div class="casAuthors">Woodward, Hannah L.; Innocenti, Paolo; Cheung, Kwai-Ming J.; Hayes, Angela; Roberts, Jennie; Henley, Alan T.; Faisal, Amir; Mak, Grace Wing-Yan; Box, Gary; Westwood, Isaac M.; Cronin, Nora; Carter, Michael; Valenti, Melanie; De Haven Brandon, Alexis; O'Fee, Lisa; Saville, Harry; Schmitt, Jessica; Burke, Rosemary; Broccatelli, Fabio; van Montfort, Rob L. M.; Raynaud, Florence I.; Eccles, Suzanne A.; Linardopoulos, Spiros; Blagg, Julian; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8226-8240</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monopolar spindle (MPS1) occupies a central role in mitosis as one of the main components of the spindle assembly checkpoint.  The MPS1 kinase is an attractive cancer target and herein we report the discovery of the clin. candidate BOS172722.  The starting point for our work was a series of pyrido[3,4-d]pyrimidine inhibitors that demonstrated excellent potency and kinase selectivity but suffered from rapid turnover in human liver microsomes (HLM).  Optimizing HLM stability proved challenging since it was not possible to identify a consistent site of metab. and lowering lipophilicity proved unsuccessful.  Key to overcoming this problem was the finding that introduction of a Me group at the 6-position of the pyrido[3,4-d]pyrimidine core significantly improved HLM stability.  Met ID studies suggested that the Me group suppressed metab. at the distant aniline portion of the mol., likely by blocking the preferred pharmacophore through which P 450 recognized the compd.  This work ultimately led to the discovery of BOS172722 as a Phase 1 clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGtOFZ_iiUQrVg90H21EOLACvtfcHk0lj9M2nETBs2pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Kku7jF&md5=7d899afeb61ab58f970b63b1313177ec</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00690%26sid%3Dliteratum%253Aachs%26aulast%3DWoodward%26aufirst%3DH.%2BL.%26aulast%3DInnocenti%26aufirst%3DP.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DHenley%26aufirst%3DA.%2BT.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%2BW.-Y.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DCronin%26aufirst%3DN.%26aulast%3DCarter%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Fee%26aufirst%3DL.%26aulast%3DSaville%26aufirst%3DH.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DBroccatelli%26aufirst%3DF.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DIntroduction%2520of%2520a%2520methyl%2520group%2520curbs%2520metabolism%2520of%2520pyrido%255B3%252C4-d%255Dpyrimidine%2520monopolar%2520spindle%25201%2520%2528mps1%2529%2520inhibitors%2520and%2520enables%2520the%2520discovery%2520of%2520the%2520phase%25201%2520clinical%2520candidate%2520N%25282%2529-%25282-ethoxy-4-%25284-methyl-4H-1%252C2%252C4-triazol-3-yl%2529phenyl%2529-6-methyl-N%25288%2529-neopentylpyrido%255B3%252C4-d%255Dpyrimidine-2%252C8-diamine%2520%2528bos172722%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8226%26epage%3D8240%26doi%3D10.1021%2Facs.jmedchem.8b00690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiarash, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Functional characterization of cfi-402257, a potent and selective mps1/ttk kinase inhibitor, for the treatment of cancer</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">3127</span>– <span class="NLM_lpage">3132</span>, <span class="refDoi"> DOI: 10.1073/pnas.1700234114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1073%2Fpnas.1700234114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=28270606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVyjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=3127-3132&author=J.+M.+Masonauthor=X.+Weiauthor=G.+C.+Fletcherauthor=R.+Kiarashauthor=R.+Brokxauthor=R.+Hodgsonauthor=I.+Beletskayaauthor=M.+R.+Brayauthor=T.+W.+Mak&title=Functional+characterization+of+cfi-402257%2C+a+potent+and+selective+mps1%2Fttk+kinase+inhibitor%2C+for+the+treatment+of+cancer&doi=10.1073%2Fpnas.1700234114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer</span></div><div class="casAuthors">Mason, Jacqueline M.; Wei, Xin; Fletcher, Graham C.; Kiarash, Reza; Brokx, Richard; Hodgson, Richard; Beletskaya, Irina; Bray, Mark R.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3127-3132</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Loss of cell-cycle control is a hallmark of human cancer.  Cell-cycle checkpoints are essential for maintaining genome integrity and balanced growth and division.  They are specifically deregulated in cancer cells and contain regulators that represent potential therapeutic targets.  Monopolar spindle 1 (Mps1; also known as TTK protein kinase) is a core component of the spindle assembly checkpoint (SAC), a genome-surveillance mechanism that is important for cell survival, and has emerged as a candidate target for anticancer therapy.  Here, the authors report the cellular and antitumor effects of CFI-402257, a potent (Mps1 Ki = 0.09±0.02 nM; cellular Mps1 EC50 = 6.5±0.5 nM), highly selective, and orally active small-mol. inhibitor of Mps1 that was identified through a drug-discovery program.  Human cancer cells treated with CFI-402257 exhibit effects consistent with Mps1 kinase inhibition, specifically SAC inactivation, leading to chromosome missegregation, aneuploidy, and ultimately cell death.  Oral administration of CFI-402257 in monotherapy or in combination with an anti-programmed cell death 1 (PD-1) antibody in mouse models of human cancer results in inhibition of tumor growth at doses that are well-tolerated.  The authors' findings provide a rationale for the clin. evaluation of CFI-402257 in patients with solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFQJ3eg_c-qLVg90H21EOLACvtfcHk0liUtXek84E7tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVyjsL8%253D&md5=bb9742c8d07314e7d3c322bef71ef0ff</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1700234114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1700234114%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DFletcher%26aufirst%3DG.%2BC.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DBrokx%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DFunctional%2520characterization%2520of%2520cfi-402257%252C%2520a%2520potent%2520and%2520selective%2520mps1%252Fttk%2520kinase%2520inhibitor%252C%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3D3127%26epage%3D3132%26doi%3D10.1073%2Fpnas.1700234114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosemund, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wengner, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemeister, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stöckigt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prechtl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briem, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquardt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirok, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jautelat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohlmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Montalván, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bömer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberspaecher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüning, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döhr, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raschke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreft, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mumberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegelbauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brands, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Nussbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koppitz, M.</span></span> <span> </span><span class="NLM_article-title">Treating cancer by spindle assembly checkpoint abrogation: discovery of two clinical candidates, bay 1161909 and bay 1217389, targeting mps1 kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">8025</span>– <span class="NLM_lpage">8042</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b02035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b02035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnslKgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=8025-8042&author=V.+K.+Schulzeauthor=U.+Klarauthor=D.+Kosemundauthor=A.+M.+Wengnerauthor=G.+Siemeisterauthor=D.+St%C3%B6ckigtauthor=R.+Neuhausauthor=P.+Lienauauthor=B.+Baderauthor=S.+Prechtlauthor=S.+J.+Holtonauthor=H.+Briemauthor=T.+Marquardtauthor=H.+Schirokauthor=R.+Jautelatauthor=R.+Bohlmannauthor=D.+Nguyenauthor=A.+E.+Fern%C3%A1ndez-Montalv%C3%A1nauthor=U.+B%C3%B6merauthor=U.+Eberspaecherauthor=M.+Br%C3%BCningauthor=O.+D%C3%B6hrauthor=M.+Raschkeauthor=B.+Kreftauthor=D.+Mumbergauthor=K.+Ziegelbauerauthor=M.+Brandsauthor=F.+von+Nussbaumauthor=M.+Koppitz&title=Treating+cancer+by+spindle+assembly+checkpoint+abrogation%3A+discovery+of+two+clinical+candidates%2C+bay+1161909+and+bay+1217389%2C+targeting+mps1+kinase&doi=10.1021%2Facs.jmedchem.9b02035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase</span></div><div class="casAuthors">Schulze, Volker K.; Klar, Ulrich; Kosemund, Dirk; Wengner, Antje M.; Siemeister, Gerhard; Stoeckigt, Detlef; Neuhaus, Roland; Lienau, Philip; Bader, Benjamin; Prechtl, Stefan; Holton, Simon J.; Briem, Hans; Marquardt, Tobias; Schirok, Hartmut; Jautelat, Rolf; Bohlmann, Rolf; Nguyen, Duy; Fernandez-Montalvan, Amaury E.; Boemer, Ulf; Eberspaecher, Uwe; Bruening, Michael; Doehr, Olaf; Raschke, Marian; Kreft, Bertolt; Mumberg, Dominik; Ziegelbauer, Karl; Brands, Michael; von Nussbaum, Franz; Koppitz, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">8025-8042</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of monopolar spindle 1 (MPS1) kinase represents a novel approach to cancer treatment: instead of arresting the cell cycle in tumor cells, cells are driven into mitosis irresp. of DNA damage and unattached/misattached chromosomes, resulting in aneuploidy and cell death.  Starting points for our optimization efforts with the goal to identify MPS1 inhibitors were two HTS hits from the distinct chem. series "triazolopyridines" and "imidazopyrazines".  The major initial issue of the triazolopyridine series was the moderate potency of the HTS hits.  The imidazopyrazine series displayed more than 10-fold higher potencies; however, in the early project phase, this series suffered from poor metabolic stability.  Here, we outline the evolution of the two hit series to clin. candidates BAY 1161909 (I) and BAY 1217389 (II), and reveal how both clin. candidates bind to the ATP site of MPS1 kinase, while addressing different pockets utilizing different binding interactions, along with their synthesis and preclin. characterization in selected in vivo efficacy models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq_7hRpVUQrbVg90H21EOLACvtfcHk0liUtXek84E7tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnslKgsLY%253D&md5=68edb5e4d5ffc731fcb890fa062c268e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b02035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b02035%26sid%3Dliteratum%253Aachs%26aulast%3DSchulze%26aufirst%3DV.%2BK.%26aulast%3DKlar%26aufirst%3DU.%26aulast%3DKosemund%26aufirst%3DD.%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DSt%25C3%25B6ckigt%26aufirst%3DD.%26aulast%3DNeuhaus%26aufirst%3DR.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DBader%26aufirst%3DB.%26aulast%3DPrechtl%26aufirst%3DS.%26aulast%3DHolton%26aufirst%3DS.%2BJ.%26aulast%3DBriem%26aufirst%3DH.%26aulast%3DMarquardt%26aufirst%3DT.%26aulast%3DSchirok%26aufirst%3DH.%26aulast%3DJautelat%26aufirst%3DR.%26aulast%3DBohlmann%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DD.%26aulast%3DFern%25C3%25A1ndez-Montalv%25C3%25A1n%26aufirst%3DA.%2BE.%26aulast%3DB%25C3%25B6mer%26aufirst%3DU.%26aulast%3DEberspaecher%26aufirst%3DU.%26aulast%3DBr%25C3%25BCning%26aufirst%3DM.%26aulast%3DD%25C3%25B6hr%26aufirst%3DO.%26aulast%3DRaschke%26aufirst%3DM.%26aulast%3DKreft%26aufirst%3DB.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DZiegelbauer%26aufirst%3DK.%26aulast%3DBrands%26aufirst%3DM.%26aulast%3Dvon%2BNussbaum%26aufirst%3DF.%26aulast%3DKoppitz%26aufirst%3DM.%26atitle%3DTreating%2520cancer%2520by%2520spindle%2520assembly%2520checkpoint%2520abrogation%253A%2520discovery%2520of%2520two%2520clinical%2520candidates%252C%2520bay%25201161909%2520and%2520bay%25201217389%252C%2520targeting%2520mps1%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D8025%26epage%3D8042%26doi%3D10.1021%2Facs.jmedchem.9b02035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelluma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manak, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deveraux, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kops, G. J. P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Small-molecule kinase inhibitors provide insight into mps1 cell cycle function</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.1038/nchembio.345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1038%2Fnchembio.345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=20383151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=359-368&author=N.+Kwiatkowskiauthor=N.+Jellumaauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=M.+S.+Manakauthor=M.+Kwonauthor=H.+G.+Choiauthor=T.+Simauthor=Q.+L.+Deverauxauthor=S.+Rottmannauthor=D.+Pellmanauthor=J.+V.+Shahauthor=G.+J.+P.+L.+Kopsauthor=S.+Knappauthor=N.+S.+Gray&title=Small-molecule+kinase+inhibitors+provide+insight+into+mps1+cell+cycle+function&doi=10.1038%2Fnchembio.345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span></div><div class="casAuthors">Kwiatkowski, Nicholas; Jelluma, Nannette; Filippakopoulos, Panagis; Soundararajan, Meera; Manak, Michael S.; Kwon, Mijung; Choi, Hwan Geun; Sim, Taebo; Deveraux, Quinn L.; Rottmann, Sabine; Pellman, David; Shah, Jagesh V.; Kops, Geert J. P. L.; Knapp, Stefan; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-368</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mps1, a dual-specificity kinase, is required for the proper functioning of the spindle assembly checkpoint and for the maintenance of chromosomal stability.  As Mps1 function has been implicated in numerous phases of the cell cycle, the development of a potent, selective small-mol. inhibitor of Mps1 should facilitate dissection of Mps1-related biol.  We describe the cellular effects and Mps1 cocrystal structures of new, selective small-mol. inhibitors of Mps1.  Consistent with RNAi studies, chem. inhibition of Mps1 leads to defects in Mad1 and Mad2 establishment at unattached kinetochores, decreased Aurora B kinase activity, premature mitotic exit and gross aneuploidy, without any evidence of centrosome duplication defects.  However, in U2OS cells having extra centrosomes (an abnormality found in some cancers), Mps1 inhibition increases the frequency of multipolar mitoses.  Lastly, Mps1 inhibitor treatment resulted in a decrease in cancer cell viability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUsnJhF04gwrVg90H21EOLACvtfcHk0ljA2Dq9ZV2pGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D&md5=965e5e5e4f85e21c5ec27b0ea9417914</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.345%26sid%3Dliteratum%253Aachs%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DJelluma%26aufirst%3DN.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DManak%26aufirst%3DM.%2BS.%26aulast%3DKwon%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DDeveraux%26aufirst%3DQ.%2BL.%26aulast%3DRottmann%26aufirst%3DS.%26aulast%3DPellman%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DJ.%2BV.%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSmall-molecule%2520kinase%2520inhibitors%2520provide%2520insight%2520into%2520mps1%2520cell%2520cycle%2520function%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D359%26epage%3D368%26doi%3D10.1038%2Fnchembio.345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tannous, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der
Stoop, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewandrowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiddingh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sol, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagerweij, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedekind, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niers, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barazas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, R. J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geerts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Witt Hamer, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagemann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandertop, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Tellingen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noske, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Würdinger, T.</span></span> <span> </span><span class="NLM_article-title">Effects of the selective mps1 inhibitor mps1-in-3 on glioblastoma sensitivity to antimitotic drugs</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">1322</span>– <span class="NLM_lpage">1331</span>, <span class="refDoi"> DOI: 10.1093/jnci/djt168</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1093%2Fjnci%2Fdjt168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=23940287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKgu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2013&pages=1322-1331&author=B.+A.+Tannousauthor=M.+Keramiauthor=P.+M.+Van+der%0AStoopauthor=N.+Kwiatkowskiauthor=J.+Wangauthor=W.+Zhouauthor=A.+F.+Kesslerauthor=G.+Lewandrowskiauthor=L.+Hiddinghauthor=N.+Solauthor=T.+Lagerweijauthor=L.+Wedekindauthor=J.+M.+Niersauthor=M.+Barazasauthor=R.+J.+A.+Nilssonauthor=D.+Geertsauthor=P.+C.+De+Witt+Hamerauthor=C.+Hagemannauthor=W.+P.+Vandertopauthor=O.+Van+Tellingenauthor=D.+P.+Noskeauthor=N.+S.+Grayauthor=T.+W%C3%BCrdinger&title=Effects+of+the+selective+mps1+inhibitor+mps1-in-3+on+glioblastoma+sensitivity+to+antimitotic+drugs&doi=10.1093%2Fjnci%2Fdjt168"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs</span></div><div class="casAuthors">Tannous, Bakhos A.; Kerami, Mariam; Van der Stoop, Petra M.; Kwiatkowski, Nicholas; Wang, Jinhua; Zhou, Wenjun; Kessler, Almuth F.; Lewandrowski, Grant; Hiddingh, Lotte; Sol, Nik; Lagerweij, Tonny; Wedekind, Laurine; Niers, Johanna M.; Barazas, Marco; Nilsson, R. Jonas A.; Geerts, Dirk; De Witt Hamer, Philip C.; Hagemann, Carsten; Vandertop, W. Peter; Van Tellingen, Olaf; Noske, David P.; Gray, Nathanael S.; Wuerdinger, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1322-1331</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Glioblastomas exhibit a high level of chemotherapeutic resistance, including to the antimitotic agents vincristine and taxol.  During the mitotic agent-induced arrest, glioblastoma cells are able to perform damage-control and self-repair to continue proliferation.  Monopolar spindle 1 (MPS1/TTK) is a checkpoint kinase and a gatekeeper of the mitotic arrest.  Methods We used glioblastoma cells to det. the expression of MPS1 and to det. the effects of MPS1 inhibition on mitotic errors and cell viability in combination with vincristine and taxol.  The effect of MPS1 inhibition was assessed in different orthotopic glioblastoma mouse models (n = 3-7 mice/group).  MPS1 expression levels were examd. in relation to patient survival.  Results Using publicly available gene expression data, we detd. that MPS1 overexpression corresponds pos. with tumor grade and neg. with patient survival (two-sided t test, P < .001).  Patients with high MPS1 expression (n = 203) had a median and mean survival of 487 and 913 days (95% confidence intervals [CI] = 751 to 1075), resp., and a 2-yr survival rate of 35%, whereas patients with intermediate MPS1 expression (n = 140) had a median and mean survival of 858 and 1183 days (95% CI = 1177 to 1189), resp., and a 2-yr survival rate of 56%.  We demonstrate that MPS1 inhibition by RNAi results in sensitization to antimitotic agents.  We developed a selective small-mol. inhibitor of MPS1, MPS1-IN-3, which caused mitotic aberrancies in glioblastoma cells and, in combination with vincristine, induced mitotic checkpoint override, increased aneuploidy, and augmented cell death.  MPS1-IN-3 sensitizes glioblastoma cells to vincristine in orthotopic mouse models (two-sided log-rank test, P < .01), resulting in prolonged survival without toxicity.  Conclusions Our results collectively demonstrate that MPS1, a putative therapeutic target in glioblastoma, can be selectively inhibited by MPS1-IN-3 sensitizing glioblastoma cells to antimitotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUG67Lkc5qcbVg90H21EOLACvtfcHk0ljA2Dq9ZV2pGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKgu7fK&md5=b7e51ef38e02d9fbf0ce0191af530b3a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjt168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjt168%26sid%3Dliteratum%253Aachs%26aulast%3DTannous%26aufirst%3DB.%2BA.%26aulast%3DKerami%26aufirst%3DM.%26aulast%3DVan%2Bder%2BStoop%26aufirst%3DP.%2BM.%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DKessler%26aufirst%3DA.%2BF.%26aulast%3DLewandrowski%26aufirst%3DG.%26aulast%3DHiddingh%26aufirst%3DL.%26aulast%3DSol%26aufirst%3DN.%26aulast%3DLagerweij%26aufirst%3DT.%26aulast%3DWedekind%26aufirst%3DL.%26aulast%3DNiers%26aufirst%3DJ.%2BM.%26aulast%3DBarazas%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DR.%2BJ.%2BA.%26aulast%3DGeerts%26aufirst%3DD.%26aulast%3DDe%2BWitt%2BHamer%26aufirst%3DP.%2BC.%26aulast%3DHagemann%26aufirst%3DC.%26aulast%3DVandertop%26aufirst%3DW.%2BP.%26aulast%3DVan%2BTellingen%26aufirst%3DO.%26aulast%3DNoske%26aufirst%3DD.%2BP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DW%25C3%25BCrdinger%26aufirst%3DT.%26atitle%3DEffects%2520of%2520the%2520selective%2520mps1%2520inhibitor%2520mps1-in-3%2520on%2520glioblastoma%2520sensitivity%2520to%2520antimitotic%2520drugs%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2013%26volume%3D105%26spage%3D1322%26epage%3D1331%26doi%3D10.1093%2Fjnci%2Fdjt168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawant, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisk, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chettiar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darby, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brueggemeier, R. W.</span></span> <span> </span><span class="NLM_article-title">Novel pyrrolopyrimidines as mps1/ttk kinase inhibitors for breast cancer</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2156</span>– <span class="NLM_lpage">2166</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1016%2Fj.bmc.2017.02.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=28259529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1OrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=2156-2166&author=Y.+Sugimotoauthor=D.+B.+Sawantauthor=H.+A.+Fiskauthor=L.+Maoauthor=C.+Liauthor=S.+Chettiarauthor=P.-K.+Liauthor=M.+V.+Darbyauthor=R.+W.+Brueggemeier&title=Novel+pyrrolopyrimidines+as+mps1%2Fttk+kinase+inhibitors+for+breast+cancer&doi=10.1016%2Fj.bmc.2017.02.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Novel pyrrolopyrimidines as Mps1/TTK kinase inhibitors for breast cancer</span></div><div class="casAuthors">Sugimoto, Yasuro; Sawant, Dwitiya B.; Fisk, Harold A.; Mao, Liguang; Li, Chenglong; Chettiar, Somsundaram; Li, Pui-Kai; Darby, Michael V.; Brueggemeier, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2156-2166</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">New targeted therapy approaches for certain subtypes of breast cancer, such as triple-neg. breast cancers and other aggressive phenotypes, are desired.  High levels of the mitotic checkpoint kinase Mps1/TTK have correlated with high histol. grade in breast cancer, suggesting a potential new therapeutic target for aggressive breast cancers (BC).  Novel small mols. targeting Mps1 were designed by computer assisted docking analyses, and several candidate compds. were synthesized.  These compds. were evaluated in anti-proliferative assays of a panel of 15 breast cancer cell lines and further examd. for their ability to inhibit a variety of Mps1-dependent biol. functions.  The results indicate that the lead compds. have strong anti-proliferative potential through Mps1/TTK inhibition in both basal and luminal BC cell lines, exhibiting IC50 values ranging from 0.05 to 1.0 μM.  In addn., the lead compds. 1 and 13 inhibit Mps1 kinase enzymic activity with IC50 values from 0.356 μM to 0.809 μM, and inhibited Mps1-assocd. cellular functions such as centrosome duplication and the spindle checkpoint in triple neg. breast cancer cells.  The most promising analog, compd. 13, significantly decreased tumor growth in nude mice contg. Cal-51 triple neg. breast cancer cell xenografts.  Using drug discovery technologies, computational modeling, medicinal chem., cell culture and in vivo assays, novel small mol. Mps1/TTK inhibitors have been identified as potential targeted therapies for breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgeWzEbJTDiLVg90H21EOLACvtfcHk0ljA2Dq9ZV2pGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1OrsLs%253D&md5=627c45230117d6f261f2b098e8a9ebff</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DSawant%26aufirst%3DD.%2BB.%26aulast%3DFisk%26aufirst%3DH.%2BA.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DChettiar%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DP.-K.%26aulast%3DDarby%26aufirst%3DM.%2BV.%26aulast%3DBrueggemeier%26aufirst%3DR.%2BW.%26atitle%3DNovel%2520pyrrolopyrimidines%2520as%2520mps1%252Fttk%2520kinase%2520inhibitors%2520for%2520breast%2520cancer%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D2156%26epage%3D2166%26doi%3D10.1016%2Fj.bmc.2017.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riggs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cashion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehrani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deyanat-Yazdi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narla, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moghaddam, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahmanyar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagarigan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBrun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamberlain, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canan, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leftheris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boylan, J. F.</span></span> <span> </span><span class="NLM_article-title">The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8989</span>– <span class="NLM_lpage">9002</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01223</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01223" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1amu77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8989-9002&author=J.+R.+Riggsauthor=M.+Nagyauthor=J.+Elsnerauthor=P.+Erdmanauthor=D.+Cashionauthor=D.+Robinsonauthor=R.+Harrisauthor=D.+Huangauthor=L.+Tehraniauthor=G.+Deyanat-Yazdiauthor=R.+K.+Narlaauthor=X.+Pengauthor=T.+Tranauthor=L.+Barnesauthor=T.+Millerauthor=J.+Katzauthor=Y.+Tangauthor=M.+Chenauthor=M.+F.+Moghaddamauthor=S.+Bahmanyarauthor=B.+Pagariganauthor=S.+Delkerauthor=L.+LeBrunauthor=P.+P.+Chamberlainauthor=A.+Calabreseauthor=S.+S.+Cananauthor=K.+Leftherisauthor=D.+Zhuauthor=J.+F.+Boylan&title=The+Discovery+of+a+Dual+TTK+Protein+Kinase%2FCDC2-Like+Kinase+%28CLK2%29+Inhibitor+for+the+Treatment+of+Triple+Negative+Breast+Cancer+Initiated+from+a+Phenotypic+Screen&doi=10.1021%2Facs.jmedchem.7b01223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen</span></div><div class="casAuthors">Riggs, Jennifer R.; Nagy, Mark; Elsner, Jan; Erdman, Paul; Cashion, Dan; Robinson, Dale; Harris, Roy; Huang, Dehua; Tehrani, Lida; Deyanat-Yazdi, Gordafaried; Narla, Rama Krishna; Peng, Xiaohui; Tran, Tam; Barnes, Leo; Miller, Terra; Katz, Jason; Tang, Yang; Chen, Ming; Moghaddam, Mehran F.; Bahmanyar, Sogole; Pagarigan, Barbra; Delker, Silvia; LeBrun, Laurie; Chamberlain, Philip P.; Calabrese, Andrew; Canan, Stacie S.; Leftheris, Katerina; Zhu, Dan; Boylan, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8989-9002</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Triple neg. breast cancer (TNBC) remains a serious unmet medical need with discouragingly high relapse rates.  The authors report here the synthesis and structure-activity relationship (SAR) of a novel series of 2,4,5-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines with potent activity against TNBC tumor cell lines.  These compds. were discovered from a TNBC phenotypic screen and possess a unique dual inhibition profile targeting TTK (mitotic exit) and CLK2 (mRNA splicing).  Design and optimization, driven with a TNBC tumor cell assay, identified potent and selective compds. with favorable in vitro and in vivo activity profiles and good iv PK properties.  This cell-based driven SAR produced compds. with strong single agent in vivo efficacy in multiple TNBC xenograft models without significant body wt. loss.  These data supported the nomination of CC-671 (compd. I) into IND-enabling studies as a single agent TNBC therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZC5zKGXAFFLVg90H21EOLACvtfcHk0lgO_PwjmlK6kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1amu77E&md5=0e55c6e9ad0e57dd189cccfd19b574bc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01223%26sid%3Dliteratum%253Aachs%26aulast%3DRiggs%26aufirst%3DJ.%2BR.%26aulast%3DNagy%26aufirst%3DM.%26aulast%3DElsner%26aufirst%3DJ.%26aulast%3DErdman%26aufirst%3DP.%26aulast%3DCashion%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DD.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DDeyanat-Yazdi%26aufirst%3DG.%26aulast%3DNarla%26aufirst%3DR.%2BK.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DBarnes%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DKatz%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DMoghaddam%26aufirst%3DM.%2BF.%26aulast%3DBahmanyar%26aufirst%3DS.%26aulast%3DPagarigan%26aufirst%3DB.%26aulast%3DDelker%26aufirst%3DS.%26aulast%3DLeBrun%26aufirst%3DL.%26aulast%3DChamberlain%26aufirst%3DP.%2BP.%26aulast%3DCalabrese%26aufirst%3DA.%26aulast%3DCanan%26aufirst%3DS.%2BS.%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DBoylan%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520Discovery%2520of%2520a%2520Dual%2520TTK%2520Protein%2520Kinase%252FCDC2-Like%2520Kinase%2520%2528CLK2%2529%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Triple%2520Negative%2520Breast%2520Cancer%2520Initiated%2520from%2520a%2520Phenotypic%2520Screen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8989%26epage%3D9002%26doi%3D10.1021%2Facs.jmedchem.7b01223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riggs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cashion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehrani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fultz, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna Narla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahmanyar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condroski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagarigan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenalti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeBrun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leftheris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boylan, J. F.</span></span> <span> </span><span class="NLM_article-title">Design and optimization leading to an orally active ttk protein kinase inhibitor with robust single agent efficacy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4401</span>– <span class="NLM_lpage">4410</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01869</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01869" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvVGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4401-4410&author=J.+R.+Riggsauthor=J.+Elsnerauthor=D.+Cashionauthor=D.+Robinsonauthor=L.+Tehraniauthor=M.+Nagyauthor=K.+E.+Fultzauthor=R.+Krishna+Narlaauthor=X.+Pengauthor=T.+Tranauthor=A.+Kulkarniauthor=S.+Bahmanyarauthor=K.+Condroskiauthor=B.+Pagariganauthor=G.+Fenaltiauthor=L.+LeBrunauthor=K.+Leftherisauthor=D.+Zhuauthor=J.+F.+Boylan&title=Design+and+optimization+leading+to+an+orally+active+ttk+protein+kinase+inhibitor+with+robust+single+agent+efficacy&doi=10.1021%2Facs.jmedchem.8b01869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design and optimization leading to an orally active TTK protein kinase inhibitor with robust single agent efficacy</span></div><div class="casAuthors">Riggs, Jennifer R.; Elsner, Jan; Cashion, Dan; Robinson, Dale; Tehrani, Lida; Nagy, Mark; Fultz, Kimberly E.; Krishna Narla, Rama; Peng, Xiaohui; Tran, Tam; Kulkarni, Ashutosh; Bahmanyar, Sogole; Condroski, Kevin; Pagarigan, Barbra; Fenalti, Gustavo; LeBrun, Laurie; Leftheris, Katerina; Zhu, Dan; Boylan, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4401-4410</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Triple neg. breast cancer (TNBC) is an aggressive disease with high relapse rates and few treatment options.  Outlined in previous publications, we identified a series of potent, dual TTK/CLK2 inhibitors with strong efficacy in TNBC xenograft models.  Pharmacokinetic properties and kinome selectivity were optimized, resulting in the identification of a new series of potent, selective, and orally bioavailable TTK inhibitors.  We describe here the structure-activity relationship of the 2,4-disubstituted-7H-pyrrolo[2,3-d]pyrimidine series, leading to significant single agent efficacy in a TNBC xenograft model without body wt. loss.  The design effort evolving an iv-dosed TTK/CLK2 inhibitor to an orally bioavailable TTK inhibitor is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2GvWr4APbYLVg90H21EOLACvtfcHk0lgO_PwjmlK6kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvVGkur0%253D&md5=d72fcc3bc1da378b804738d83bf5133b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01869%26sid%3Dliteratum%253Aachs%26aulast%3DRiggs%26aufirst%3DJ.%2BR.%26aulast%3DElsner%26aufirst%3DJ.%26aulast%3DCashion%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DD.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DNagy%26aufirst%3DM.%26aulast%3DFultz%26aufirst%3DK.%2BE.%26aulast%3DKrishna%2BNarla%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DBahmanyar%26aufirst%3DS.%26aulast%3DCondroski%26aufirst%3DK.%26aulast%3DPagarigan%26aufirst%3DB.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLeBrun%26aufirst%3DL.%26aulast%3DLeftheris%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DBoylan%26aufirst%3DJ.%2BF.%26atitle%3DDesign%2520and%2520optimization%2520leading%2520to%2520an%2520orally%2520active%2520ttk%2520protein%2520kinase%2520inhibitor%2520with%2520robust%2520single%2520agent%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4401%26epage%3D4410%26doi%3D10.1021%2Facs.jmedchem.8b01869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uitdehaag, J. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Man, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemsen-Seegers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinsen, M. B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libouban, M. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterrenburg, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Wit, J. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de
Vetter, J. R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Roos, J. A. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buijsman, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, G. J. R.</span></span> <span> </span><span class="NLM_article-title">Target residence time-guided optimization on ttk kinase results in inhibitors with potent anti-proliferative activity</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>429</i></span>,  <span class="NLM_fpage">2211</span>– <span class="NLM_lpage">2230</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2017.05.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1016%2Fj.jmb.2017.05.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=28539250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1Wiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=429&publication_year=2017&pages=2211-2230&author=J.+C.+M.+Uitdehaagauthor=J.+de+Manauthor=N.+Willemsen-Seegersauthor=M.+B.+W.+Prinsenauthor=M.+A.+A.+Liboubanauthor=J.+G.+Sterrenburgauthor=J.+J.+P.+de+Witauthor=J.+R.+F.+de%0AVetterauthor=J.+A.+D.+M.+de+Roosauthor=R.+C.+Buijsmanauthor=G.+J.+R.+Zaman&title=Target+residence+time-guided+optimization+on+ttk+kinase+results+in+inhibitors+with+potent+anti-proliferative+activity&doi=10.1016%2Fj.jmb.2017.05.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative Activity</span></div><div class="casAuthors">Uitdehaag, Joost C. M.; de Man, Jos; Willemsen-Seegers, Nicole; Prinsen, Martine B. W.; Libouban, Marion A. A.; Sterrenburg, Jan Gerard; de Wit, Joeri J. P.; de Vetter, Judith R. F.; de Roos, Jeroen A. D. M.; Buijsman, Rogier C.; Zaman, Guido J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">429</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2211-2230</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The protein kinase threonine tyrosine kinase (TTK; also known as Mps1) is a crit. component of the spindle assembly checkpoint and a promising drug target for the treatment of aggressive cancers, such as triple neg. breast cancer.  While the first TTK inhibitors have entered clin. trials, little is known about how the inhibition of TTK with small-mol. compds. affects cellular activity.  The authors studied the selective TTK inhibitor NTRC 0066-0, which was developed in the authors' own lab., together with 11 TTK inhibitors developed by other companies, including Mps-BAY2b, BAY 1161909, BAY 1217389 (Bayer), TC-Mps1-12 (Shionogi), and MPI-0479605 (Myrexis).  Parallel testing shows that the cellular activity of these TTK inhibitors correlates with their binding affinity to TTK and, more strongly, with target residence time.  TTK inhibitors are therefore an example where target residence time dets. activity in in vitro cellular assays.  X-ray structures and thermal stability expts. reveal that the most potent compds. induce a shift of the glycine-rich loop as a result of binding to the catalytic lysine at position 553.  This "lysine trap" disrupts the catalytic machinery.  Based on these insights, the authors developed TTK inhibitors, based on a (5,6-dihydro)pyrimido[4,5-e]indolizine scaffold, with longer target residence times, which further exploit an allosteric pocket surrounding Lys 553.  Their binding mode is new for kinase inhibitors and can be classified as hybrid Type I/Type III.  These inhibitors have very potent anti-proliferative activity that rivals classic cytotoxic therapy.  The authors' findings will open up new avenues for more applications for TTK inhibitors in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT_6mZVMoVTrVg90H21EOLACvtfcHk0lg943wdscAauA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1Wiuro%253D&md5=c02b149e673dec7b0212b37a4c7b0831</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2017.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2017.05.014%26sid%3Dliteratum%253Aachs%26aulast%3DUitdehaag%26aufirst%3DJ.%2BC.%2BM.%26aulast%3Dde%2BMan%26aufirst%3DJ.%26aulast%3DWillemsen-Seegers%26aufirst%3DN.%26aulast%3DPrinsen%26aufirst%3DM.%2BB.%2BW.%26aulast%3DLibouban%26aufirst%3DM.%2BA.%2BA.%26aulast%3DSterrenburg%26aufirst%3DJ.%2BG.%26aulast%3Dde%2BWit%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3Dde%2BVetter%26aufirst%3DJ.%2BR.%2BF.%26aulast%3Dde%2BRoos%26aufirst%3DJ.%2BA.%2BD.%2BM.%26aulast%3DBuijsman%26aufirst%3DR.%2BC.%26aulast%3DZaman%26aufirst%3DG.%2BJ.%2BR.%26atitle%3DTarget%2520residence%2520time-guided%2520optimization%2520on%2520ttk%2520kinase%2520results%2520in%2520inhibitors%2520with%2520potent%2520anti-proliferative%2520activity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2017%26volume%3D429%26spage%3D2211%26epage%3D2230%26doi%3D10.1016%2Fj.jmb.2017.05.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tardif, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassiano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimbora, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douce, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorweiler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostanin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papac, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baichwal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlexander, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wettstein, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B. L.</span></span> <span> </span><span class="NLM_article-title">Characterization of the cellular and antitumor effects of mpi-0479605, a small-molecule inhibitor of the mitotic kinase mps1</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2267</span>– <span class="NLM_lpage">2275</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.mct-11-0453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1158%2F1535-7163.MCT-11-0453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=21980130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2267-2275&author=K.+D.+Tardifauthor=A.+Rogersauthor=J.+Cassianoauthor=B.+L.+Rothauthor=D.+M.+Cimboraauthor=R.+McKinnonauthor=A.+Petersonauthor=T.+B.+Douceauthor=R.+Robinsonauthor=I.+Dorweilerauthor=T.+Davisauthor=M.+A.+Hessauthor=K.+Ostaninauthor=D.+I.+Papacauthor=V.+Baichwalauthor=I.+McAlexanderauthor=J.+A.+Willardsenauthor=M.+Saundersauthor=H.+Christopheauthor=D.+V.+Kumarauthor=D.+A.+Wettsteinauthor=R.+O.+Carlsonauthor=B.+L.+Williams&title=Characterization+of+the+cellular+and+antitumor+effects+of+mpi-0479605%2C+a+small-molecule+inhibitor+of+the+mitotic+kinase+mps1&doi=10.1158%2F1535-7163.mct-11-0453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1</span></div><div class="casAuthors">Tardif, Keith D.; Rogers, Aaron; Cassiano, Jared; Roth, Bruce L.; Cimbora, Daniel M.; McKinnon, Rena; Peterson, Ashley; Douce, Thomas B.; Robinson, Rosann; Dorweiler, Irene; Davis, Thaylon; Hess, Mark A.; Ostanin, Kirill; Papac, Damon I.; Baichwal, Vijay; McAlexander, Ian; Willardsen, J. Adam; Saunders, Michael; Christophe, Hoarau; Kumar, D. Vijay; Wettstein, Daniel A.; Carlson, Robert O.; Williams, Brandi L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2267-2275</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mps1 is a dual specificity protein kinase that is essential for the bipolar attachment of chromosomes to the mitotic spindle and for maintaining the spindle assembly checkpoint until all chromosomes are properly attached.  Mps1 is expressed at high levels during mitosis and is abundantly expressed in cancer cells.  Disruption of Mps1 function induces aneuploidy and cell death.  We report the identification of MPI-0479605, a potent and selective ATP competitive inhibitor of Mps1.  Cells treated with MPI-0479605 undergo aberrant mitosis, resulting in aneuploidy and formation of micronuclei.  In cells with wild-type p53, this promotes the induction of a postmitotic checkpoint characterized by the ATM- and RAD3-related-dependent activation of the p53-p21 pathway.  In both wild-type and p53 mutant cells lines, there is a growth arrest and inhibition of DNA synthesis.  Subsequently, cells undergo mitotic catastrophe and/or an apoptotic response.  In xenograft models, MPI-0479605 inhibits tumor growth, suggesting that drugs targeting Mps1 may have utility as novel cancer therapeutics.  Mol Cancer Ther; 10(12); 2267-75.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMIODujnZWCLVg90H21EOLACvtfcHk0lg943wdscAauA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO&md5=e243764443e9dfda40fc84a329d776c2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0453%26sid%3Dliteratum%253Aachs%26aulast%3DTardif%26aufirst%3DK.%2BD.%26aulast%3DRogers%26aufirst%3DA.%26aulast%3DCassiano%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCimbora%26aufirst%3DD.%2BM.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DPeterson%26aufirst%3DA.%26aulast%3DDouce%26aufirst%3DT.%2BB.%26aulast%3DRobinson%26aufirst%3DR.%26aulast%3DDorweiler%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DHess%26aufirst%3DM.%2BA.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DPapac%26aufirst%3DD.%2BI.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DMcAlexander%26aufirst%3DI.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DChristophe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DD.%2BV.%26aulast%3DWettstein%26aufirst%3DD.%2BA.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DWilliams%26aufirst%3DB.%2BL.%26atitle%3DCharacterization%2520of%2520the%2520cellular%2520and%2520antitumor%2520effects%2520of%2520mpi-0479605%252C%2520a%2520small-molecule%2520inhibitor%2520of%2520the%2520mitotic%2520kinase%2520mps1%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2267%26epage%3D2275%26doi%3D10.1158%2F1535-7163.mct-11-0453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santaguida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tighe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Alise, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musacchio, A.</span></span> <span> </span><span class="NLM_article-title">Dissecting the role of mps1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1083/jcb.201001036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1083%2Fjcb.201001036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=20624901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVOhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2010&pages=73-87&author=S.+Santaguidaauthor=A.+Tigheauthor=A.+M.+D%E2%80%99Aliseauthor=S.+S.+Taylorauthor=A.+Musacchio&title=Dissecting+the+role+of+mps1+in+chromosome+biorientation+and+the+spindle+checkpoint+through+the+small+molecule+inhibitor+reversine&doi=10.1083%2Fjcb.201001036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine</span></div><div class="casAuthors">Santaguida, Stefano; Tighe, Anthony; D'Alise, Anna Morena; Taylor, Stephen S.; Musacchio, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-87</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The catalytic activity of the MPS1 kinase is crucial for the spindle assembly checkpoint and for chromosome biorientation on the mitotic spindle.  We report that the small mol. reversine is a potent mitotic inhibitor of MPS1.  Reversine inhibits the spindle assembly checkpoint in a dose-dependent manner.  Its addn. to mitotic HeLa cells causes the ejection of Mad1 and the ROD-ZWILCH-ZW10 complex, both of which are important for the spindle checkpoint, from unattached kinetochores.  By using reversine, we also demonstrate that MPS1 is required for the correction of improper chromosome-microtubule attachments.  We provide evidence that MPS1 acts downstream from the AURORA B kinase, another crucial component of the error correction pathway.  Our expts. describe a very useful tool to interfere with MPS1 activity in human cells.  They also shed light on the relationship between the error correction pathway and the spindle checkpoint and suggest that these processes are coregulated and are likely to share at least a subset of their catalytic machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPbUVMH1KC_7Vg90H21EOLACvtfcHk0liLjIC1rZH4_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVOhtL0%253D&md5=fd022c4a8a7284eb5da7d67b04a6f8bb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201001036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201001036%26sid%3Dliteratum%253Aachs%26aulast%3DSantaguida%26aufirst%3DS.%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Alise%26aufirst%3DA.%2BM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DMusacchio%26aufirst%3DA.%26atitle%3DDissecting%2520the%2520role%2520of%2520mps1%2520in%2520chromosome%2520biorientation%2520and%2520the%2520spindle%2520checkpoint%2520through%2520the%2520small%2520molecule%2520inhibitor%2520reversine%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2010%26volume%3D190%26spage%3D73%26epage%3D87%26doi%3D10.1083%2Fjcb.201001036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niesen, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berglund, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span> <span> </span><span class="NLM_article-title">The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2212</span>– <span class="NLM_lpage">2221</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1038%2Fnprot.2007.321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=17853878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFagsb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=2212-2221&author=F.+H.+Niesenauthor=H.+Berglundauthor=M.+Vedadi&title=The+use+of+differential+scanning+fluorimetry+to+detect+ligand+interactions+that+promote+protein+stability&doi=10.1038%2Fnprot.2007.321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability</span></div><div class="casAuthors">Niesen, Frank H.; Berglund, Helena; Vedadi, Masoud</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2212-2221</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Differential scanning fluorometry (DSF) is a rapid and inexpensive screening method to identify low-mol.-wt. ligands that bind and stabilize purified proteins.  The temp. at which a protein unfolds is measured by an increase in the fluorescence of a dye with affinity for hydrophobic parts of the protein, which are exposed as the protein unfolds.  A simple fitting procedure allows quick calcn. of the transition midpoint; the difference in the temp. of this midpoint in the presence and absence of ligand is related to the binding affinity of the small mol., which can be a low-mol.-wt. compd., a peptide or a nucleic acid.  DSF is best performed using a conventional real-time PCR instrument.  Ligand solns. from a storage plate are added to a soln. of protein and dye, distributed into the wells of the PCR plate and fluorescence intensity measured as the temp. is raised gradually.  Results can be obtained in a single day.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomViqp6Tq7krVg90H21EOLACvtfcHk0liLjIC1rZH4_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFagsb7N&md5=8a74dbb348ab81179614ab4ae5797d94</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.321%26sid%3Dliteratum%253Aachs%26aulast%3DNiesen%26aufirst%3DF.%2BH.%26aulast%3DBerglund%26aufirst%3DH.%26aulast%3DVedadi%26aufirst%3DM.%26atitle%3DThe%2520use%2520of%2520differential%2520scanning%2520fluorimetry%2520to%2520detect%2520ligand%2520interactions%2520that%2520promote%2520protein%2520stability%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D2212%26epage%3D2221%26doi%3D10.1038%2Fnprot.2007.321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faisal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrake, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavetsias, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atrash, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K.-M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurden, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haven Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAndrew, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matijssen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoelder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linardopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Montfort, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of orally bioavailable 1H-pyrrolo[3,2-c]pyridine inhibitors of mitotic kinase monopolar spindle 1 (mps1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">10045</span>– <span class="NLM_lpage">10065</span>, <span class="refDoi"> DOI: 10.1021/jm401395s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401395s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVShsLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10045-10065&author=S.+Naudauthor=I.+M.+Westwoodauthor=A.+Faisalauthor=P.+Sheldrakeauthor=V.+Bavetsiasauthor=B.+Atrashauthor=K.-M.+J.+Cheungauthor=M.+Liuauthor=A.+Hayesauthor=J.+Schmittauthor=A.+Woodauthor=V.+Choiauthor=K.+Boxallauthor=G.+Makauthor=M.+Gurdenauthor=M.+Valentiauthor=A.+de+Haven+Brandonauthor=A.+Henleyauthor=R.+Bakerauthor=C.+McAndrewauthor=B.+Matijssenauthor=R.+Burkeauthor=S.+Hoelderauthor=S.+A.+Ecclesauthor=F.+I.+Raynaudauthor=S.+Linardopoulosauthor=R.+L.+M.+van+Montfortauthor=J.+Blagg&title=Structure-based+design+of+orally+bioavailable+1H-pyrrolo%5B3%2C2-c%5Dpyridine+inhibitors+of+mitotic+kinase+monopolar+spindle+1+%28mps1%29&doi=10.1021%2Fjm401395s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)</span></div><div class="casAuthors">Naud, Sebastien; Westwood, Isaac M.; Faisal, Amir; Sheldrake, Peter; Bavetsias, Vassilios; Atrash, Butrus; Cheung, Kwai-Ming J.; Liu, Manjuan; Hayes, Angela; Schmitt, Jessica; Wood, Amy; Choi, Vanessa; Boxall, Kathy; Mak, Grace; Gurden, Mark; Valenti, Melanie; de Haven Brandon, Alexis; Henley, Alan; Baker, Ross; McAndrew, Craig; Matijssen, Berry; Burke, Rosemary; Hoelder, Swen; Eccles, Suzanne A.; Raynaud, Florence I.; Linardopoulos, Spiros; van Montfort, Rob L. M.; Blagg, Julian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10045-10065</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protein kinase MPS1 is a crucial component of the spindle assembly checkpoint signal and is aberrantly overexpressed in many human cancers.  MPS1 is one of the top 25 genes overexpressed in tumors with chromosomal instability and aneuploidy.  PTEN-deficient breast tumor cells are particularly dependent upon MPS1 for their survival, making it a target of significant interest in oncol.  The authors report the discovery and optimization of potent and selective MPS1 inhibitors based on the 1H-pyrrolo-[3,2-c]-pyridine scaffold, guided by structure-based design and cellular characterization of MPS1 inhibition, leading to CCT251455.  This potent and selective chem. tool stabilizes an inactive conformation of MPS1 with the activation loop ordered in a manner incompatible with ATP and substrate-peptide binding; it displays a favorable oral pharmacokinetic profile, shows dose-dependent inhibition of MPS1 in an HCT116 human tumor xenograft model, and is an attractive tool compd. to elucidate further the therapeutic potential of MPS1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVRsRcyzCEBLVg90H21EOLACvtfcHk0lhNNEkMww34gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVShsLzO&md5=6564efe14dec83774e94c355be756845</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm401395s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401395s%26sid%3Dliteratum%253Aachs%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DSheldrake%26aufirst%3DP.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DV.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DGurden%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DMcAndrew%26aufirst%3DC.%26aulast%3DMatijssen%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DStructure-based%2520design%2520of%2520orally%2520bioavailable%25201H-pyrrolo%255B3%252C2-c%255Dpyridine%2520inhibitors%2520of%2520mitotic%2520kinase%2520monopolar%2520spindle%25201%2520%2528mps1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10045%26epage%3D10065%26doi%3D10.1021%2Fjm401395s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, M. L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavas, L. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorova, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabernero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyers, P. A.</span></span> <span> </span><span class="NLM_article-title">Biophysical and x-ray crystallographic analysis of mps1 kinase inhibitor complexes</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1689</span>– <span class="NLM_lpage">1701</span>, <span class="refDoi"> DOI: 10.1021/bi901970c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi901970c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVyhu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1689-1701&author=M.+L.+H.+Chuauthor=Z.+Langauthor=L.+M.+G.+Chavasauthor=J.+Neresauthor=O.+S.+Fedorovaauthor=L.+Taberneroauthor=M.+Cherryauthor=D.+H.+Williamsauthor=K.+T.+Douglasauthor=P.+A.+Eyers&title=Biophysical+and+x-ray+crystallographic+analysis+of+mps1+kinase+inhibitor+complexes&doi=10.1021%2Fbi901970c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Biophysical and X-ray Crystallographic Analysis of Mps1 Kinase Inhibitor Complexes</span></div><div class="casAuthors">Chu, Matthew L. H.; Lang, Zhaolei; Chavas, Leonard M. G.; Neres, Joao; Fedorova, Olga S.; Tabernero, Lydia; Cherry, Mike; Williams, David H.; Douglas, Kenneth T.; Eyers, Patrick A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1689-1701</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dual-specificity protein kinase monopolar spindle 1 (Mps1) is a central component of the mitotic spindle assembly checkpoint (SAC), a sensing mechanism that prevents anaphase until all chromosomes are bioriented on the metaphase plate.  Partial depletion of Mps1 protein levels sensitizes transformed, but not untransformed, human cells to therapeutic doses of the anticancer agent Taxol, making it an attractive novel therapeutic cancer target.  We have previously detd. the x-ray structure of the catalytic domain of human Mps1 in complex with the anthrapyrazolone kinase inhibitor SP600125.  In order to validate distinct inhibitors that target this enzyme and improve our understanding of nucleotide binding site architecture, we now report a biophys. and structural evaluation of the Mps1 catalytic domain in the presence of ATP and the aspecific model kinase inhibitor staurosporine.  Collective in silico, enzymic, and fluorescent screens also identified several new lead quinazoline Mps1 inhibitors, including a low-affinity compd. termed Compd. 4 (Cpd 4), whose interaction with the Mps1 kinase domain was further characterized by x-ray crystallog.  A novel biophys. anal. demonstrated that the intrinsic fluorescence of SP600125 changed markedly upon Mps1 binding, allowing spectrophotometric displacement anal. and detn. of dissocn. consts. for ATP-competitive Mps1 inhibitors.  By illuminating the structure of the Mps1 ATP-binding site our results provide novel biophys. insights into Mps1-ligand interactions that will be useful for the development of specific Mps1 inhibitors, including those employing a therapeutically validated quinazoline template.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOzu1FDS9vwrVg90H21EOLACvtfcHk0lhNNEkMww34gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVyhu7Y%253D&md5=4cf60cff2d475fa0233d7519574d31d8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fbi901970c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi901970c%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DM.%2BL.%2BH.%26aulast%3DLang%26aufirst%3DZ.%26aulast%3DChavas%26aufirst%3DL.%2BM.%2BG.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3DFedorova%26aufirst%3DO.%2BS.%26aulast%3DTabernero%26aufirst%3DL.%26aulast%3DCherry%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DDouglas%26aufirst%3DK.%2BT.%26aulast%3DEyers%26aufirst%3DP.%2BA.%26atitle%3DBiophysical%2520and%2520x-ray%2520crystallographic%2520analysis%2520of%2520mps1%2520kinase%2520inhibitor%2520complexes%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D1689%26epage%3D1701%26doi%3D10.1021%2Fbi901970c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roorda, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joosten, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiruma, Y.</span></span> <span> </span><span class="NLM_article-title">A crystal structure of the human protein kinase mps1 reveals an ordered conformation of the activation loop</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">352</span>, <span class="refDoi"> DOI: 10.1002/prot.25651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.1002%2Fprot.25651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=30582207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlvVOmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2019&pages=348-352&author=J.+C.+Roordaauthor=R.+P.+Joostenauthor=A.+Perrakisauthor=Y.+Hiruma&title=A+crystal+structure+of+the+human+protein+kinase+mps1+reveals+an+ordered+conformation+of+the+activation+loop&doi=10.1002%2Fprot.25651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A crystal structure of the human protein kinase Mps1 reveals an ordered conformation of the activation loop</span></div><div class="casAuthors">Roorda, Jacomina C.; Joosten, Robbie P.; Perrakis, Anastassis; Hiruma, Yoshitaka</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">348-352</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>;
        ISSN:<span class="NLM_cas:issn">1097-0134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (Mps1) is a dual-specificity protein kinase, orchestrating faithful chromosome segregation during mitosis.  All reported structures of the Mps1 kinase adopt the hallmarks of an inactive conformation, which includes a mostly disordered activation loop.  Here, we present a 2.4 Å resoln. crystal structure of an "extended" version of the Mps1 kinase domain, which shows an ordered activation loop.  However, the other structural characteristics of an active kinase are not present.  Our structure shows that the Mps1 activation loop can fit to the ATP binding pocket and interferes with ATP, but less so with inhibitors binding, partly explain the potency of various Mps1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4ShF4RiGVE7Vg90H21EOLACvtfcHk0lhNNEkMww34gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlvVOmsA%253D%253D&md5=813fe6deb987db9009039d56c95db247</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fprot.25651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.25651%26sid%3Dliteratum%253Aachs%26aulast%3DRoorda%26aufirst%3DJ.%2BC.%26aulast%3DJoosten%26aufirst%3DR.%2BP.%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DHiruma%26aufirst%3DY.%26atitle%3DA%2520crystal%2520structure%2520of%2520the%2520human%2520protein%2520kinase%2520mps1%2520reveals%2520an%2520ordered%2520conformation%2520of%2520the%2520activation%2520loop%26jtitle%3DProteins%26date%3D2019%26volume%3D87%26spage%3D348%26epage%3D352%26doi%3D10.1002%2Fprot.25651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ebelt, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaoud, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edupuganti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ravenstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalby, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Berg, C. L.</span></span> <span> </span><span class="NLM_article-title">A c-jun n-terminal kinase inhibitor, jnk-in-8, sensitizes triple negative breast cancer cells to lapatinib</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">104894</span>– <span class="NLM_lpage">104912</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.20581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=10.18632%2Foncotarget.20581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=29285221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;key=1%3ACAS%3A280%3ADC%252BC1MzlvVynug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=104894-104912&author=N.+D.+Ebeltauthor=T.+S.+Kaoudauthor=R.+Edupugantiauthor=S.+Van+Ravensteinauthor=K.+N.+Dalbyauthor=C.+L.+Van+Den+Berg&title=A+c-jun+n-terminal+kinase+inhibitor%2C+jnk-in-8%2C+sensitizes+triple+negative+breast+cancer+cells+to+lapatinib&doi=10.18632%2Foncotarget.20581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib</span></div><div class="casAuthors">Ebelt Nancy D; Van Den Berg Carla L; Ebelt Nancy D; Kaoud Tamer S; Edupuganti Ramakrishna; Van Ravenstein Sabrina; Dalby Kevin N; Kaoud Tamer S; Van Den Berg Carla L</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">62</span>),
    <span class="NLM_cas:pages">104894-104912</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Triple negative breast cancers (TNBC) have poor prognosis compared to other breast cancer subtypes and represent 15-20% of breast cancers diagnosed.  Unique targets and new molecularly-targeted therapies are urgently needed for this subtype.  Despite high expression of Epidermal Growth Factor Receptor, inhibitors such as lapatinib have not shown therapeutic efficacy in TNBC patients.  Herein, we report that treatment with the covalent JNK inhibitor, JNK-IN-8, synergizes with lapatinib to cause cell death, while these compounds as single agents have little effect.  The combination significantly increases survival of mice bearing xenografts of MDA-MB-231 human TNBC cells.  Our studies demonstrate that lapatinib treatment increases c-Jun and JNK phosphorylation indicating a mechanism of resistance.  Combined, these compounds significantly reduce transcriptional activity of Nuclear Factor kappa B, Activating Protein 1, and Nuclear factor erythroid 2-Related Factor 2.  As master regulators of antioxidant response, their decreased activity induces a 10-fold increase in reactive oxygen species that is cytotoxic, and is rescued by addition of exogenous antioxidants.  Over expression of p65 or Nrf2 also significantly rescues viability during JNK-IN-8 and lapatinib treatment.  Further studies combining JNK-IN-8 and lapatinib may reveal a benefit for patients with TNBC, fulfilling a critical medical need.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6Zmm-z5wHBBpyrDyM_m9cfW6udTcc2ebhJQ96jb0Hy7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzlvVynug%253D%253D&md5=85d59d746549e5dec4ba985b3390145b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.20581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.20581%26sid%3Dliteratum%253Aachs%26aulast%3DEbelt%26aufirst%3DN.%2BD.%26aulast%3DKaoud%26aufirst%3DT.%2BS.%26aulast%3DEdupuganti%26aufirst%3DR.%26aulast%3DVan%2BRavenstein%26aufirst%3DS.%26aulast%3DDalby%26aufirst%3DK.%2BN.%26aulast%3DVan%2BDen%2BBerg%26aufirst%3DC.%2BL.%26atitle%3DA%2520c-jun%2520n-terminal%2520kinase%2520inhibitor%252C%2520jnk-in-8%252C%2520sensitizes%2520triple%2520negative%2520breast%2520cancer%2520cells%2520to%2520lapatinib%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D104894%26epage%3D104912%26doi%3D10.18632%2Foncotarget.20581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N7V" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5N7V','PDB','5N7V'); return false;">PDB: 5N7V</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LJJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LJJ','PDB','5LJJ'); return false;">PDB: 5LJJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AP2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AP2','PDB','5AP2'); return false;">PDB: 5AP2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZEG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZEG','PDB','4ZEG'); return false;">PDB: 4ZEG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CIL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CIL','PDB','7CIL'); return false;">PDB: 7CIL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WZJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WZJ','PDB','3WZJ'); return false;">PDB: 3WZJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHM','PDB','7CHM'); return false;">PDB: 7CHM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHN','PDB','7CHN'); return false;">PDB: 7CHN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AP1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AP1','PDB','5AP1'); return false;">PDB: 5AP1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JS8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JS8','PDB','4JS8'); return false;">PDB: 4JS8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4C4J','PDB','4C4J'); return false;">PDB: 4C4J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HMN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HMN','PDB','3HMN'); return false;">PDB: 3HMN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CJA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CJA','PDB','7CJA'); return false;">PDB: 7CJA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CHT','PDB','7CHT'); return false;">PDB: 7CHT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CLH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7CLH','PDB','7CLH'); return false;">PDB: 7CLH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B4W" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B4W','PDB','6B4W'); return false;">PDB: 6B4W</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i46"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00542">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_04686"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00542?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00542</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures; the comparison of enzymatic and thermal shift assay of compounds; correlation of activity evaluation methods; kinase profiling results of <b>8</b> and <b>9</b>; cell proliferation and other enzymatic activity of <b>9</b>; plasma and tumor concentration of MDA-MB-231 xenograft model; crystallographic data for <b>7</b>, <b>8</b>, <b>9</b>, <b>19</b>, <b>28</b>, and <b>30</b>; expression of MPS1 in cancer cell lines; histological features of the representative small intestine of each group; and villous length of the individuals in each group (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_002.csv">CSV</a>)</p></li><li><p class="inline">Molecular docking model of <b>7</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Molecular docking model of <b>8</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_004.pdb">PDB</a>)</p></li><li><p class="inline">HPLC–MS result of compound <b>9</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_005.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_001.pdf">jm1c00542_si_001.pdf (842.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_002.csv">jm1c00542_si_002.csv (2.18 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_003.pdb">jm1c00542_si_003.pdb (349.69 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_004.pdb">jm1c00542_si_004.pdb (351.67 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00542/suppl_file/jm1c00542_si_005.pdf">jm1c00542_si_005.pdf (78.7 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00542&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-10%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00542%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00542" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a94c2886f3d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
